e10vq
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
|
|
|
þ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2009
OR
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 000-22339
RAMBUS INC.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
(State or other jurisdiction of
incorporation or organization)
|
|
94-3112828
(I.R.S. Employer
Identification No.) |
|
|
|
4440 El Camino Real, Los Altos, CA 94022
(Address of principal executive offices) (zip code)
Registrants telephone number, including area code: (650) 947-5000
Indicate by check mark whether the registrant (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant has submitted electronically and posted on its
corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months
(or for such shorter period that the registrant was required to submit and post such files). Yes
o No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large
accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the
Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer þ |
|
Accelerated filer o |
|
Non-accelerated filer o
(Do not check if a smaller reporting company) |
|
Smaller reporting company o |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of
the Exchange Act). Yes o No þ
The number of shares outstanding of the registrants Common Stock, par value $.001 per share,
was 104,900,875 as of June 30, 2009.
RAMBUS INC.
TABLE OF CONTENTS
|
|
|
|
|
|
|
PAGE |
|
|
|
3 |
|
PART I. FINANCIAL INFORMATION |
|
|
|
|
Item 1. Financial Statements: |
|
|
|
|
|
|
|
5 |
|
|
|
|
6 |
|
|
|
|
7 |
|
|
|
|
8 |
|
|
|
|
35 |
|
|
|
|
44 |
|
|
|
|
45 |
|
|
|
|
46 |
|
|
|
|
46 |
|
|
|
|
46 |
|
|
|
|
62 |
|
|
|
|
62 |
|
|
|
|
63 |
|
|
|
|
63 |
|
|
|
|
63 |
|
|
|
|
64 |
|
|
|
|
65 |
|
EX-31.1 |
EX-31.2 |
EX-32.1 |
EX-32.2 |
2
NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q (Quarterly Report) contains forward-looking statements.
These forward-looking statements include, without limitation, predictions regarding the following
aspects of our future:
|
|
|
Outcome and effect of current and potential future intellectual property litigation; |
|
|
|
|
Litigation expenses; |
|
|
|
|
Resolution of the European Commission matters involving us; |
|
|
|
|
Protection of intellectual property; |
|
|
|
|
Deterioration of financial health of commercial counterparties and their ability to meet
their obligations to us; |
|
|
|
|
Amounts owed under licensing agreements; |
|
|
|
|
Terms of our licenses; |
|
|
|
|
Indemnification and technical support obligations; |
|
|
|
|
Success in the markets of our or our licensees products; |
|
|
|
|
Research and development costs and improvements in technology; |
|
|
|
|
Sources, amounts and concentration of revenue, including royalties; |
|
|
|
|
Effective tax rates; |
|
|
|
|
Realization of deferred tax assets/release of deferred tax valuation allowance; |
|
|
|
|
Product development; |
|
|
|
|
Sources of competition; |
|
|
|
|
Pricing policies of our licensees; |
|
|
|
|
Success in renewing license agreements; |
|
|
|
|
Operating results; |
|
|
|
|
International licenses and operations, including our design facility in Bangalore, India; |
|
|
|
|
Methods, estimates and judgments in accounting policies; |
|
|
|
|
Growth in our business; |
|
|
|
|
Acquisitions, mergers or strategic transactions; |
|
|
|
|
Ability to identify, attract, motivate and retain qualified personnel; |
|
|
|
|
Trading price of our Common Stock; |
|
|
|
|
Internal control environment; |
|
|
|
|
Corporate governance; |
3
|
|
|
Accounting, tax, regulatory, legal and other outcomes and effects of the stock option
investigation; |
|
|
|
|
Consequences of the lawsuits related to the stock option investigation; |
|
|
|
|
The level and terms of our outstanding debt; |
|
|
|
|
Engineering, marketing and general and administration expenses; |
|
|
|
|
Contract revenue; |
|
|
|
|
Interest and other income, net; |
|
|
|
|
Adoption of new accounting pronouncements; |
|
|
|
|
Likelihood of paying dividends; |
|
|
|
|
Effects of changes in the economy and credit market on our industry and business; and |
|
|
|
|
Restructuring activities. |
You can identify these and other forward-looking statements by the use of words such as may,
future, shall, should, expects, plans, anticipates, believes, estimates,
predicts, intends, potential, continue, or the negative of such terms, or other comparable
terminology. Forward-looking statements also include the assumptions underlying or relating to any
of the foregoing statements.
Actual results could differ materially from those anticipated in these forward-looking
statements as a result of various factors, including those set forth under Item 1A, Risk Factors.
All forward-looking statements included in this document are based on our assessment of information
available to us at this time. We assume no obligation to update any forward-looking statements.
4
RAMBUS INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
June 30, |
|
|
December 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(In thousands, except shares |
|
|
|
and par value) |
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
317,986 |
|
|
$ |
116,241 |
|
Marketable securities |
|
|
162,400 |
|
|
|
229,612 |
|
Accounts receivable |
|
|
1,550 |
|
|
|
1,503 |
|
Prepaids and other current assets |
|
|
8,534 |
|
|
|
8,486 |
|
Deferred taxes |
|
|
919 |
|
|
|
88 |
|
|
|
|
|
|
|
|
Total current assets |
|
|
491,389 |
|
|
|
355,930 |
|
Restricted cash |
|
|
632 |
|
|
|
632 |
|
Deferred taxes, long-term |
|
|
957 |
|
|
|
1,857 |
|
Intangible assets, net |
|
|
7,268 |
|
|
|
7,244 |
|
Property and equipment, net |
|
|
18,378 |
|
|
|
22,290 |
|
Goodwill |
|
|
4,454 |
|
|
|
4,454 |
|
Other assets |
|
|
5,745 |
|
|
|
4,963 |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
528,823 |
|
|
$ |
397,370 |
|
|
|
|
|
|
|
|
LIABILITIES |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
10,932 |
|
|
$ |
6,374 |
|
Accrued salaries and benefits |
|
|
7,358 |
|
|
|
9,859 |
|
Accrued litigation expenses |
|
|
8,592 |
|
|
|
14,265 |
|
Income taxes payable |
|
|
478 |
|
|
|
638 |
|
Other accrued liabilities |
|
|
2,991 |
|
|
|
3,178 |
|
Convertible notes |
|
|
130,646 |
|
|
|
|
|
Deferred revenue |
|
|
396 |
|
|
|
1,787 |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
161,393 |
|
|
|
36,101 |
|
Deferred revenue, non-current |
|
|
20 |
|
|
|
90 |
|
Convertible notes |
|
|
92,450 |
|
|
|
125,474 |
|
Long-term income taxes payable |
|
|
1,880 |
|
|
|
1,953 |
|
Other long-term liabilities |
|
|
486 |
|
|
|
811 |
|
|
|
|
|
|
|
|
Total liabilities |
|
|
256,229 |
|
|
|
164,429 |
|
|
|
|
|
|
|
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
STOCKHOLDERS EQUITY |
|
|
|
|
|
|
|
|
Convertible preferred stock, $.001 par value: |
|
|
|
|
|
|
|
|
Authorized: 5,000,000 shares |
|
|
|
|
|
|
|
|
Issued and outstanding: no shares at June 30, 2009 and December 31, 2008 |
|
|
|
|
|
|
|
|
Common stock, $.001 par value: |
|
|
|
|
|
|
|
|
Authorized: 500,000,000 shares |
|
|
|
|
|
|
|
|
Issued and outstanding: 104,900,875 shares at June 30, 2009 and
103,803,006 shares at December 31, 2008 |
|
|
105 |
|
|
|
104 |
|
Additional paid-in capital |
|
|
784,744 |
|
|
|
703,640 |
|
Accumulated deficit |
|
|
(513,069 |
) |
|
|
(471,672 |
) |
Accumulated other comprehensive income |
|
|
814 |
|
|
|
869 |
|
|
|
|
|
|
|
|
Total stockholders equity |
|
|
272,594 |
|
|
|
232,941 |
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity |
|
$ |
528,823 |
|
|
$ |
397,370 |
|
|
|
|
|
|
|
|
See Notes to Unaudited Condensed Consolidated Financial Statements
5
RAMBUS INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(In thousands, except per share amounts) |
|
Revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Royalties |
|
$ |
24,759 |
|
|
$ |
32,288 |
|
|
$ |
50,928 |
|
|
$ |
65,381 |
|
Contract revenue |
|
|
2,224 |
|
|
|
3,427 |
|
|
|
3,389 |
|
|
|
10,072 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue |
|
|
26,983 |
|
|
|
35,715 |
|
|
|
54,317 |
|
|
|
75,453 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of contract revenue* |
|
|
1,438 |
|
|
|
6,567 |
|
|
|
3,621 |
|
|
|
13,800 |
|
Research and development* |
|
|
15,713 |
|
|
|
20,035 |
|
|
|
33,550 |
|
|
|
41,537 |
|
Marketing, general and administrative* |
|
|
32,563 |
|
|
|
23,768 |
|
|
|
69,719 |
|
|
|
57,089 |
|
Costs (recovery) of restatement and related legal
activities |
|
|
(429 |
) |
|
|
2,260 |
|
|
|
(14,068 |
) |
|
|
3,172 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses |
|
|
49,285 |
|
|
|
52,630 |
|
|
|
92,822 |
|
|
|
115,598 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating loss |
|
|
(22,302 |
) |
|
|
(16,915 |
) |
|
|
(38,505 |
) |
|
|
(40,145 |
) |
Interest and other income, net |
|
|
1,173 |
|
|
|
2,908 |
|
|
|
2,613 |
|
|
|
7,503 |
|
Interest expense |
|
|
(2,817 |
) |
|
|
(2,944 |
) |
|
|
(5,487 |
) |
|
|
(5,832 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and other income (expense), net |
|
|
(1,644 |
) |
|
|
(36 |
) |
|
|
(2,874 |
) |
|
|
1,671 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes |
|
|
(23,946 |
) |
|
|
(16,951 |
) |
|
|
(41,379 |
) |
|
|
(38,474 |
) |
Provision for income taxes |
|
|
25 |
|
|
|
121,364 |
|
|
|
18 |
|
|
|
114,195 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(23,971 |
) |
|
$ |
(138,315 |
) |
|
$ |
(41,397 |
) |
|
$ |
(152,669 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
(0.23 |
) |
|
$ |
(1.32 |
) |
|
$ |
(0.40 |
) |
|
$ |
(1.46 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
$ |
(0.23 |
) |
|
$ |
(1.32 |
) |
|
$ |
(0.40 |
) |
|
$ |
(1.46 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares used in per share calculation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
104,675 |
|
|
|
104,804 |
|
|
|
104,536 |
|
|
|
104,743 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
|
104,675 |
|
|
|
104,804 |
|
|
|
104,536 |
|
|
|
104,743 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* Includes stock-based compensation: |
|
Cost of contract revenue |
|
$ |
233 |
|
|
$ |
1,365 |
|
|
$ |
623 |
|
|
$ |
3,283 |
|
Research and development |
|
$ |
2,214 |
|
|
$ |
3,767 |
|
|
$ |
4,954 |
|
|
$ |
7,671 |
|
Marketing, general and administrative |
|
$ |
5,403 |
|
|
$ |
3,821 |
|
|
$ |
10,692 |
|
|
$ |
8,528 |
|
See Notes to Unaudited Condensed Consolidated Financial Statements
6
RAMBUS INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended |
|
|
|
June 30, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(In thousands) |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(41,397 |
) |
|
$ |
(152,669 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
Stock-based compensation |
|
|
16,269 |
|
|
|
19,482 |
|
Depreciation |
|
|
5,439 |
|
|
|
5,537 |
|
Impairment of investments |
|
|
164 |
|
|
|
|
|
Amortization of intangible assets |
|
|
1,526 |
|
|
|
2,713 |
|
Non-cash interest expense and amortization of convertible debt issuance costs |
|
|
5,445 |
|
|
|
5,832 |
|
Deferred tax provision |
|
|
69 |
|
|
|
113,854 |
|
Loss on disposal of property plant and equipment |
|
|
|
|
|
|
10 |
|
Change in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
(47 |
) |
|
|
(264 |
) |
Prepaids and other assets |
|
|
360 |
|
|
|
(1,246 |
) |
Accounts payable |
|
|
4,050 |
|
|
|
(1,197 |
) |
Accrued salaries and benefits and other accrued liabilities |
|
|
(2,773 |
) |
|
|
(2,965 |
) |
Accrued litigation expenses |
|
|
(5,673 |
) |
|
|
(14,491 |
) |
Income taxes payable |
|
|
(233 |
) |
|
|
87 |
|
Deferred revenue |
|
|
(1,461 |
) |
|
|
(232 |
) |
Increase in restricted cash |
|
|
|
|
|
|
(126 |
) |
|
|
|
|
|
|
|
Net cash used in operating activities |
|
|
(18,262 |
) |
|
|
(25,675 |
) |
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Purchases of property and equipment |
|
|
(1,510 |
) |
|
|
(6,954 |
) |
Acquisition of intangible assets |
|
|
(1,550 |
) |
|
|
(300 |
) |
Purchases of marketable securities |
|
|
(97,008 |
) |
|
|
(246,479 |
) |
Maturities of marketable securities |
|
|
164,165 |
|
|
|
280,143 |
|
Proceeds from sale of marketable securities |
|
|
|
|
|
|
24,996 |
|
|
|
|
|
|
|
|
Net cash provided by investing activities |
|
|
64,097 |
|
|
|
51,406 |
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Proceeds from issuance of convertible senior notes |
|
|
150,000 |
|
|
|
|
|
Issuance costs related to the issuance of convertible senior notes |
|
|
(3,750 |
) |
|
|
|
|
Proceeds received from issuance of common stock under employee stock plans |
|
|
9,660 |
|
|
|
12,781 |
|
Payments under installment payment arrangement |
|
|
|
|
|
|
(1,250 |
) |
Repurchase and retirement of common stock |
|
|
|
|
|
|
(24,921 |
) |
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities |
|
|
155,910 |
|
|
|
(13,390 |
) |
|
|
|
|
|
|
|
Effect of exchange rates on cash and cash equivalents |
|
|
|
|
|
|
60 |
|
|
|
|
|
|
|
|
Net increase in cash and cash equivalents |
|
|
201,745 |
|
|
|
12,401 |
|
Cash and cash equivalents at beginning of period |
|
|
116,241 |
|
|
|
119,391 |
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
$ |
317,986 |
|
|
$ |
131,792 |
|
|
|
|
|
|
|
|
See Notes to Unaudited Condensed Consolidated Financial Statements
7
RAMBUS INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. Basis of Presentation
The accompanying unaudited condensed consolidated financial statements include the accounts of
Rambus Inc. (Rambus or the Company) and its wholly-owned subsidiaries. All intercompany
accounts and transactions have been eliminated in the accompanying unaudited condensed consolidated
financial statements. Investments in entities with less than 20% ownership and in which Rambus does
not have the ability to significantly influence the operations of the investee are being accounted
for using the cost method and are included in other assets.
In the opinion of management, the unaudited condensed consolidated financial statements
include all adjustments (consisting only of normal recurring items) necessary to state fairly the
financial position and results of operations for each interim period presented. Interim results are
not necessarily indicative of results for a full year.
The unaudited condensed consolidated financial statements have been prepared in accordance
with the rules and regulations of the Securities and Exchange Commission (the SEC) applicable to
interim financial information. Certain information and Note disclosures included in financial
statements prepared in accordance with generally accepted accounting principles have been omitted
in these interim statements pursuant to such SEC rules and regulations. The information included in
this Form 10-Q should be read in conjunction with the consolidated financial statements and notes
thereto in and the Current Report on Form 8-K filed on June 22, 2009 to reflect changes to the
Companys accounting for convertible debt to retrospectively apply the provisions of Financial
Accounting Standards Board Staff Position (FSP) Accounting Principles Board (APB) 14-1,
Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including
Partial Cash Settlement), on previously issued financial statements.
In accordance with the adoption of FSP APB 14-1 as of January 1, 2009 as noted above, the
Company has changed its accounting for its zero coupon convertible senior notes due 2010 and has
retrospectively adjusted the financial statements for the three years ended December 31, 2008. See
Note 15 Convertible Notes for the impact of the adoption of FSP APB 14-1.
Subsequent
events have been disclosed through July 30, 2009.
We have reclassified certain prior year balances to conform to the current years presentation
in the condensed consolidated statements of cash flows. None of these reclassifications had an
impact on reported net loss for any of the periods presented.
2. Summary of Significant Accounting Policies
Cash and Cash Equivalents
Cash equivalents are highly liquid investments with original maturity of three months or less
at the date of purchase. The Company maintains its cash balances with high quality financial
institutions and has not experienced any material losses.
Marketable Securities
Available-for-sale securities are carried at fair value, based on quoted market prices, with
the unrealized gains or losses reported, net of tax, in stockholders equity as part of accumulated
other comprehensive income (loss). The amortized cost of debt securities is adjusted for
amortization of premiums and accretion of discounts to maturity, both of which are included in
interest and other income, net. Realized gains and losses are recorded on the specific
identification method and are included in interest and other income, net. The Company reviews its
investments in marketable securities for possible other than temporary impairments on a regular
basis. If any loss on investment is believed to be other than temporary, a charge will be
recognized in operations. In evaluating whether a loss on a debt security is other than temporary,
the Company considers the following factors: 1) the Companys intent to sell the security, 2) if
the Company intends to hold the security, whether or not it is more likely than not that the
Company will be required to sell the security before recovery of the securitys amortized cost
basis and 3) even if the Company intends to hold the security, whether or not the Company expects
the security to recover the entire amortized cost basis. Due to the high credit quality and short
term nature of the Companys investments, there have been no other than temporary impairments
recorded to date. The classification of funds between short-term and long-term is based on whether
the securities are available for use in operations or other purposes.
8
Fair Value of Financial Instruments
The amounts reported for cash equivalents, marketable
securities, accounts receivable,
unbilled receivables, accounts payable, and accrued liabilities are considered to approximate fair
values based upon comparable market information available at the respective balance sheet dates.
The Company adopted Statement of Financial Accounting Standards (SFAS) No. 157, Fair Value
Measurements, effective January 1, 2008 for financial assets and liabilities measured on a
recurring basis. SFAS No. 157 applies to all financial assets and financial liabilities that are
being measured and reported on a fair value basis and requires disclosure that establishes a
framework for measuring fair value and expands disclosure about fair value measurements. For the
discussion regarding the impact of the adoption of SFAS No. 157 on the Companys marketable
securities, see Note 14, Fair Value of Financial Instruments. Additionally, the Company has
adopted SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities
Including an amendment of FASB Statement No. 115, effective January 1, 2008. The Company has not
elected the fair value option for financial instruments not already carried at fair value.
Recent Accounting Pronouncements
In May 2009, the FASB issued SFAS No. 165, Subsequent Events, which established general
standards of accounting for and disclosure of events that occur after the balance sheet date but
before financial statements are issued or are available to be issued. This standard required the
Company to disclose the date through which the Company has evaluated subsequent events and the
basis for the date. This standard was effective for interim periods which ended after June 15,
2009. See Note 1, Basis of Presentation, for disclosure of the date to which subsequent events
are disclosed and Note 16, Subsequent Events, for disclosure of subsequent events.
In April 2009, the FASB issued FASB Staff Position No. 107-1 (FSP FAS 107-1) and APB 28-1,
which amended FASB Statement No. 107, Disclosures about Fair Value of Financial Instruments and APB
Opinion No. 28, Interim Financial Reporting, which required disclosures about the fair value of
financial instruments for interim reporting periods. FSP FAS 107-1 and APB 28-1 was effective for
interim reporting periods which ended after June 15, 2009. These new pronouncements have been
incorporated into the disclosure related to the fair value of financial instruments as discussed in
Note 14, Fair Value of Financial Instruments.
In April 2009, the FASB issued FASB Staff Position No. 157-4 (FSP FAS 157-4), which provided
additional guidance in accordance with FASB No. 157, Fair Value Measurements, when the volume and
level of activity for the asset or liability has significantly decreased. FSP FAS 157-4 was
effective for interim and annual reporting periods which ended after June 15, 2009. The adoption of
this staff position did not have a material impact on the Companys financial statements. This new
pronouncement has been incorporated into the disclosure related to the fair value of financial
instruments as discussed in Note 14, Fair Value of Financial Instruments.
In April 2009, the FASB issued FASB Staff Position No. 115-2 (FSP FAS 115-2) and FASB Staff
Position No. 124-2 (FSP FAS 124-2), which amended the other-than-temporary impairment guidance
for debt and equity securities. FSP FAS 115-2 and FSP FAS 124-2 were effective for interim and
annual reporting periods which ended after June 15, 2009. The adoption of these staff positions did
not have a material impact on the Companys financial statements and are more fully disclosed in
Note 6, Marketable Securities.
In February 2008, the FASB issued FASB Staff Position 157-1, Application of FASB Statement
No. 157 to FASB Statement No. 13 and Other Accounting Pronouncements That Address Fair Value
Measurements for Purposes of Lease Classification or Measurement under Statement 13 (FSP 157-1)
and FSP 157-2, Effective Date of FASB Statement No. 157. FSP 157-1 amended SFAS No. 157 to remove
certain leasing transactions from its scope. FSP 157-2 delayed the effective date to January 1,
2009 of SFAS No. 157 for all non-financial assets and non-financial liabilities, except for items
that are recognized or disclosed at fair value in the financial statements on a recurring basis.
These nonfinancial items include assets and liabilities such as reporting units measured at fair
value in a goodwill impairment test and nonfinancial assets acquired and liabilities assumed in a
business combination. The provisions of SFAS No. 157 were adopted by the Company, as it applied to
its financial instruments, effective beginning January 1, 2008 and FSP 157-2, as it applies to
nonfinancial investments, effective beginning January 1, 2009. There may be an impact from the
adoption of FSP 157-2 in the second half of 2009 when the Company performs its annual impairment
test. The impact of adoption of SFAS No. 157 is discussed in Note 14, Fair Value of Financial
Instruments.
9
3. Revenue Recognition
Overview
Rambus recognizes revenue when persuasive evidence of an arrangement exists, Rambus has
delivered the product or performed the service, the fee is fixed or determinable and collection is
reasonably assured. If any of these criteria are not met, Rambus defers recognizing the revenue
until such time as all criteria are met. Determination of whether or not these criteria have been
met may require the Company to make judgments, assumptions and estimates based upon current
information and historical experience.
Rambus revenue consists of royalty revenue and contract revenue generated from agreements
with semiconductor companies, system companies and certain reseller arrangements. Royalty revenue
consists of patent license and technology license royalties. Contract revenue consist of fixed
license fees, fixed engineering fees and service fees associated with integration of Rambus chip
interface products into its customers products. Contract revenue may also include support or
maintenance. Reseller arrangements generally provide for the pass-through of a percentage of the
fees paid to the reseller by the resellers customer for use of Rambus patent and technology
licenses. Rambus does not recognize revenue for these arrangements until it has received notice of
revenue earned by and paid to the reseller, accompanied by the pass-through payment from the
reseller. Rambus does not pay commissions to the reseller for these arrangements.
Many of Rambus licensees have the right to cancel their licenses. In such arrangements,
revenue is only recognized to the extent that is consistent with the cancellation provisions.
Cancellation provisions within such contracts generally provide for a prospective cancellation with
no refund of fees already remitted by customers for products provided and payment for services
rendered prior to the date of cancellation. Unbilled receivables represent enforceable claims and
are deemed collectible in connection with the Companys revenue recognition policy.
Royalty Revenue
Rambus recognizes royalty revenue upon notification by its licensees and when deemed
collectible. The terms of the royalty agreements generally either require licensees to give Rambus
notification and to pay the royalties within 60 days of the end of the quarter during which the
sales occur or are based on a fixed royalty that is due within 45 days of the end of the quarter.
Rambus has two types of royalty revenue: (1) patent license royalties and (2) technology license
royalties.
Patent licenses. Rambus licenses its broad portfolio of patented inventions to semiconductor
and systems companies who use these inventions in the development and manufacture of their own
products. Such licensing agreements may cover the license of part, or all, of Rambus patent
portfolio. Rambus generally recognizes revenue from these arrangements as amounts become due. The
contractual terms of the agreements generally provide for payments over an extended period of time.
Technology licenses. Rambus develops proprietary and industry-standard chip interface
products, such as RDRAM and XDR that Rambus provides to its customers under technology license
agreements. These arrangements include royalties, which can be based on either a percentage of
sales or number of units sold. Rambus recognizes revenue from these arrangements upon notification
from the licensee of the royalties earned and when collectability is deemed reasonably assured.
Contract Revenue
Rambus generally recognizes revenue using percentage of completion for development contracts
related to licenses of its interface solutions, such as XDR and FlexIO that involve significant
engineering and integration services. For all license and service agreements accounted for using
the percentage-of-completion method, Rambus determines progress to completion using input measures
based upon contract costs incurred. Part of these contract fees may be due upon the achievement of
certain milestones, such as provision of certain deliverables by Rambus or production of chips by
the licensee. The remaining fees may be due on pre-determined dates and include significant
up-front fees.
A provision for estimated losses on fixed price contracts is made, if necessary, in the period
in which the loss becomes probable and can be reasonably estimated. If Rambus determines that it is
necessary to revise the estimates of the total costs required to complete a contract, the total
amount of revenue recognized over the life of the contract would not be affected. However, to the
extent the new assumptions regarding the total efforts necessary to complete a project were less
than the original assumptions, the contract fees would be recognized sooner than originally
expected. Conversely, if the newly estimated total efforts necessary to complete a project were
longer than the original assumptions, the contract fees will be recognized over a longer period. As
of June 30, 2009, we have accrued a liability of approximately $0.2 million related to estimated
loss contracts.
10
If application of the percentage-of-completion method results in recognizable revenue prior to
an invoicing event under a customer contract, the Company will recognize the revenue and record an
unbilled receivable. Amounts invoiced to Rambus customers in excess of recognizable revenue are
recorded as deferred revenue. The timing and amounts invoiced to customers can vary significantly
depending on specific contract terms and can therefore have a significant impact on deferred
revenue or unbilled receivables in any given period.
Rambus also recognizes revenue in accordance with SOP 97-2, SOP 98-4 and SOP 98-9 for
development contracts related to licenses of its chip interface products that involve non-essential
engineering services and post contract support (PCS). These SOPs apply to all entities that earn
revenue on products containing software, where software is not incidental to the product as a
whole. Contract fees for the products and services provided under these arrangements are comprised
of license fees and engineering service fees which are not essential to the functionality of the
product. Rambus rates for PCS and for engineering services are specific to each development
contract and not standardized in terms of rates or length. Because of these characteristics, the
Company does not have a sufficient population of contracts from which to derive vendor specific
objective evidence for each of the elements.
Therefore, as required by SOP 97-2, after Rambus delivers the product, if the only undelivered
element is PCS, Rambus will recognize all revenue ratably over either the contractual PCS period or
the period during which PCS is expected to be provided. Rambus reviews assumptions regarding the
PCS periods on a regular basis. If Rambus determines that it is necessary to revise the estimates
of the support periods, the total amount of revenue to be recognized over the life of the contract
would not be affected.
4. Comprehensive Loss
Rambus comprehensive loss consists of its net loss plus other comprehensive income (loss)
consisting of foreign currency translation adjustments and unrealized gains and losses on
marketable securities, net of taxes.
The components of comprehensive loss, net of tax, are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 30, |
|
|
June 30, |
|
(In thousands) |
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
Net loss |
|
$ |
(23,971 |
) |
|
$ |
(138,315 |
) |
|
$ |
(41,397 |
) |
|
$ |
(152,669 |
) |
Other comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments, net of tax |
|
|
|
|
|
|
(85 |
) |
|
|
|
|
|
|
60 |
|
Unrealized gain (loss) on marketable securities, net of tax |
|
|
482 |
|
|
|
(1,208 |
) |
|
|
(55 |
) |
|
|
(753 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
|
|
482 |
|
|
|
(1,293 |
) |
|
|
(55 |
) |
|
|
(693 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive loss |
|
$ |
(23,489 |
) |
|
$ |
(139,608 |
) |
|
$ |
(41,452 |
) |
|
$ |
(153,362 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
As a result of providing a full valuation allowance of the net deferred tax assets in the
U.S., the Company reversed $0.4 million of unrealized gain (loss) previously recorded in other
comprehensive income (loss) during the six months ended June 30, 2008.
5. Equity Incentive Plans and Stock-Based Compensation
Stock Option Plans
As of
June 30, 2009, 7,660,930 shares of the 14,900,000 shares approved under the 2006 Plan
remained available for grant which includes an increase of 6,500,000
shares approved by stockholders
on April 30, 2009. The 2006 Plan is now Rambus only plan for providing stock-based incentive
compensation to eligible employees, executive officers and non-employee directors and consultants.
A summary of shares available for grant under the Companys plans is as follows:
|
|
|
|
|
|
|
Shares Available |
|
|
for Grant |
Shares available as of December 31, 2008 |
|
|
2,556,984 |
|
Increase in shares approved for issuance |
|
|
6,500,000 |
|
Stock options granted |
|
|
(1,383,613 |
) |
Stock options forfeited |
|
|
1,555,258 |
|
Stock options expired under former plans |
|
|
(1,336,837 |
) |
Nonvested equity stock and stock units granted (1) |
|
|
(269,862 |
) |
Nonvested equity stock and stock units forfeited (1) |
|
|
39,000 |
|
|
|
|
|
|
Total available for grant as of June 30, 2009 |
|
|
7,660,930 |
|
|
|
|
|
|
|
|
|
(1) |
|
For purposes of determining the number of shares available for grant under the 2006 Plan
against the maximum number of shares authorized, each restricted stock granted reduces the
number of shares available for grant by 1.5 shares and each restricted stock forfeited
increases shares available for grant by 1.5 shares. |
11
General Stock Option Information
The following table summarizes stock option activity under the 1997, 1999 and 2006 Plans for
the six months ended June 30, 2009 and information regarding stock options outstanding,
exercisable, and vested and expected to vest as of June 30, 2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
|
|
|
|
Weighted |
|
Average |
|
|
|
|
|
|
|
|
Average |
|
Remaining |
|
Aggregate |
|
|
Number of |
|
Exercise Price |
|
Contractual |
|
Intrinsic |
|
|
Shares |
|
Per Share |
|
Term |
|
Value |
|
|
(Dollars in thousands, except per share amounts) |
Outstanding as of December 31, 2008 |
|
|
16,573,739 |
|
|
$ |
21.19 |
|
|
|
|
|
|
|
|
|
Options granted |
|
|
1,383,613 |
|
|
|
8.68 |
|
|
|
|
|
|
|
|
|
Options exercised |
|
|
(794,875 |
) |
|
|
8.98 |
|
|
|
|
|
|
|
|
|
Options forfeited |
|
|
(1,555,258 |
) |
|
|
24.77 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding as of June 30, 2009 |
|
|
15,607,219 |
|
|
|
20.35 |
|
|
|
5.55 |
|
|
$ |
31,997 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vested or expected to vest at June 30, 2009 |
|
|
14,430,047 |
|
|
|
21.21 |
|
|
|
5.58 |
|
|
|
23,404 |
|
Options exercisable at June 30, 2009 |
|
|
9,944,198 |
|
|
|
22.87 |
|
|
|
4.53 |
|
|
|
15,314 |
|
The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value
for in-the-money options at June 30, 2009, based on the $15.47 closing stock price of Rambus
Common Stock on June 30, 2009 on the Nasdaq Global Select Market, which would have been received by
the option holders had all option holders exercised their options as of that date. The total number
of in-the-money options outstanding and exercisable as of June 30, 2009 was 5,065,438 and
2,749,453, respectively.
As of June 30, 2009, there was $46.4 million of total unrecognized compensation cost, net of
expected forfeitures, related to non-vested stock-based compensation arrangements granted under the
stock option plans. That cost is expected to be recognized over a weighted-average period of 3.0
years. The total fair value of shares vested as of June 30, 2009 was $191.0 million.
Employee Stock Purchase Plans
Under the 2006 Employee Stock Purchase Plan (ESPP), the Company issued 254,748 shares at a
price of $8.06 per share during the six months ended June 30, 2009. The Company issued 146,633
shares at a price of $16.77 per share during the six months ended June 30, 2008. As of June 30,
2009, 1,010,323 shares under the 2006 ESPP remained available for issuance. For the three
and six months ended June 30, 2009, the Company recorded compensation expense related to the
ESPP of $0.5 million and $1.0 million, respectively. For the three and six
months ended June 30, 2008, the Company recorded compensation expense related to the
ESPP of $0.4 million and $1.0 million, respectively. As of June 30, 2009, there was $0.7
million of total unrecognized compensation cost related to stock-based compensation arrangements
granted under the ESPP. That cost is expected to be recognized over four
months.
Stock-Based Compensation
Stock Options
For the six months ended June 30, 2009 and 2008, the Company maintained stock plans covering a
broad range of potential equity grants including stock options, nonvested equity stock and equity
stock units and performance based instruments. In addition, the Company sponsors an ESPP, whereby
eligible employees are entitled to purchase Common Stock semi-annually, by means of limited payroll
deductions, at a 15% discount from the fair market value of the Common Stock as of specific dates.
During the three and six months ended June 30, 2009, Rambus granted 33,844 and 1,383,613 stock
options, respectively, with an estimated total grant-date fair value of $0.3 million and $8.9
million, respectively. During the three and six months ended June 30, 2009, Rambus recorded
stock-based compensation related to stock options of $6.0 million and $12.6 million, respectively.
12
During the three and six months ended June 30, 2008, Rambus granted 91,930 and 1,763,890 stock
options, respectively, with an estimated total grant-date fair value of $1.3 million and $20.1
million, respectively. During the three and six months ended June 30, 2008, Rambus recorded
stock-based compensation related to stock options of $8.1 million and $17.3 million, respectively.
The total intrinsic value of options exercised was $0.9 million and $5.0 million for the three
and six months ended June 30, 2009, respectively. The total intrinsic value of options exercised
was $4.7 million and $10.2 million for the three and six months ended June 30, 2008, respectively.
Intrinsic value is the total value of exercised shares based on the price of the Companys common
stock at the time of exercise less the cash received from the employees to exercise the options.
During the six months ended June 30, 2009, proceeds from employee stock option exercises
totaled approximately $7.1 million.
There were no tax benefits realized as a result of employee stock option exercises, stock
purchase plan purchases, and vesting of equity stock and stock units for the three and six months
ended June 30, 2009 and 2008 calculated in accordance with SFAS No. 123(R), Share-based Payment.
Valuation Assumptions
The fair value of stock awards is estimated as of the grant date using the
Black-Scholes-Merton (BSM) option-pricing model assuming a dividend yield of 0% and the
additional weighted-average assumptions as listed in the following tables:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Option Plans |
|
|
Three Months Ended |
|
Six Months Ended |
|
|
June 30, |
|
June 30, |
|
|
2009 |
|
2008 |
|
2009 |
|
2008 |
Stock Option Plans |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected stock price volatility |
|
|
94 |
% |
|
|
66 |
% |
|
|
94-96 |
% |
|
|
63-66 |
% |
Risk free interest rate |
|
|
2.1 |
% |
|
|
3.0 |
% |
|
|
1.8-2.1 |
% |
|
|
3.0-3.1 |
% |
Expected term (in years) |
|
|
5.8 |
|
|
|
5.3 |
|
|
|
5.3 5.8 |
|
|
|
5.3 |
|
Weighted-average fair value of stock options granted |
|
$ |
9.18 |
|
|
$ |
13.64 |
|
|
$ |
6.45 |
|
|
$ |
11.41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee Stock Purchase Plan |
|
|
Three Months Ended |
|
Six Months Ended |
|
|
June 30, |
|
June 30, |
|
|
2009 |
|
2008 |
|
2009 |
|
2008 |
Employee Stock Purchase Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected stock price volatility |
|
|
92 |
% |
|
|
58 |
% |
|
|
92 |
% |
|
|
58 |
% |
Risk free interest rate |
|
|
0.3 |
% |
|
|
1.7 |
% |
|
|
0.3 |
% |
|
|
1.7 |
% |
Expected term (in years) |
|
|
0.5 |
|
|
|
0.5 |
|
|
|
0.5 |
|
|
|
0.5 |
|
Weighted-average fair value of
purchase rights granted under the
purchase plan |
|
$ |
4.97 |
|
|
$ |
7.41 |
|
|
$ |
4.97 |
|
|
$ |
7.41 |
|
Nonvested Equity Stock and Stock Units
For the six months ended June 30, 2009, Rambus granted nonvested equity stock units to certain
officers and employees, totaling 179,908 shares under the 2006 Plan. These awards have a service
condition, generally a service period of four years. The nonvested equity stock units were valued
at the date of grant giving them a fair value of approximately $1.5 million.
For the three and six months ended June 30, 2009, Rambus recorded stock-based compensation
expense of approximately $1.4 million and $2.7 million, respectively, related to all outstanding
unvested equity stock grants. For the three and six months ended June 30, 2008, Rambus recorded
stock-based compensation expense of approximately $0.4 million and $1.2 million, respectively,
related to all outstanding unvested equity stock grants. Unrecognized stock-based compensation
related to all nonvested equity stock grants, net of estimated forfeitures, was approximately $10.5
million at June 30, 2009. This is expected to be recognized over a weighted average of 2.7 years.
13
The following table reflects the activity related to nonvested equity stock and stock units
for the six months ended June 30, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted- |
|
|
|
|
|
|
|
Average |
|
|
|
|
|
|
|
Grant-Date |
|
Nonvested Equity Stock and Stock Units |
|
Shares |
|
|
Fair Value |
|
Nonvested at December 31, 2008 |
|
|
821,064 |
|
|
$ |
18.46 |
|
Granted |
|
|
179,908 |
|
|
|
8.36 |
|
Vested |
|
|
(81,000 |
) |
|
|
22.18 |
|
Forfeited |
|
|
(26,000 |
) |
|
|
18.05 |
|
|
|
|
|
|
|
|
Nonvested at June 30, 2009 |
|
|
893,972 |
|
|
$ |
16.10 |
|
|
|
|
|
|
|
|
6. Marketable Securities
Rambus invests its excess cash primarily in U.S. government agency and treasury notes,
commercial paper, corporate notes and bonds, money market funds and municipal notes and bonds that
mature within three years. During the three months ended
June 30, 2009, the Company issued $150.0
million aggregate principal amount of 5% convertible senior notes due June 15, 2014. See
Note 15, Convertible Notes, for further discussion. The net cash received from the issuance of
these convertible notes is included in cash, cash equivalents and marketable securities as of June
30, 2009.
All cash equivalents and marketable securities are classified as available-for-sale and are
summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2009 |
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Weighted |
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Rate of |
|
(dollars in thousands) |
|
Fair Value |
|
|
Book Value |
|
|
Gains |
|
|
Losses |
|
|
Return |
|
Money Market Funds |
|
$ |
311,452 |
|
|
$ |
311,452 |
|
|
$ |
|
|
|
$ |
|
|
|
|
0.19 |
% |
Municipal Bonds and Notes |
|
|
1,011 |
|
|
|
1,000 |
|
|
|
11 |
|
|
|
|
|
|
|
3.85 |
% |
U.S. Government Bonds and Notes |
|
|
116,514 |
|
|
|
115,691 |
|
|
|
823 |
|
|
|
|
|
|
|
2.10 |
% |
Corporate Notes, Bonds, and Commercial Paper |
|
|
47,873 |
|
|
|
47,604 |
|
|
|
284 |
|
|
|
(15 |
) |
|
|
2.82 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash equivalents and marketable securities |
|
|
476,850 |
|
|
|
475,747 |
|
|
|
1,118 |
|
|
|
(15 |
) |
|
|
|
|
Cash |
|
|
3,536 |
|
|
|
3,536 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash, cash equivalents and marketable securities |
|
$ |
480,386 |
|
|
$ |
479,283 |
|
|
$ |
1,118 |
|
|
$ |
(15 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008 |
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Weighted |
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Rate of |
|
(dollars in thousands) |
|
Fair Value |
|
|
Book Value |
|
|
Gains |
|
|
Losses |
|
|
Return |
|
Money Market Funds |
|
$ |
110,732 |
|
|
$ |
110,732 |
|
|
$ |
|
|
|
$ |
|
|
|
|
0.90 |
% |
Municipal Bonds and Notes |
|
|
1,000 |
|
|
|
1,000 |
|
|
|
|
|
|
|
|
|
|
|
3.85 |
% |
U.S. Government Bonds and Notes |
|
|
149,304 |
|
|
|
148,178 |
|
|
|
1,126 |
|
|
|
|
|
|
|
2.79 |
% |
Corporate Notes, Bonds, and Commercial Paper |
|
|
79,308 |
|
|
|
79,275 |
|
|
|
197 |
|
|
|
(164 |
) |
|
|
3.06 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash equivalents and marketable securities |
|
|
340,344 |
|
|
|
339,185 |
|
|
|
1,323 |
|
|
|
(164 |
) |
|
|
|
|
Cash |
|
|
5,509 |
|
|
|
5,509 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash, cash equivalents and marketable securities |
|
$ |
345,853 |
|
|
$ |
344,694 |
|
|
$ |
1,323 |
|
|
$ |
(164 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Available-for-sale securities are reported at fair value on the balance sheets and classified
as follows:
|
|
|
|
|
|
|
|
|
|
|
June 30, |
|
|
December 31, |
|
(dollars in thousands) |
|
2009 |
|
|
2008 |
|
Cash equivalents |
|
$ |
314,450 |
|
|
$ |
110,732 |
|
Short term marketable securities |
|
|
162,400 |
|
|
|
229,612 |
|
|
|
|
|
|
|
|
Total cash equivalent and marketable securities |
|
|
476,850 |
|
|
|
340,344 |
|
Cash |
|
|
3,536 |
|
|
|
5,509 |
|
|
|
|
|
|
|
|
Total cash, cash equivalents and marketable securities |
|
$ |
480,386 |
|
|
$ |
345,853 |
|
|
|
|
|
|
|
|
The Company continues to invest in high quality, highly liquid debt securities that mature
within three years. The Company holds all of its marketable securities as available-for-sale, marks
them to market, and regularly reviews its portfolio to ensure adherence to its investment policy
and to monitor individual investments for risk analysis, proper valuation, and unrealized losses
that may be other than temporary. As of June 30, 2009, three of its corporate debt investments with
a fair value of $7.8 million, which mature within approximately one year, have insignificant
unrealized losses. The Company has considered all available evidence and determined that these
unrealized losses are due to current market conditions. The Company has no intent to sell, there is
no requirement to sell and the Company believes that it can recover the amortized cost of these
investments. The Company has found no evidence of impairment due
14
to credit losses in its portfolio. Therefore, these unrealized losses were recorded in other
comprehensive income. However, the Company cannot provide any assurance that its portfolio of cash,
cash equivalents and marketable securities will not be impacted by adverse conditions in the
financial markets, which may require the Company in the future to record an impairment charge that
could adversely impact its financial results.
The estimated fair value of cash equivalents and marketable securities classified by date of
contractual maturity and the associated unrealized gain at June 30, 2009 and December 31, 2008 are
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
Unrealized Gains, net |
|
|
|
June 30, |
|
|
December 31, |
|
|
June 30, |
|
|
December 31, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(In thousands) |
|
Contractual maturity: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Due within one year |
|
$ |
388,552 |
|
|
$ |
223,458 |
|
|
$ |
692 |
|
|
$ |
345 |
|
Due from one year through three years |
|
|
88,298 |
|
|
|
116,886 |
|
|
|
411 |
|
|
|
814 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
476,850 |
|
|
$ |
340,344 |
|
|
$ |
1,103 |
|
|
$ |
1,159 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The unrealized gains, net, were insignificant in relation to the Companys total
available-for-sale portfolio. The unrealized gains, net, can be primarily attributed to a
combination of market conditions as well as the demand for and duration of the Companys U.S.
government bonds and notes. See Note 14, Fair Value of Financial Instruments, for fair value
discussion regarding the Companys cash equivalents and marketable securities.
7. Commitments and Contingencies
On February 1, 2005, Rambus issued $300.0 million aggregate principal amount of zero coupon
convertible senior notes (the 2010 Notes) due February 1, 2010 to Credit Suisse First Boston LLC
and Deutsche Bank Securities as initial purchasers who then sold the convertible notes to
institutional investors. Rambus has elected to pay the principal amount of the 2010 Notes in cash
when they are due. Subsequently, Rambus repurchased a total of $163.1 million face value of the
outstanding 2010 Notes in 2005 and 2008. The aggregate principal amount of the 2010 Notes
outstanding as of June 30, 2009 was $137.0 million, offset by an unamortized debt discount of $6.3
million. The debt discount is expected to be amortized over the remaining 7 months until maturity
of the 2010 Notes, see Note 15, Convertible Notes, for additional details.
On
June 29, 2009, Rambus entered into an Indenture (the
Indenture) by and between Rambus and U.S. Bank, National
Association, as trustee, relating to the issuance by Rambus of $150.0 million aggregate principal amount of 5% convertible senior notes due June 15, 2014 (the 2014 Notes). The aggregate principal amount of
the 2014 Notes outstanding as of June 30, 2009 was $150.0 million, offset by unamortized debt
discount of $57.5 million in the accompanying condensed consolidated balance sheets. The debt
discount is expected to be amortized over the remaining 60 months until maturity of the 2014 Notes
on June 15, 2014, see Note 15, Convertible Notes, for additional details.
As of June 30, 2009, Rambus material contractual obligations are (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due by Year |
|
|
|
|
|
|
|
Remainder |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
of 2009 |
|
|
2010 |
|
|
2011 |
|
|
2012 |
|
|
2013 |
|
|
Thereafter |
|
Contractual obligations(1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating leases |
|
$ |
12,825 |
|
|
$ |
4,941 |
|
|
$ |
6,668 |
|
|
$ |
747 |
|
|
$ |
469 |
|
|
$ |
|
|
|
$ |
|
|
Convertible notes |
|
|
286,950 |
|
|
|
|
|
|
|
136,950 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
150,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
299,775 |
|
|
$ |
4,941 |
|
|
$ |
143,618 |
|
|
$ |
747 |
|
|
$ |
469 |
|
|
$ |
|
|
|
$ |
150,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The above table does not reflect possible payments in connection with uncertain tax benefits
associated with FASB Interpretation No. (FIN) 48 of approximately $10.0 million, including
$8.1 million recorded as a reduction of long-term deferred tax assets and $1.9 million in
long-term income taxes payable, as of June 30, 2009. As noted below in Note 9, Income Taxes,
although it is possible that some of the unrecognized tax benefits could be settled within the
next 12 months, the Company cannot reasonably estimate the outcome at this time. |
Rent expense was approximately $1.6 million and $3.2 million for the three and six months
ended June 30, 2009, respectively. Rent expense was approximately $1.7 million and $3.5 million for
the three and six months ended June 30, 2008, respectively.
15
Deferred rent, included primarily in other long-term liabilities, was approximately $0.9
million and $1.1 million as of June 30, 2009 and December 31, 2008, respectively.
Indemnifications
Rambus enters into standard license agreements in the ordinary course of business. Although
Rambus does not indemnify most of its customers, there are times when an indemnification is a
necessary means of doing business. Indemnifications cover customers for losses suffered or incurred
by them as a result of any patent, copyright, or other intellectual property infringement claim by
any third party with respect to Rambus products. The maximum amount of indemnification Rambus
could be required to make under these agreements is generally limited to fees received by Rambus.
Rambus estimates the fair value of its indemnification obligation as insignificant, based upon its
history of litigation concerning product and patent infringement claims.
Several securities fraud class actions, private lawsuits and shareholder derivative actions
were filed in state and federal courts against certain of the Companys current and former officers
and directors related to the stock option granting actions. As permitted under Delaware law, Rambus
has agreements whereby its officers and directors are indemnified for certain events or occurrences
while the officer or director is, or was serving, at Rambus request in such capacity. The term of
the indemnification period is for the officers or directors term in such capacity. The maximum
potential amount of future payments Rambus could be required to make under these indemnification
agreements is unlimited. Rambus has a director and officer insurance policy that reduces Rambus
exposure and enables Rambus to recover a portion of future amounts to be paid. As a result of these
indemnification agreements, Rambus continues to make payments on behalf of current and former
officers and directors. As of June 30, 2009, the Company had made payments of approximately $10.8
million on their behalf, including $1.5 million in the three
months ended June 30, 2009. The Company
received approximately $5.3 million from the former officers related to their settlement agreements
with the Company in connection with the derivative and class action lawsuits which was comprised of
approximately $4.5 million in cash received in the first quarter of 2009 as well as approximately
163,000 shares of Rambus stock with a value of approximately $0.8 million in the fourth quarter of
2008. Additionally, as of June 30, 2009, the Company has received $11.9 million from insurance
settlements related to the defense of the Company, its directors and
its officers which were recorded under costs (recovery) of
restatement and related legal activities in the condensed consolidated statements of operations. As
of June 30, 2008, the Company had made payments of approximately $6.4 million on their behalf,
including $0.3 million in the quarter ended June 30, 2008. These payments made by the Company and
the repayments by the former officers to the Company were recorded under costs (recovery) of
restatement and related legal activities in the condensed consolidated statements of operations.
8. Stockholders Equity
Share Repurchase Program
In October 2001, Rambus Board of Directors (the Board) approved a share repurchase program
of its Common Stock, principally to reduce the dilutive effect of employee stock options. To date,
the Board has approved the authorization to repurchase up to 19.0 million shares of the Companys
outstanding Common Stock over an undefined period of time. During the six months ended June 30,
2009, the Company did not repurchase any Common Stock. As of June 30, 2009, Rambus had repurchased
a cumulative total of approximately 16.8 million shares of its Common Stock with an aggregate price
of approximately $233.8 million since the commencement of this program. As of June 30, 2009, there
remained an outstanding authorization to repurchase approximately 2.2 million shares of Rambus
outstanding Common Stock.
Rambus records stock repurchases as a reduction to stockholders equity. As prescribed by APB
Opinion No. 6, Status of Accounting Research Bulletins, Rambus records a portion of the purchase
price of the repurchased shares as an increase to accumulated deficit when the cost of the shares
repurchased exceeds the average original proceeds per share received from the issuance of Common
Stock.
9. Income Taxes
The effective tax rate for the three months ended June 30, 2009 was 0.1% which is lower than
the U.S. statutory tax rate applied to the Companys net loss primarily due to a full valuation
allowance on its U.S. net deferred tax assets, foreign income taxes and state income taxes,
partially offset by refundable research and development tax credits. The effective tax rate for the
three months ended June 30, 2008 was 716.0% which was higher than the U.S. statutory tax rate
applied to the Companys net loss primarily due to the establishment of a full valuation allowance
on our U.S. net deferred tax assets.
16
As of June 30, 2009, the Companys condensed consolidated balance sheet included net deferred
tax assets, before valuation allowance, of approximately $144.5 million, which consists of net
operating loss carryovers, tax credit carryovers, depreciation and amortization, employee
stock-based compensation expenses and certain liabilities, partially reduced by deferred tax
liabilities associated with FSP APB 14-1. As of June 30, 2009, a valuation allowance of $142.6 million has been recorded
against the deferred tax assets. Management periodically evaluates the realizability of the
Companys net deferred tax assets based on all available evidence, both positive and negative. The
realization of net deferred tax assets is solely dependent on the Companys ability to generate
sufficient future taxable income during periods prior to the expiration of tax statutes to fully
utilize these assets. The Company intends to maintain the valuation allowance until sufficient
positive evidence exists to support reversal of the valuation allowance.
The Company maintains liabilities for uncertain tax benefits within its non-current income
taxes payable accounts. These liabilities involve judgment and estimation and are monitored by
management based on the best information available including changes in tax regulations, the
outcome of relevant court cases and other information.
As of June 30, 2009, the Company had $10.0 million of unrecognized tax benefits, including
$7.3 million recorded as a reduction of long-term deferred tax assets, which is net of
approximately $0.9 million of federal tax benefit, and including $1.9 million in long-term income
taxes payable. If recognized, approximately $0.7 million would be recorded as an income tax
benefit. No benefit would be recorded for the remaining unrecognized tax benefits as the
recognition would require a corresponding increase in the valuation allowance. As of December 31,
2008, the Company had $9.6 million of unrecognized tax benefits, including $6.9 million recorded as
a reduction of long-term deferred tax assets, which is net of approximately $0.8 million of federal
tax benefits, and including $1.9 million in long-term income taxes payable.
Although it is possible that some of the unrecognized tax benefits could be settled within the
next 12 months, the Company cannot reasonably estimate the outcome at this time.
The Company recognizes interest and penalties related to uncertain tax positions as a
component of the income tax provision (benefit). At June 30, 2009 and December 31, 2008, an
insignificant amount of interest and penalties are included in long-term income taxes payable.
The Company files U.S. federal income tax returns as well as income tax returns in various
states and foreign jurisdictions. The Company is currently under a payroll examination by the
Internal Revenue Service for the years ended December 31, 2004 and 2005. The Company is also under
examination by the California Franchise Tax Board for the fiscal year ended March 31, 2003 and the
years ended December 31, 2003 and 2004. Although the outcome of any tax audit is uncertain, the
Company believes it has adequately provided for any additional taxes that may be required to be
paid as a result of such examinations. If the Company determines that no payment will ultimately be
required, the reversal of these tax liabilities may result in tax benefits being recognized in the
period when that conclusion is reached. However, if an ultimate tax assessment exceeds the recorded
tax liability for that item, an additional tax provision may need to be recorded. The impact of
such adjustments in the Companys tax accounts could have a material impact on the consolidated
results of operations in future periods.
The Company is subject to examination by the IRS for tax years ended 2005 through 2007. The
Company is also subject to examination by the State of California for tax years ended 2004 through
2007. In addition, any R&D credit and net operating loss carryforwards generated in prior years and
utilized in these or future years may also be subject to examination by the IRS and the State of
California. The Company is also subject to examination in various other jurisdictions for various
periods.
10. Earnings (Loss) Per Share
Earnings (loss) per share is calculated in accordance with, SFAS No. 128, Earnings Per
Share. Basic earnings (loss) per share is calculated by dividing the net income (loss) by the
weighted average number of common shares outstanding during the period. Diluted earnings (loss) per
share is calculated by dividing the earnings (loss) by the weighted average number of common shares
and potentially dilutive securities outstanding during the period. Potentially dilutive common
shares consist of incremental common shares issuable upon exercise of stock options, employee stock
purchases, restricted stock and restricted stock units and shares issuable upon the conversion of
convertible notes. The dilutive effect of outstanding shares is reflected in diluted earnings per
share by application of the treasury stock method. This method includes consideration of the
amounts to be paid by the employees, the amount of excess tax benefits that would be recognized in
equity if the instrument was exercised and the amount of unrecognized stock-based compensation
related to future services. No potential dilutive common shares are included in the computation of
any diluted per share amount when a net loss is reported.
17
The following table sets forth the computation of basic and diluted loss per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(In thousands, except per share amounts) |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(23,971 |
) |
|
$ |
(138,315 |
) |
|
$ |
(41,397 |
) |
|
$ |
(152,669 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares used to compute basic EPS |
|
|
104,675 |
|
|
|
104,804 |
|
|
|
104,536 |
|
|
|
104,743 |
|
Dilutive potential shares from stock options, ESPP
and nonvested equity stock and stock units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares used to compute diluted EPS |
|
|
104,675 |
|
|
|
104,804 |
|
|
|
104,536 |
|
|
|
104,743 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
(0.23 |
) |
|
$ |
(1.32 |
) |
|
$ |
(0.40 |
) |
|
$ |
(1.46 |
) |
Diluted |
|
$ |
(0.23 |
) |
|
$ |
(1.32 |
) |
|
$ |
(0.40 |
) |
|
$ |
(1.46 |
) |
For the three and six months ended June 30, 2009, approximately 12.9 million shares that would
be issued upon the conversion of the convertible notes were excluded from the calculation of
earnings per share because the conversion price was higher than the average market price of the
Common Stock during this period. For the three and six months ended June 30, 2008, approximately
5.9 million shares that would be issued upon the conversion of the contingently issuable
convertible notes were excluded from the calculation of earnings per share because the conversion
price was higher than the average market price of the Common Stock during this period. For the
three months ended June 30, 2009 and 2008, options to purchase approximately 13.5 million and 9.9
million shares, respectively, and for the six months ended June 30, 2009 and 2008, options to
purchase approximately 13.8 million and 10.4 million shares, respectively, were excluded from the
calculation because they were anti-dilutive after considering proceeds from exercise, taxes and
related unrecognized stock-based compensation expense. For the three months ended June 30, 2009 and
2008, an additional 1.2 million and 3.9 million shares, respectively, and for the six months ended
June 30, 2009 and 2008, an additional 0.7 million and 3.6 million shares, respectively, including
nonvested equity stock and stock units, that would be dilutive have been excluded from the weighted
average dilutive shares because there was a net loss for the period.
11. Business Segments, Exports and Major Customers
Rambus operates in a single industry segment, the design, development and licensing of chip
interface technologies and architectures. Five customers accounted for 26%, 15%, 14%, 13% and 12%,
respectively, of revenue in the three months ended June 30, 2009. Five customers accounted for 19%,
17%, 12%, 11% and 11%, respectively, of revenue in the three months ended June 30, 2008. Five
customers accounted for 25%, 15%, 14%, 12% and 12%, respectively, of revenue in the six months
ended June 30, 2009. Three customers accounted for 18%, 18% and 13%, respectively, of revenue in
the six months ended June 30, 2008. Rambus expects that its revenue concentration will decrease
over the long term as Rambus licenses new customers.
Rambus sells its chip interfaces and licenses to customers in the Far East, North America, and
Europe. Revenue from customers in the following geographic regions were recognized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 30, |
|
|
June 30, |
|
(In thousands) |
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
Japan |
|
$ |
22,070 |
|
|
$ |
29,579 |
|
|
$ |
43,881 |
|
|
$ |
60,561 |
|
North America |
|
|
4,624 |
|
|
|
5,813 |
|
|
|
9,892 |
|
|
|
12,661 |
|
Taiwan |
|
|
18 |
|
|
|
180 |
|
|
|
41 |
|
|
|
521 |
|
Korea |
|
|
230 |
|
|
|
56 |
|
|
|
372 |
|
|
|
439 |
|
Singapore |
|
|
|
|
|
|
75 |
|
|
|
43 |
|
|
|
174 |
|
Europe |
|
|
41 |
|
|
|
12 |
|
|
|
88 |
|
|
|
1,097 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
26,983 |
|
|
$ |
35,715 |
|
|
$ |
54,317 |
|
|
$ |
75,453 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At June 30, 2009, of the $18.4 million of total property and equipment, approximately $15.9
million are located in the United States, $2.0 million are located in India and $0.5 million are
located in other foreign locations. At December 31, 2008, of the $22.3 million of total property
and equipment, approximately $19.3 million are located in the United States, $2.4 million are
located in India and $0.6 million are located in other foreign locations.
18
12. Amortizable Intangible Assets
The components of the Companys intangible assets as of June 30, 2009 and December 31, 2008
were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of June 30, 2009 |
|
|
|
Gross Carrying |
|
|
Accumulated |
|
|
Net Carrying |
|
|
|
Amount |
|
|
Amortization |
|
|
Amount |
|
|
|
(In thousands) |
|
Patents |
|
$ |
11,491 |
|
|
$ |
(6,182 |
) |
|
$ |
5,309 |
|
Intellectual property |
|
|
10,384 |
|
|
|
(9,956 |
) |
|
|
428 |
|
Customer contracts and contractual relationships |
|
|
4,000 |
|
|
|
(2,469 |
) |
|
|
1,531 |
|
Existing technology |
|
|
2,700 |
|
|
|
(2,700 |
) |
|
|
|
|
Non-competition agreement |
|
|
100 |
|
|
|
(100 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total intangible assets |
|
$ |
28,675 |
|
|
$ |
(21,407 |
) |
|
$ |
7,268 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2008 |
|
|
|
Gross Carrying |
|
|
Accumulated |
|
|
Net Carrying |
|
|
|
Amount |
|
|
Amortization |
|
|
Amount |
|
|
|
(In thousands) |
|
Patents |
|
$ |
9,941 |
|
|
$ |
(5,527 |
) |
|
$ |
4,414 |
|
Intellectual property |
|
|
10,384 |
|
|
|
(9,527 |
) |
|
|
857 |
|
Customer contracts and contractual relationships |
|
|
4,000 |
|
|
|
(2,224 |
) |
|
|
1,776 |
|
Existing technology |
|
|
2,700 |
|
|
|
(2,503 |
) |
|
|
197 |
|
Non-competition agreement |
|
|
100 |
|
|
|
(100 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total intangible assets |
|
$ |
27,125 |
|
|
$ |
(19,881 |
) |
|
$ |
7,244 |
|
|
|
|
|
|
|
|
|
|
|
Amortization expense for intangible assets for the three and six months ended June 30, 2009
was $0.7 million and $1.5 million, respectively. Amortization expense for intangible assets for the
three and six months ended June 30, 2008 was $1.3 million and $2.7 million, respectively.
During the three months ended March 31, 2009, the company purchased patents related to mobile
memory and other applications in an asset acquisition from Inapac Technology, Inc for approximately
$1.6 million.
The estimated future amortization expense of intangible assets as of June 30, 2009 was as
follows (amounts in thousands):
|
|
|
|
|
Years Ending December 31: |
|
Amount |
|
2009 (remaining 6 months) |
|
$ |
1,366 |
|
2010 |
|
|
1,743 |
|
2011 |
|
|
1,414 |
|
2012 |
|
|
1,143 |
|
2013 |
|
|
1,122 |
|
Thereafter |
|
|
480 |
|
|
|
|
|
|
|
$ |
7,268 |
|
|
|
|
|
13. Litigation and Asserted Claims
Hynix Litigation
U.S District Court of the Northern District of California
On August 29, 2000, Hynix (formerly Hyundai) and various subsidiaries filed suit against
Rambus in the U.S. District Court for the Northern District of California. The complaint, as
amended and narrowed through motion practice, asserts claims for fraud, violations of federal
antitrust laws and deceptive practices in connection with Rambus participation in a standards
setting organization called JEDEC, and seeks a declaratory judgment that the Rambus patents-in-suit
are unenforceable, invalid and not infringed by Hynix, compensatory and punitive damages, and
attorneys fees. Rambus denied Hynixs claims and filed counterclaims for patent infringement
against Hynix.
The case was divided into three phases. In the first phase, Hynix tried its unclean hands
defense beginning on October 17, 2005 and concluding on November 1, 2005. In its January 4, 2006
Findings of Fact and Conclusions of Law, the court held that Hynixs unclean hands defense failed.
Among other things, the court found that Rambus did not adopt its document retention policy in bad
faith, did
19
not engage in unlawful spoliation of evidence, and that while Rambus disposed of some relevant
documents pursuant to its document retention policy, Hynix was not prejudiced by the destruction of
Rambus documents. On January 19, 2009, Hynix filed a motion for reconsideration of the courts
unclean hands order and for summary judgment on the ground that the decision by the Delaware court
in the pending Micron-Rambus litigation (described below) should be given preclusive effect. In its
motion Hynix requested alternatively that the courts unclean hands order be certified for appeal
and that the remainder of the case be stayed. Rambus filed an opposition to Hynixs motion on
January 26, 2009, and a hearing was held on January 30, 2009. On February 3, 2009, the court denied
Hynixs motions and restated its conclusions that Rambus had not anticipated litigation until late
1999 and that Hynix had not demonstrated any prejudice from any alleged destruction of evidence.
The second phase of the Hynix-Rambus trial on patent infringement, validity and damages
began on March 15, 2006, and was submitted to the jury on April 13, 2006. On April 24, 2006, the
jury returned a verdict in favor of Rambus on all issues and awarded Rambus a total of
approximately $307 million in damages, excluding prejudgment interest. Specifically, the jury found
that each of the ten selected patent claims was supported by the written description, and was not
anticipated or rendered obvious by prior art; therefore, none of the
patent claims was invalid.
The jury also found that Hynix infringed all eight of the patent claims for which the jury was
asked to determine infringement; the court had previously determined on summary judgment that Hynix
infringed the other two claims at issue in the trial. On July 14, 2006, the court granted Hynixs
motion for a new trial on the issue of damages unless Rambus agreed to a reduction of the total
jury award to approximately $134 million. The court found that the record supported a maximum
royalty rate of 1% for SDR SDRAM and 4.25% for DDR SDRAM, which the court applied to the stipulated
U.S. sales of infringing Hynix products through December 31, 2005. On July 27, 2006, Rambus elected
remittitur of the jurys award to approximately $134 million. On August 30, 2006, the court awarded
Rambus prejudgment interest for the period June 23, 2000 through December 31, 2005. Hynix filed a
motion on July 7, 2008 to reduce the amount of remitted damages and any supplemental damages that
the court may award, as well as to limit the products that could be affected by any injunction that
the court may grant, on the grounds of patent exhaustion. Following a hearing on August 29, 2008,
the court denied Hynixs motion. In separate orders issued December 2, 2008, January 16, 2009, and
January 27, 2009, the court denied Hynixs post-trial motions for judgment as a matter of law and
new trial on infringement and validity.
On June 24, 2008, the court heard oral argument on Rambus motion to supplement the damages
award and for equitable relief related to Hynixs infringement of Rambus patents. On February 23,
2009, the court issued an order (1) granting Rambus motion for supplemental damages and
prejudgment interest for the period after December 31, 2005, at the same rates ordered for the
prior period; (2) denying Rambus motion for an injunction; and (3) ordering the parties to begin
negotiations regarding the terms of a compulsory license regarding Hynixs continued manufacture,
use, and sale of infringing devices.
The third phase of the Hynix-Rambus trial involved Hynixs affirmative JEDEC-related antitrust
and fraud allegations against Rambus. On April 24, 2007, the court ordered a coordinated trial of
certain common JEDEC-related claims alleged by the manufacturer parties (i.e., Hynix, Micron, Nanya
and Samsung) and defenses asserted by Rambus in Hynix v Rambus, Case No. C 00-20905 RMW, and three
other cases pending before the same court (Rambus Inc. v. Samsung Electronics Co. Ltd. et al., Case
No. 05-02298 RMW, Rambus Inc. v. Hynix Semiconductor Inc., et al., Case No. 05-00334, and Rambus
Inc. v. Micron Technology, Inc., et al., Case No. C 06-00244 RMW, each described in further detail
below). On December 14, 2007, the court excused Samsung from the coordinated trial based on
Samsungs agreement to certain conditions, including trial of its claims against Rambus by the
court within six months following the conclusion of the coordinated trial. The coordinated trial
involving Rambus, Hynix, Micron and Nanya began on January 29, 2008, and was submitted to the jury
on March 25, 2008. On March 26, 2008, the jury returned a verdict in favor of Rambus and against
Hynix, Micron, and Nanya on each of their claims. Specifically, the jury found that Hynix, Micron,
and Nanya failed to meet their burden of proving that: (1) Rambus engaged in anticompetitive
conduct; (2) Rambus made important representations that it did not have any intellectual property
pertaining to the work of JEDEC and intended or reasonably expected that the representations would
be heard by or repeated to others including Hynix, Micron or Nanya; (3) Rambus uttered deceptive
half-truths about its intellectual property coverage or potential coverage of products compliant
with synchronous DRAM standards then being considered by JEDEC by disclosing some facts but failing
to disclose other important facts; or (4) JEDEC members shared a clearly defined expectation that
members would disclose relevant knowledge they had about patent applications or the intent to file
patent applications on technology being considered for adoption as a JEDEC standard. Hynix, Micron,
and Nanya filed motions for a new trial and for judgment on certain of their equitable claims and
defenses. A hearing on those motions was held on May 1, 2008. A further hearing on the equitable
claims and defenses was held on May 27, 2008. On July 24, 2008, the court issued an order denying
Hynix, Micron, and Nanyas motions for new trial.
On March 3, 2009, the court issued an order rejecting Hynix, Micron, and Nanyas equitable
claims and defenses that had been tried during the coordinated trial. The court concluded (among
other things) that (1) Rambus did not have an obligation to disclose pending or anticipated patent
applications and had sound reasons for not doing so; (2) the evidence supported the jurys finding
that
20
JEDEC members did not share a clearly defined expectation that members would disclose relevant
knowledge they had about patent applications or the intent to file patent applications on
technology being considered for adoption as a JEDEC standard; (3) the written JEDEC disclosure
policies did not clearly require members to disclose information about patent applications and the
intent to file patent applications in the future; (4) there was no clearly understood or legally
enforceable agreement of JEDEC members to disclose information about patent applications or the
intent to seek patents relevant to standards being discussed at JEDEC; (5) during the time Rambus
attended JEDEC meetings, Rambus did not have any patent application pending that covered a JEDEC
standard, and none of the patents in suit was applied for until well after Rambus resigned from
JEDEC; (6) Rambuss conduct at JEDEC did not constitute an estoppel or waiver of its rights to
enforce its patents; (7) Hynix, Micron, and Nanya failed to carry their burden to prove their
asserted waiver and estoppel defenses not directly based on Rambuss conduct at JEDEC; (8) the
evidence did not support a finding of any material misrepresentation, half truths or fraudulent
concealment by Rambus related to JEDEC upon which Nanya relied; (9) the manufacturers failed to
establish that Rambus violated unfair competition law by its conduct before JEDEC; (10) the
evidence related to Rambuss patent prosecution did not establish that Rambus unduly delayed in
prosecuting the claims in suit; (11) Rambus did not unreasonably delay bringing its patent
infringement claims; and (12) there is no basis for any unclean hands defense or unenforceability
claim arising from Rambuss conduct.
On March 10, 2009, the court entered final judgment against Hynix in the amount of
approximately $397 million as follows: approximately $134 million for infringement through December
31, 2005; approximately $215 million for infringement from January 1, 2006 through January 31,
2009; and approximately $48 million in pre-judgment interest. Post-judgment interest will accrue at
the statutory rate. In addition, the judgment orders Hynix to pay Rambus royalties on net sales for
U.S. infringement after January 31, 2009 and before April 18, 2010 of 1% for SDR SDRAM and 4.25%
for DDR DDR2, DDR3, GDDR, GDDR2 and GDDR3 SDRAM memory devices. On April 9, 2009, Rambus submitted
its cost bill in the amount of approximately $0.85 million. On March 24, 2009, Hynix filed a motion
under Rule 62 seeking relief from the requirement that it post a supersedeas bond in the full
amount of the final judgment in order to stay its execution pending an appeal. Rambus filed a brief
opposing Hynixs motion on April 10, 2009. A hearing on Hynixs motion was heard on May 8, 2009. On
May 14, 2009, the court granted Hynixs motion in part and ordered that execution of the judgment
be stayed on the condition that, within 45 days, Hynix post a supersedeas bond in the amount of
$250 million and provide Rambus with documentation establishing a lien in Rambuss favor on
property owned by Hynix in Korea in the amount of the judgment not covered by the supersedeas bond.
The Court also ordered that Hynix pay the ongoing royalties set forth in the final judgment into an
escrow account to be arranged by the parties; the escrowed funds would be released only upon
agreement of the parties or further order of the court. Hynix posted the $250 million supersedeas
bond on June 26, 2009. The parties are continuing to work on establishing the lien and the escrow
arrangement.
On April 6, 2009, Hynix filed its notice of appeal. On April 17, 2009, Rambus filed its notice
of cross appeal. The parties opening briefs are not yet due. Hynix filed a motion to dismiss
Rambus cross-appeal on July 1, 2009, and Rambus filed an opposition to Hynixs motion on July 15,
2009, and Hynix filed a reply on July 22, 2009. On July 23,
2009, Rambus and Hynix filed a joint motion to assign this appeal to
the same panel hearing the appeal in the Micron Delaware case
(discussed below) and to coordinate oral arguments of the two
appeals. No decision on either Hynixs motion or the joint
motion has issued to date.
Micron Litigation
U.S District Court in Delaware: Case No. 00-792-SLR
On August 28, 2000, Micron filed suit against Rambus in the U.S. District Court for Delaware.
The suit asserts violations of federal antitrust laws, deceptive trade practices, breach of
contract, fraud and negligent misrepresentation in connection with Rambus participation in JEDEC.
Micron seeks a declaration of monopolization by Rambus, compensatory and punitive damages,
attorneys fees, a declaratory judgment that eight Rambus patents are invalid and not infringed,
and the award to Micron of a royalty-free license to the Rambus patents. Rambus has filed an answer
and counterclaims disputing Microns claims and asserting infringement by Micron of 12 U.S.
patents.
This case has been divided into three phases in the same general order as in the Hynix
00-20905 action: (1) unclean hands; (2) patent infringement; and (3) antitrust, equitable estoppel,
and other JEDEC-related issues. A bench trial on Microns unclean hands defense began on November
8, 2007 and concluded on November 15, 2007. The court ordered post-trial briefing on the issue of
when Rambus became obligated to preserve documents because it anticipated litigation. A hearing on
that issue was held on May 20, 2008. The court ordered further post-trial briefing on the remaining
issues from the unclean hands trial, and a hearing on those issues was held on September 19, 2008.
On January 9, 2009, the court issued an opinion in which it determined that Rambus had engaged
in spoliation of evidence by failing to suspend general implementation of a document retention
policy after the point at which the court determined that Rambus
should have known litigation was reasonably foreseeable. The court issued an
accompanying order declaring the 12 patents in suit unenforceable against Micron (the Delaware
21
Order). On February 9, 2009, the court stayed all other proceedings pending appeal of the
Delaware Order. On February 10, 2009, judgment was entered against Rambus and in favor of Micron on
Rambus patent infringement claims and Microns corresponding claims for declaratory relief. On
March 11, 2009, Rambus filed its notice of appeal. Rambus filed its opening brief on July 2, 2009.
Microns answering brief is not yet due. On July 24, 2009,
Rambus filed a motion to assign this appeal to the same panel hearing
the appeal in the Hynix case (discussed above) and to coordinate oral
arguments of the two appeals. No decision on this motion has issued
to date.
U.S. District Court of the Northern District of California
On January 13, 2006, Rambus filed suit against Micron in the U.S. District Court for the
Northern District of California. Rambus alleges that 14 Rambus patents are infringed by Microns
DDR2, DDR3, GDDR3, and other advanced memory products. Rambus seeks compensatory and punitive
damages, attorneys fees, and injunctive relief. Micron has denied Rambus allegations and is
alleging counterclaims for violations of federal antitrust laws, unfair trade practices, equitable
estoppel, fraud and negligent misrepresentation in connection with Rambus participation in JEDEC.
Micron seeks a declaration of monopolization by Rambus, injunctive relief, compensatory and
punitive damages, attorneys fees, and a declaratory judgment of invalidity, unenforceability, and
noninfringement of the 14 patents in suit.
As explained above, the court ordered a coordinated trial (without Samsung) of certain common
JEDEC-related claims and defenses asserted in Hynix v Rambus, Case No. C 00-20905 RMW, Rambus Inc.
v. Samsung Electronics Co. Ltd. et al., Case No. 05-02298 RMW, Rambus Inc. v. Hynix Semiconductor
Inc., et al., Case No. 05-00334, and Rambus Inc. v. Micron Technology, Inc., et al., Case No. C
06-00244 RMW. The coordinated trial involving Rambus, Hynix, Micron and Nanya began on January 29,
2008, and was submitted to the jury on March 25, 2008. On March 26, 2008, the jury returned a
verdict in favor of Rambus and against Hynix, Micron, and Nanya on each of their claims.
Specifically, the jury found that Hynix, Micron, and Nanya failed to meet their burden of proving
that: (1) Rambus engaged in anticompetitive conduct; (2) Rambus made important representations that
it did not have any intellectual property pertaining to the work of JEDEC and intended or
reasonably expected that the representations would be heard by or repeated to others including
Hynix, Micron or Nanya; (3) Rambus uttered deceptive half-truths about its intellectual property
coverage or potential coverage of products compliant with synchronous DRAM standards then being
considered by JEDEC by disclosing some facts but failing to disclose other important facts; or (4)
JEDEC members shared a clearly defined expectation that members would disclose relevant knowledge
they had about patent applications or the intent to file patent applications on technology being
considered for adoption as a JEDEC standard. Hynix, Micron, and Nanya filed motions for a new trial
and for judgment on certain of their equitable claims and defenses. A hearing on those motions was
held on May 1, 2008. A further hearing on the equitable claims and defenses was held on May 27,
2008. On July 24, 2008, the court issued an order denying Hynix, Micron, and Nanyas motions for
new trial.
On March 3, 2009, the court issued an order rejecting Hynix, Micron, and Nanyas equitable
claims and defenses that had been tried during the coordinated trial. The court concluded (among
other things) that (1) Rambus did not have an obligation to disclose pending or anticipated patent
applications and had sound reasons for not doing so; (2) the evidence supported the jurys finding
that JEDEC members did not share a clearly defined expectation that members would disclose relevant
knowledge they had about patent applications or the intent to file patent applications on
technology being considered for adoption as a JEDEC standard; (3) the written JEDEC disclosure
policies did not clearly require members to disclose information about patent applications and the
intent to file patent applications in the future; (4) there was no clearly understood or legally
enforceable agreement of JEDEC members to disclose information about patent applications or the
intent to seek patents relevant to standards being discussed at JEDEC; (5) during the time Rambus
attended JEDEC meetings, Rambus did not have any patent application pending that covered a JEDEC
standard, and none of the patents in suit was applied for until well after Rambus resigned from
JEDEC; (6) Rambuss conduct at JEDEC did not constitute an estoppel or waiver of its rights to
enforce its patents; (7) Hynix, Micron, and Nanya failed to carry their burden to prove their
asserted waiver and estoppel defenses not directly based on Rambuss conduct at JEDEC; (8) the
evidence did not support a finding of any material misrepresentation, half truths or fraudulent
concealment by Rambus related to JEDEC upon which Nanya relied; (9) the manufacturers failed to
establish that Rambus violated unfair competition law by its conduct before JEDEC; (10) the
evidence related to Rambuss patent prosecution did not establish that Rambus unduly delayed in
prosecuting the claims in suit; (11) Rambus did not unreasonably delay bringing its patent
infringement claims; and (12) there is no basis for any unclean hands defense or unenforceability
claim arising from Rambuss conduct.
In these cases (except for the Hynix 00-20905 action), a hearing on claim construction and the
parties cross-motions for summary judgment on infringement and validity was held on June 4 and 5,
2008. On July 10, 2008, the court issued its claim construction order relating to the
Farmwald/Horowitz patents in suit and denied Hynix, Micron, Nanya, and Samsungs (collectively, the
Manufacturers) motions for summary judgment of noninfringement and invalidity based on their
proposed claim construction. The court issued claim construction orders relating to the Ware
patents in suit on July 25 and August 27, 2008, and denied the Manufacturers motion for summary
judgment of noninfringement of certain claims. On September 4, 2008, at the courts direction,
22
Rambus elected to proceed to trial on 12 patent claims, each from the Farmwald/Horowitz
family. On September 16, 2008, Rambus granted a covenant not to assert any claim of patent
infringement against the Manufacturers under the Ware patents in suit (U.S. Patent Nos. 6,493,789
and 6,496,897), and each partys claims relating to those patents were dismissed with prejudice. On
November 21, 2008, the court entered an order clarifying certain aspects of its July 10, 2008,
claim construction order. On November 24, 2008, the court granted Rambus motion for summary
judgment of direct infringement with respect to claim 16 of Rambus U.S. Patent No. 6,266,285 by
the Manufacturers DDR2, DDR3, gDDR2, GDDR3, GDDR4 memory chip products (except for Nanyas DDR3
memory chip products). In the same order, the court denied the remainder of Rambus motion for
summary judgment of infringement.
On January 19, 2009, Micron filed a motion for summary judgment on the ground that the
Delaware Order should be given preclusive effect. Rambus filed an opposition to Microns motion on
January 26, 2009, and a hearing was held on January 30, 2009. On February 3, 2009, the court
entered a stay of this action pending resolution of Rambus appeal of the Delaware Order.
European Patent Infringement Cases
On September 11, 2000, Rambus filed suit against Micron in multiple European jurisdictions for
infringement of its European patent, EP 0 525 068 (the 068 patent), which was later revoked.
Additional suits were filed pertaining to a second Rambus patent, EP 1 022 642 (the 642 patent)
and a third Rambus patent, EP 1 004 956 (the 956 patent). Rambus suit against Micron for
infringement of the 642 patent in Mannheim, Germany, has not been active. The Mannheim court
issued an Order of Cost with respect to the 068 proceeding requiring Rambus to reimburse Micron
attorneys fees in the amount of $0.45 million. This amount has since been paid. One proceeding in
Italy relating to the 642 patent was adjourned at a hearing on June 15, 2007, each party bearing
its own costs. Two other proceedings in Italy relating to the 956 patent remain ongoing.
DDR2, DDR3, gDDR2, GDDR3, GDDR4 Litigation (DDR2)
U.S District Court in the Northern District of California
On January 25, 2005, Rambus filed a patent infringement suit in the U.S. District Court for
the Northern District of California court against Hynix, Infineon, Nanya, and Inotera. Infineon and
Inotera were subsequently dismissed from this litigation and Samsung was added as a defendant.
Rambus alleges that certain of its patents are infringed by certain of the defendants SDRAM, DDR,
DDR2, DDR3, gDDR2, GDDR3, GDDR4 and other advanced memory products. Hynix, Samsung and Nanya have
denied Rambus claims and asserted counterclaims against Rambus for, among other things, violations
of federal antitrust laws, unfair trade practices, equitable estoppel, and fraud in connection with
Rambus participation in JEDEC.
As explained above, the court ordered a coordinated trial of certain common JEDEC-related
claims and defenses asserted in Hynix v Rambus, Case No. C 00-20905 RMW, Rambus Inc. v. Samsung
Electronics Co. Ltd. et al., Case No. 05-02298 RMW, Rambus Inc. v. Hynix Semiconductor Inc., et
al., Case No. 05-00334, and Rambus Inc. v. Micron Technology, Inc., et al., Case No. C 06-00244
RMW. The court subsequently excused Samsung from the coordinated trial on December 14, 2007, based
on Samsungs agreement to certain conditions, including trial of its claims against Rambus within
six months following the conclusion of the coordinated trial. The coordinated trial involving
Rambus, Hynix, Micron and Nanya began on January 29, 2008, and was submitted to the jury on March
25, 2008. On March 26, 2008, the jury returned a verdict in favor of Rambus and against Hynix,
Micron, and Nanya on each of their claims. Specifically, the jury found that Hynix, Micron, and
Nanya failed to meet their burden of proving that: (1) Rambus engaged in anticompetitive conduct;
(2) Rambus made important representations that it did not have any intellectual property pertaining
to the work of JEDEC and intended or reasonably expected that the representations would be heard by
or repeated to others including Hynix, Micron or Nanya; (3) Rambus uttered deceptive half- truths
about its intellectual property coverage or potential coverage of products compliant with
synchronous DRAM standards then being considered by JEDEC by disclosing some facts but failing to
disclose other important facts; or (4) JEDEC members shared a clearly defined expectation that
members would disclose relevant knowledge they had about patent applications or the intent to file
patent applications on technology being considered for adoption as a JEDEC standard. Hynix, Micron,
and Nanya filed motions for a new trial and for judgment on certain of their equitable claims and
defenses. A hearing on those motions was held on May 1, 2008. A further hearing on the equitable
claims and defenses was held on May 27, 2008. On July 24, 2008, the court issued an order denying
Hynix, Micron, and Nanyas motions for new trial.
On March 3, 2009, the court issued an order rejecting Hynix, Micron, and Nanyas equitable
claims and defenses that had been tried during the coordinated trial. The court concluded (among
other things) that (1) Rambus did not have an obligation to disclose pending or anticipated patent
applications and had sound reasons for not doing so; (2) the evidence supported the jurys finding
that JEDEC members did not share a clearly defined expectation that members would disclose relevant
knowledge they had about patent applications or the intent to file patent applications on
technology being considered for adoption as a JEDEC standard; (3) the written
23
JEDEC disclosure policies did not clearly require members to disclose information about patent
applications and the intent to file patent applications in the future; (4) there was no clearly
understood or legally enforceable agreement of JEDEC members to disclose information about patent
applications or the intent to seek patents relevant to standards being discussed at JEDEC; (5)
during the time Rambus attended JEDEC meetings, Rambus did not have any patent application pending
that covered a JEDEC standard, and none of the patents in suit was applied for until well after
Rambus resigned from JEDEC; (6) Rambuss conduct at JEDEC did not constitute an estoppel or waiver
of its rights to enforce its patents; (7) Hynix, Micron, and Nanya failed to carry their burden to
prove their asserted waiver and estoppel defenses not directly based on Rambuss conduct at JEDEC;
(8) the evidence did not support a finding of any material misrepresentation, half truths or
fraudulent concealment by Rambus related to JEDEC upon which Nanya relied; (9) the manufacturers
failed to establish that Rambus violated unfair competition law by its conduct before JEDEC; (10)
the evidence related to Rambuss patent prosecution did not establish that Rambus unduly delayed in
prosecuting the claims in suit; (11) Rambus did not unreasonably delay bringing its patent
infringement claims; and (12) there is no basis for any unclean hands defense or unenforceability
claim arising from Rambuss conduct.
In these cases (except for the Hynix 00-20905 action), a hearing on claim construction and the
parties cross-motions for summary judgment on infringement and validity was held on June 4 and 5,
2008. On July 10, 2008, the court issued its claim construction order relating to the
Farmwald/Horowitz patents in suit and denied the Manufacturers motions for summary judgment of
noninfringement and invalidity based on their proposed claim construction. The court issued claim
construction orders relating to the Ware patents in suit on July 25 and August 27, 2008, and denied
the Manufacturers motion for summary judgment of noninfringement of certain claims. On September
4, 2008, at the courts direction, Rambus elected to proceed to trial on 12 patent claims, each
from the Farmwald/Horowitz family. On September 16, 2008, Rambus granted a covenant not to assert
any claim of patent infringement against the Manufacturers under U.S. Patent Nos. 6,493,789 and
6,496,897, and each partys claims relating to those patents were dismissed with prejudice. On
November 21, 2008, the court entered an order clarifying certain aspects of its July 10, 2008,
claim construction order. On November 24, 2008, the court granted Rambuss motion for summary
judgment of direct infringement with respect to claim 16 of Rambuss U.S. Patent No. 6,266,285 by
the Manufacturers DDR2, DDR3, gDDR2, GDDR3, GDDR4 memory chip products (except for Nanyas DDR3
memory chip products). In the same order, the court denied the remainder of Rambuss motion for
summary judgment of infringement.
On January 19, 2009, Samsung, Nanya, and Hynix filed motions for summary judgment on the
ground that the Delaware Order should be given preclusive effect. Rambus filed opposition briefs to
these motions on January 26, 2009, and a hearing was held on January 30, 2009. On February 3, 2009,
the court entered a stay of this action pending resolution of Rambus appeal of the Delaware Order.
Samsung Litigation
U.S District Court in the Northern District of California
On June 6, 2005, Rambus filed a patent infringement suit against Samsung in the U.S. District
Court the Northern District of California alleging that Samsungs SDRAM and DDR SDRAM parts
infringe 9 of Rambus patents. Samsung has denied Rambus claims and asserted counterclaims for
non-infringement, invalidity and unenforceability of the patents, violations of various antitrust
and unfair competition statutes, breach of license, and breach of duty of good faith and fair
dealing. Samsung has also counterclaimed that Rambus aided and abetted breach of fiduciary duty and
intentionally interfered with Samsungs contract with a former employee by knowingly hiring a
former Samsung employee who allegedly misused proprietary Samsung information. Rambus has denied
Samsungs counterclaims.
As explained above, the court ordered a coordinated trial of certain common JEDEC-related
claims and defenses asserted in Hynix v Rambus, Case No. C 00-20905 RMW, Rambus Inc. v. Samsung
Electronics Co. Ltd. et al., Case No. 05-02298 RMW, Rambus Inc. v. Hynix Semiconductor Inc., et
al., Case No. 05-00334, and Rambus Inc. v. Micron Technology, Inc., et al., Case No. C 06-00244
RMW. The court subsequently excused Samsung from the coordinated trial on December 14, 2007, based
on Samsungs agreement to certain conditions, including trial of its claims against Rambus within
six months following the conclusion of the coordinated trial (see below). In these cases (except
for the Hynix 00-20905 action), a hearing on claim construction and the parties cross-motions for
summary judgment on infringement and validity was held on June 4 and 5, 2008. On July 10, 2008, the
court issued its claim construction order relating to the Farmwald/Horowitz patents in suit and
denied the Manufacturers motions for summary judgment of noninfringement and invalidity based on
their proposed claim construction. The court issued claim construction orders relating to the Ware
patents in suit on July 25 and August 27, 2008, and denied the Manufacturers motion for summary
judgment of noninfringement of certain claims. On September 4, 2008, at the courts direction,
Rambus elected to proceed to trial on 12 patent claims, each from the Farmwald/Horowitz family. On
September 16, 2008, Rambus granted a covenant not to assert any claim of
24
patent infringement against the Manufacturers under U.S. Patent Nos. 6,493,789 and 6,496,897,
and each partys claims relating to those patents were dismissed with prejudice. On November 21,
2008, the court entered an order clarifying certain aspects of its July 10, 2008, claim
construction order. On November 24, 2008, the court granted Rambuss motion for summary judgment of
direct infringement with respect to claim 16 of Rambuss U.S. Patent No. 6,266,285 by the
Manufacturers DDR2, DDR3, gDDR2, GDDR3, GDDR4 memory chip products (except for Nanyas DDR3 memory
chip products). In the same order, the court denied the remainder of Rambuss motion for summary
judgment of infringement.
On January 19, 2009, Samsung filed a motion for summary judgment on the ground that the
Delaware Order should be given preclusive effect. Rambus filed an opposition brief to this motion
on January 26, 2009, and a hearing was held on January 30, 2009. On February 3, 2009, the court
entered a stay of this action pending resolution of Rambus appeal of the Delaware Order.
On August 11, 2008, the court granted summary judgment in Rambus favor on Samsungs claims
for aiding and abetting a breach of fiduciary duty, intentional interference with contract, and
certain aspects of Samsungs unfair competition claim. On September 16, 2008, the court entered a
stipulation and order of dismissal with prejudice of certain of Samsungs claims and defenses
(including those based on Rambus alleged JEDEC conduct) and Rambus defenses corresponding to
Samsungs claims. A bench trial on the remaining claims and defenses that are unique to Samsung
(breach of license, breach of duty of good faith and fair dealing, and estoppel based on those
claims), as well as Samsungs claims and defenses related to its allegations that Rambus spoliated
evidence, was held between September 22 and October 1, 2008. On April 27, 2009, the court issued
Findings of Fact and Conclusions of Law holding that: (1) the parties 2000 SDR/DDR license
agreement did not cover DDR2 and future generation products; (2) the license did not entitle
Samsung to most favored licensee benefits in any renewal or subsequent agreement; (3) Rambus did
not fail to negotiate an extension or renewal license in good faith, and Samsung would not have
been entitled to damages for any such failure; (4) Samsungs equitable estoppel defense failed; (5)
Rambus breached the license by not offering Samsung the benefit to which it was entitled under the
license (for the second quarter of 2005 only) of the royalty in the March 2005 settlement agreement
between Rambus and Infineon; (6) Rambus failed to prove that Samsung breached certain audit
provisions in the license, and therefore Rambuss termination of the license less than one month
before it was due to expire was improper; and (7) Rambuss actions did not cause the parties
failure to reach agreement on an extension or renewal of the license. No decision has issued to
date regarding Samsungs spoliation allegations.
Federal Trade Commission Complaint
On June 19, 2002, the FTC filed a complaint against Rambus. The FTC alleged that through
Rambus action and inaction at JEDEC, Rambus violated Section 5 of the FTC Act in a way that
allowed Rambus to obtain monopoly power in or that by acting with intent to monopolize it
created a dangerous probability of monopolization in synchronous DRAM technology markets. The
FTC also alleged that Rambus action and practices at JEDEC constituted unfair methods of
competition in violation of Section 5 of the FTC Act. As a remedy, the FTC sought to enjoin Rambus
right to enforce patents with priority dates prior to June 1996 as against products made pursuant
to certain existing and future JEDEC standards.
On February 17, 2004, the FTC Chief Administrative Law Judge issued his initial decision
dismissing the FTCs complaint against Rambus on multiple independent grounds (the Initial
Decision). The FTCs Complaint Counsel appealed this decision.
On August 2, 2006, the FTC released its July 31, 2006, opinion and order reversing and
vacating the Initial Decision and determining that Rambus violated Section 5 of the Federal Trade
Commission Act. Following further briefing and oral argument on issues relating to remedy, the FTC
released its opinion and order on remedy on February 5, 2007. The remedy order set the maximum
royalty rate that Rambus could collect on the manufacture, use or sale in the United States of
certain JEDEC-compliant parts after the effective date of the Order. The order also mandated that
Rambus offer a license for these products at rates no higher than the maximums set by the FTC,
including a further cap on rates for the affected non-memory products. The order further required
Rambus to take certain steps to comply with the terms of the order and applicable disclosure rules
of any standard setting organization of which it may become a member.
The FTCs order explicitly did not set maximum rates or other conditions with respect to
Rambus royalty rates for DDR2 SDRAM, other post-DDR JEDEC standards, or for non-JEDEC-standardized
technologies such as those used in RDRAM or XDR DRAM.
On March 16, 2007, the FTC issued an order granting in part and denying in part Rambus motion
for a stay of the remedy pending appeal. The March 16, 2007 order permitted Rambus to acquire
rights to royalty payments for use of the patented technologies affected by the February 2 remedy
order during the period of the stay in excess of the FTC-imposed maximum royalty rates on
25
SDRAM and DDR SDRAM products, provided that funds above the maximum allowed rates be either
placed into an escrow account to be distributed, or payable pursuant a contingent contractual
obligation, in accordance with the ultimate decision of the court of appeals. In an opinion
accompanying its order, the FTC clarified that it intended its remedy to be forward-looking and
prospective only, and therefore unlikely to be construed to require Rambus to refund royalties
already paid or to restrict Rambus from collecting royalties for the use of its technologies during
past periods.
On April 27, 2007, the FTC issued an order granting in part and denying in part Rambus
petition for reconsideration of the remedy order. The FTCs order and accompanying opinion on
Rambus petition for reconsideration clarified the remedy order in certain respects. For example,
(1) the FTC explicitly stated that the remedy order did not require Rambus to make refunds or
prohibit it from collecting royalties in excess of maximum allowable royalties that accrue up to
the effective date of the remedy order; (2) the remedy order was modified to specifically permit
Rambus to seek damages in litigation up to three times the specified maximum allowable royalty
rates on the ground of willful infringement and any allowable attorneys fees; and (3) under the
remedy order, licensees were permitted to pay Rambus a flat fee in lieu of running royalties, even
if such an arrangement resulted in payments above the FTCs rate caps in certain circumstances.
Rambus appealed the FTCs liability and remedy orders to the U.S. Court of Appeals for the
District of Columbia (the CADC). Oral argument was heard February 14, 2008. On April 22, 2008,
the CADC issued an opinion which requires vacatur of the FTCs orders. The CADC held that the FTC
failed to demonstrate that Rambus conduct was exclusionary, and thus failed to establish its
allegation that Rambus unlawfully monopolized any relevant market. The CADCs opinion set aside the
FTCs orders and remanded the matter to the FTC for further proceedings consistent with the
opinion. Regarding the chance of further proceedings on remand, the CADC expressed serious concerns
about the strength of the evidence relied on to support some of the FTCs crucial findings
regarding the scope of JEDECs patent disclosure policies and Rambus alleged violation of those
policies. On August 26, 2008, the CADC denied the FTCs petition to rehear the case en banc. On
October 16, 2008, the FTC issued an order explicitly authorizing Rambus to receive amounts above
the maximum rates allowed by the FTCs now-vacated order payable pursuant to any contingent
contractual obligation.
On November 24, 2008, the FTC filed a petition seeking review of the CADC decision by the
U.S. Supreme Court. Rambus filed an opposition to the FTCs petition on January 23, 2009, and the FTC
filed a reply on February 4, 2009. On February 23, 2009, the United States Supreme Court denied the
FTCs petition. On May 12, 2009, the Commission issued an order dismissing the complaint, finding
that further litigation in this matter would not be in the public interest.
European Commission Competition Directorate-General
On or about April 22, 2003, Rambus was notified by the European Commission Competition
Directorate-General (Directorate) (the European Commission) that it had received complaints from
Infineon and Hynix. Rambus answered the ensuing requests for information prompted by those
complaints on June 16, 2003. Rambus obtained a copy of Infineons complaint to the European
Commission in late July 2003, and on October 8, 2003, at the request of the European Commission,
filed its response. The European Commission sent Rambus a further request for information on
December 22, 2006, which Rambus answered on January 26, 2007. On August 1, 2007, Rambus received a
statement of objections from the European Commission. The statement of objections alleges that
through Rambus participation in the JEDEC standards setting organization and subsequent conduct,
Rambus violated European Union competition law. Rambus filed a response to the statement of
objections on October 31, 2007, and a hearing was held on December 4 and 5, 2007.
On June 12, 2009, the European Commission announced that it has reached a tentative settlement
with Rambus to resolve the pending case. Under the proposed resolution, the Commission would make
no finding of liability relative to JEDEC-related charges, and no fine would be assessed against
Rambus. In addition, Rambus would commit to offer licenses with maximum royalty rates for certain
memory types and memory controllers on a forward-going basis (the Commitment). The Commitment is
expressly made without any admission by Rambus of the allegations asserted against it. The
Commitment also does not resolve any existing claims of infringement prior to the signing of any
license with a prospective licensee, nor does it release or excuse any of the prospective licensees
from damages or royalty obligations through the date of signing a license. In accordance with
European Commission antitrust procedures, interested third parties were invited to submit comments
on the proposed Commitment to the European Commission within one month of the announcement. The
comment period has expired, but no final decision has issued to date. Under the proposed
resolution, Rambus would offer licenses with maximum royalty rates for five-year worldwide licenses
of 1.5% for DDR2, DDR3, GDDR3 and GDDR4 SDRAM memory types. Licensees who ship less than 10% of
their DRAM products in the older SDR and DDR DRAM types would be entitled to a royalty holiday for
those older types, subject to compliance with the terms of the license. In addition, Rambus would
offer licenses with maximum royalty rates for five-year worldwide licenses of 1.5% per unit for
26
SDR memory controllers through April 2010, dropping to 1.0% thereafter, and royalty rates of
2.65% per unit for DDR, DDR2, DDR3, GDDR3 and GDDR4 memory controllers through April 2010, then
dropping to 2.0%. The Commitment to license at the above rates would be valid for a period of five
years from the adoption date of the Commitment decision. All royalty rates would be applicable to
future shipments only and does not affect liability, if any, for damages or royalties that accrued
up to the time of the license grant.
Superior Court of California for the County of San Francisco
On May 5, 2004, Rambus filed a lawsuit against Micron, Hynix, Infineon and Siemens in San
Francisco Superior Court (the San Francisco court) seeking damages for conspiring to fix prices
(California Bus. & Prof. Code §§ 16720 et seq.), conspiring to monopolize under the Cartwright Act
(California Bus. & Prof. Code §§ 16720 et seq.), intentional interference with prospective economic
advantage, and unfair competition (California Bus. & Prof. Code §§ 17200 et seq.). This lawsuit
alleges that there were concerted efforts beginning in the 1990s to deter innovation in the DRAM
market and to boycott Rambus and/or deter market acceptance of Rambus RDRAM product. Subsequently,
Infineon and Siemens were dismissed from this action (as a result of a settlement with Infineon)
and three Samsung-related entities were added as defendants.
A hearing on Rambus motion for summary judgment on the grounds that Microns cross-complaint
is barred by the statute of limitations was held on August 1, 2008. At the hearing, the San
Francisco court granted Rambus motion as to Microns first cause of action (alleged violation of
Californias Cartwright Act) and continued the motion as to Microns second and third causes of
action (alleged violation of unfair business practices act and alleged intentional interference
with prospective economic advantage). No further order has issued on Rambus motion.
On November 25, 2008, Micron, Samsung, and Hynix filed eight motions for summary judgment on
various grounds. On January 26, 2009, Rambus filed briefs in opposition to all eight motions. A
hearing on these motions for summary judgment was held on March 4-6, March 16-17, and June 29,
2009. The court denied all eight motions. On June 17 and June 22, 2009, Micron, Samsung, and Hynix
filed petitions requesting that the court of appeal issue writs directing the trial court to vacate
two orders denying motions for summary judgment and enter orders
granting the motions. On July 27, 2009, the court of appeal
denied one of the two petitions. No decision
has issued to date on the remaining petition.
On March 10, 2009, defendants filed motions requesting that Rambus case be dismissed on the
ground that the Delaware Order should be given preclusive effect. Rambus filed a brief opposing
this request. The parties filed further briefs on the preclusive effect, if any, of the Delaware
Order on April 3 and April 17, 2009. The parties submitted briefs on their allegations regarding
alleged spoliation of evidence on April 20, 2009. A hearing on these issues was held on April 27
and June 1, 2009, at the conclusion of which the court denied defendants motion for issue
preclusion and terminating sanctions. On June 19, 2009, Micron and Samsung filed petitions
requesting that the court of appeal issue writs directing the trial court to vacate its order
denying defendants motion for issue preclusion and terminating sanctions and enter an order
granting the motion. Hynix filed a similar petition on June 23, 2009. On July 6, 2009, the court of
appeal denied all three of these petitions. On July 16, 2009, Samsung
and Micron filed petitions requesting that the California Supreme
Court review the court of appeals denial of their petitions. No
decision has issued to date on these petitions to the California
Supreme Court.
Trial is scheduled to begin on September 28, 2009.
Stock Option Investigation Related Claims
On May 30, 2006, the Audit Committee commenced an internal investigation of the timing of past
stock option grants and related accounting issues.
On May 31, 2006, the first of three shareholder derivative actions was filed in the U.S.
District Court for the Northern District of California against Rambus (as a nominal defendant) and
certain current and former executives and board members. These actions have been consolidated for
all purposes under the caption, In re Rambus Inc. Derivative Litigation, Master File No.
C-06-3513-JF (N.D. Cal.), and Howard Chu and Gaetano Ruggieri were appointed lead plaintiffs. The
consolidated complaint, as amended, alleges violations of certain federal and state securities laws
as well as other state law causes of action. The complaint seeks disgorgement and damages in an
unspecified amount, unspecified equitable relief, and attorneys fees and costs.
On August 22, 2006, another shareholder derivative action was filed in Delaware Chancery Court
against Rambus (as a nominal defendant) and certain current and former executives and board members
(Bell v. Tate et al., 2366-N (Del. Chancery)). On May 16, 2008, this case was dismissed pursuant to
a notice filed by the plaintiff.
27
On October 18, 2006, the Board of Directors formed a Special Litigation Committee (the SLC)
to evaluate potential claims or other actions arising from the stock option granting activities.
The Board of Directors appointed J. Thomas Bentley, Chairman of the Audit Committee, and Abraham
Sofaer, a retired federal judge and Chairman of the Legal Affairs Committee, both of whom joined
the Rambus Board of Directors in 2005, to comprise the SLC.
On August 24, 2007, the final written report setting forth the findings of the SLC was filed
with the court. As set forth in its report, the SLC determined that all claims should be terminated
and dismissed against the named defendants in In re Rambus Inc. Derivative Litigation with the
exception of claims against named defendant Ed Larsen, who served as Vice President, Human
Resources from September 1996 until December 1999, and then Senior Vice President, Administration
until July 2004. The SLC entered into settlement agreements with certain former officers of Rambus.
These settlements are conditioned upon the dismissal of the claims asserted against these
individuals in In re Rambus Inc. Derivative Litigation. The aggregate value of the settlements to
Rambus exceeds $5.3 million in cash as well as substantial additional value to Rambus relating to
the relinquishment of claims to over 2.7 million stock options. The SLC stated its intention to
assert control over the litigation. The conclusions and recommendations of the SLC are subject to
review by the court. On October 5, 2007, Rambus filed a motion to terminate in accordance with the
SLCs recommendations. Pursuant to the parties agreement, that motion was taken off calendar.
On August 30, 2007, another shareholder derivative action was filed in the U.S. District Court
for the Southern District of New York against Rambus (as a nominal defendant) and
PricewaterhouseCoopers LLP (Francl v. PricewaterhouseCoopers LLP et al., No. 07-Civ. 7650 (GBD)).
On November 21, 2007, the New York court granted PricewaterhouseCoopers LLPs motion to transfer
the action to the Northern District of California.
The parties have settled In re Rambus Inc. Derivative Litigation and Francl v.
PricewaterhouseCoopers LLP et al., No. 07-Civ. 7650 (GBD). The settlement provided for a payment by
Rambus of $2.0 million and dismissal with prejudice of all claims against all defendants, with the
exception of claims against Ed Larsen, in these actions. The $2.0 million was accrued for during
the quarter ended June 30, 2008 within accrued litigation expenses. A final approval hearing was
held on January 16, 2009, and an order of final approval was entered on January 20, 2009.
On July 17, 2006, the first of six class action lawsuits was filed in the U.S. District Court
for the Northern District of California against Rambus and certain current and former executives
and board members. These lawsuits were consolidated under the caption, In re Rambus Inc. Securities
Litigation, C-06-4346-JF (N.D. Cal.). The settlement of this action was preliminarily approved by
the court on March 5, 2008. Pursuant to the settlement agreement, Rambus paid $18.3 million into a
settlement fund on March 17, 2008. Some alleged class members requested exclusion from the
settlement. A final fairness hearing was held on May 14, 2008. That same day the court entered an
order granting final approval of the settlement agreement and entered judgment dismissing with
prejudice all claims against all defendants in the consolidated class action litigation.
On March 1, 2007, a pro se lawsuit was filed in the Northern District of California by two
alleged Rambus shareholders against Rambus, certain current and former executives and board
members, and PricewaterhouseCoopers LLP (Kelley et al. v. Rambus, Inc. et al. C-07-01238-JF (N.D.
Cal.)). This action was consolidated with a substantially identical pro se lawsuit filed by another
purported Rambus shareholder against the same parties. The consolidated complaint against Rambus
alleges violations of federal and state securities laws, and state law claims for fraud and breach
of fiduciary duty. Following several rounds of motions to dismiss, on April 17, 2008, the court
dismissed all claims with prejudice except for plaintiffs claims under sections 14(a) and 18(a) of
the Securities and Exchange Act of 1934 as to which leave to amend was granted. On June 2, 2008,
plaintiffs filed an amended complaint containing substantially the same allegations as the prior
complaint although limited to claims under sections 14(a) and 18(a) of the Securities and Exchange
Act of 1934. Rambus motion to dismiss the amended complaint was heard on September 12, 2008. On
December 9, 2008, the court granted Rambus motion and entered judgment in favor of Rambus.
Plaintiffs filed a notice of appeal on December 15, 2008. Plaintiffs filed their opening brief on
April 13, 2009. Rambus opposed on May 29, 2009, and plaintiffs filed a reply brief on June 12,
2009. No date has been set for oral argument.
On September 11, 2008, the same pro se plaintiffs filed a separate lawsuit in Santa Clara
County Superior Court against Rambus, certain current and former executives and board members, and
PricewaterhouseCoopers LLP (Kelley et al. v. Rambus, Inc. et al., Case No. 1-08-CV-122444). The
complaint alleges violations of certain California state securities statues as well as fraud and
negligent misrepresentation based on substantially the same underlying factual allegations
contained in the pro se lawsuit filed in federal court. On November 24, 2008, Rambus filed a motion
to dismiss or, in the alternative, stay this case in light of the first-filed federal action. On
January 12, 2009, Rambus filed a demurrer to plaintiffs complaint on the ground that it was barred
by the doctrine of claim preclusion. A hearing on Rambus motions was held on February 27, 2009.
The court granted Rambuss motion to stay the case pending the outcome of the appeal in the federal
action and denied the remainder of the motions without prejudice.
28
On August 25, 2008, an amended complaint was filed by certain individuals and entities in
Santa Clara County Superior Court against Rambus, certain current and former executives and board
members, and PricewaterhouseCoopers LLP (Steele et al. v. Rambus Inc. et al., Case No.
1-08-CV-113682). The amended complaint alleges violations of certain California state securities
statues as well as fraud and negligent misrepresentation. On October 10, 2008, Rambus filed a
demurrer to the amended complaint. A hearing was held on January 9, 2009. On January 12, 2009, the
court sustained Rambus demurrer without prejudice. Plaintiffs filed a second amended complaint on
February 13, 2009, containing the same causes of action as the previous complaint. On March 17,
2009, Rambus filed a demurrer to the second amended complaint. A hearing was held on May 22, 2009.
On May 26, 2009, the court sustained in part and overruled in part Rambuss demurrer. On June 5,
2009, Rambus filed an answer denying plaintiffs remaining allegations. Discovery is ongoing.
NVIDIA Litigation
U.S District Court in the Northern District of California
On July 10, 2008, Rambus filed suit against NVIDIA Corporation (NVIDIA) in the U.S. District
Court for the Northern District of California alleging that NVIDIAs products with memory
controllers for at least the SDR, DDR, DDR2, DDR3, GDDR and GDDR3 technologies infringe 17 patents.
On September 16, 2008, Rambus granted a covenant not to assert any claim of patent infringement
against NVIDIA under U.S. Patent Nos. 6,493,789 and 6,496,897, accordingly 15 patents remain in
suit. On December 30, 2008, the court granted NVIDIAs motion to stay this case as to Rambus
claims that NVIDIAs products infringe nine patents that are also the subject of proceedings in
front of the International Trade Commission (described below), and denied NVIDIAs motion to stay
the remainder of Rambus patent infringement claims. Certain limited discovery is proceeding, and a
case management conference is scheduled for August 21, 2009.
On July 11, 2008, one day after Rambus filed suit, NVIDIA filed its own action against Rambus
in the U.S. District Court for the Middle District of North Carolina alleging that Rambus committed
antitrust violations of the Sherman Act; committed antitrust violations of North Carolina law; and
engaged in unfair and deceptive practices in violation of North Carolina law. NVIDIA seeks
injunctive relief, damages, and attorneys fees and costs. This case has been transferred and
consolidated into Rambuss patent infringement case. Rambus filed a motion to dismiss NVIDIAs
claims prior to transfer of the action to California, and no decision has issued to date.
International Trade Commission
On November 6, 2008, Rambus filed a complaint with the U.S. International Trade Commission
(the ITC) requesting the commencement of an investigation pertaining to NVIDIA products. The
complaint seeks an exclusion order barring the importation, sale for importation, or sale after
importation of products that infringe nine Rambus patents from the Ware and Barth families of
patents. The accused products include NVIDIA products that incorporate DDR, DDR2, DDR3, LPDDR,
GDDR, GDDR2, and GDDR3 memory controllers, including graphics processors, and media and
communications processors. The complaint names NVIDIA as a proposed respondent, as well as
companies whose products incorporate accused NVIDIA products and are imported into the United
States. Additional respondents include: Asustek Computer Inc. and Asus Computer International, BFG
Technologies, Biostar Microtech and Biostar Microtech International Corp., Diablotek Inc., EVGA
Corp., G.B.T. Inc. and Giga-Byte Technology Co., Hewlett-Packard, MSI Computer Corp. and Micro-Star
International Co., Palit Multimedia Inc. and Palit Microsystems Ltd., Pine Technology Holdings, and
Sparkle Computer Co.
On December 4, 2008, the ITC instituted the investigation. A hearing on claim construction was
held on March 24, 2009, and a claim construction order issued on June 22, 2009. On June 5, 2009,
Rambus moved to withdraw from the investigation four of the asserted patents and certain claims of
a fifth asserted patent in order to simplify the investigation, streamline the final hearing, and
conserve Commission resources. The parties have filed motions for summary determination of various
issues, including infringement, respondents allegations of invalidity, and certain of respondents
other defenses. No decision has issued to date on any of the motions. A final hearing before the
administrative law judge is scheduled for October 13-20, 2009.
Potential Future Litigation
In addition to the litigation described above, participants in the DRAM and controller markets
continue to adopt Rambus technologies into various products. Rambus has notified many of these
companies of their use of Rambus technology and continues to evaluate how to proceed on these
matters. There can be no assurance that any ongoing or future litigation will be successful. Rambus
spends substantial company resources defending its intellectual property in litigation, which may
continue for the foreseeable future
29
given the multiple pending litigations. The outcomes of these litigations as well as any
delay in their resolution could affect Rambus ability to license its intellectual property in
the future.
The Company records a contingent liability when it is probable that a loss has been incurred
and the amount is reasonably estimable in accordance with SFAS No. 5, Accounting for
Contingencies.
14. Fair Value of Financial Instruments
The Company adopted SFAS No. 157 effective January 1, 2008 for financial assets and
liabilities measured on a recurring basis. SFAS No. 157 applies to all financial assets and
financial liabilities that are being measured and reported on a fair value basis. The adoption of
SFAS No. 157 did not impact the consolidated financial statements. SFAS No. 157 requires disclosure
that establishes a framework for measuring fair value and expands disclosure about fair value
measurements. The statement requires fair value measurement be classified and disclosed in one of
the following three categories:
Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement
date for identical, unrestricted assets or liabilities;
The Company uses unadjusted quotes to determine fair value. The financial assets in Level 1
include money market funds.
Level 2: Quoted prices in markets that are not active, or inputs which are observable, either
directly or indirectly, for substantially the full term of the asset or liability;
The Company uses observable pricing inputs including benchmark yields, reported trades, and
broker/dealer quotes. The financial assets in Level 2 include U.S. government bonds and notes,
corporate notes, commercial paper and municipal bonds and notes.
Level 3: Prices or valuation techniques that require inputs that are both significant to the
fair value measurement and unobservable (i.e., supported by little or no market activity).
The Company does not hold financial assets categorized in Level 3.
The Company tests the pricing inputs by obtaining prices from two different sources for the
same security on a sample of its portfolio. The Company has not adjusted the pricing inputs it has
obtained.
The following table presents the financial instruments that are carried at fair value and
summarizes the valuation of our cash equivalents and marketable securities by the above SFAS No.
157 pricing levels as of June 30, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of June 30, 2009 |
|
|
|
|
|
|
|
Quoted |
|
|
|
|
|
|
|
|
|
|
|
|
|
market |
|
|
Significant |
|
|
|
|
|
|
|
|
|
|
prices in |
|
|
other |
|
|
Significant |
|
|
|
|
|
|
|
active |
|
|
observable |
|
|
unobservable |
|
|
|
|
|
|
|
markets |
|
|
inputs |
|
|
inputs |
|
(in thousands) |
|
Total |
|
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
Cash equivalents |
|
$ |
314,450 |
|
|
$ |
314,450 |
|
|
$ |
|
|
|
$ |
|
|
Marketable securities |
|
|
162,400 |
|
|
|
|
|
|
|
162,400 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total available-for-sale securities |
|
$ |
476,850 |
|
|
$ |
314,450 |
|
|
$ |
162,400 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table presents the financial instruments that are not carried at fair value but
which require fair value disclosure as of June 30, 2009 and December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of June 30, 2009 |
|
|
As of December 31, 2008 |
|
|
|
Face |
|
|
Carrying |
|
|
|
|
|
|
Face |
|
|
Carrying |
|
|
|
|
(in thousands) |
|
Value |
|
|
Value |
|
|
Fair Value |
|
|
Value |
|
|
Value |
|
|
Fair Value |
|
Zero Coupon Convertible Senior Notes due 2010 |
|
$ |
136,950 |
|
|
$ |
130,646 |
|
|
$ |
137,806 |
|
|
$ |
136,950 |
|
|
$ |
125,474 |
|
|
$ |
125,493 |
|
5% Convertible Senior Notes due 2014 |
|
|
150,000 |
|
|
|
92,450 |
|
|
|
157,200 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Convertible notes |
|
$ |
286,950 |
|
|
$ |
223,096 |
|
|
$ |
295,006 |
|
|
$ |
136,950 |
|
|
$ |
125,474 |
|
|
$ |
125,493 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The fair value of the convertible notes at each balance sheet date is determined based on
recent quoted market prices for these notes. As discussed in Note 15, Convertible Notes, the
convertible notes are carried at face value of $287 million, less any
unamortized debt discount in accordance with FSP APB 14-1. The carrying value of other
financial instruments, including cash, accounts receivable, accounts payable and other payables,
approximate fair value due to their short maturities.
30
15. Convertible Notes
In May 2008, the FASB issued FSP APB 14-1, Accounting for Convertible Debt Instruments That
May Be Settled in Cash upon Conversion (Including Partial Cash Settlement), which clarifies the
accounting for convertible debt instruments that may be settled in cash upon conversion, including
partial cash settlement. FSP APB 14-1 specifies that an issuer of such instruments should
separately account for the liability and equity components of the instruments in a manner that
reflects the issuers non-convertible debt borrowing rate when interest costs are recognized in
subsequent periods. The debt component was determined based on a binomial lattice model. The equity
component, recorded as additional paid-in capital, represents the difference between the proceeds
from the issuance of the convertible notes and the fair value of the liability, net of deferred
taxes, as of the date of issuance. Both of the Companys convertible notes satisfy the criteria for
accounting under FSP APB 14-1. FSP APB 14-1 was effective for the Companys fiscal year beginning
January 1, 2009, and retrospective application is required for all periods presented. The Company
accounted for this change in accounting principle by retrospectively adjusting its prior period
financial statements to reflect the impact of FSP APB 14-1 on its zero coupon convertible senior
notes due 2010. The Companys historical annual financial statements, including the consolidated
condensed statement of operations for the three months ended June 30, 2008, were retrospectively
adjusted for the adoption of FSP APB 14-1 in the Current Report on Form 8-K filed with the SEC on
June 22, 2009.
The following adjustments to reflect the retrospective application of FSP APB 14-1 on the zero
coupon convertible senior notes due 2010 have been made to the previously reported consolidated
condensed statement of operations which were not included in the Current Report on Form 8-K filed with the SEC
on June 22, 2009 based on the periods presented therein.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended June 30, 2008 |
|
|
|
As previously reported |
|
|
Adjustments |
|
|
As adjusted |
|
|
|
(In thousands, except per share amounts) |
|
Interest expense |
|
$ |
|
|
|
$ |
(5,832 |
) |
|
$ |
(5,832 |
) |
Net loss before income taxes |
|
$ |
(32,642 |
) |
|
$ |
(5,832 |
) |
|
$ |
(38,474 |
) |
Provision for income taxes |
|
|
124,656 |
|
|
|
(10,461 |
) |
|
|
114,195 |
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(157,298 |
) |
|
$ |
4,629 |
|
|
$ |
(152,669 |
) |
|
|
|
|
|
|
|
|
|
|
Net loss per share: Basic |
|
$ |
(1.50 |
) |
|
$ |
0.04 |
|
|
$ |
(1.46 |
) |
Net loss per share: Diluted |
|
$ |
(1.50 |
) |
|
$ |
0.04 |
|
|
$ |
(1.46 |
) |
The Companys convertible notes are shown in the following table.
|
|
|
|
|
|
|
|
|
|
|
As of June 30, |
|
|
As of December 31, |
|
(dollars in thousands) |
|
2009 |
|
|
2008 |
|
Zero Coupon Convertible Senior Notes due 2010 |
|
$ |
136,950 |
|
|
$ |
136,950 |
|
5% Convertible Senior Notes due 2014 |
|
|
150,000 |
|
|
|
|
|
|
|
|
|
|
|
|
Total principal amount of convertible notes |
|
|
286,950 |
|
|
|
136,950 |
|
Unamortized discount |
|
|
(63,854 |
) |
|
|
(11,476 |
) |
|
|
|
|
|
|
|
Total convertible notes |
|
$ |
223,096 |
|
|
$ |
125,474 |
|
Less current portion |
|
|
(130,646 |
) |
|
|
|
|
|
|
|
|
|
|
|
Total long-term convertible notes |
|
$ |
92,450 |
|
|
$ |
125,474 |
|
|
|
|
|
|
|
|
5% Convertible Senior Notes due 2014. On June 29, 2009, Rambus issued $150.0 million aggregate
principal amount of 5% convertible senior notes due June 15, 2014. As of the
date of issuance Rambus determined that the liability component of the 2014 Notes was $92.4 million
and the equity component of the 2014 Notes was $57.6 million. The unamortized discount related to
the 2014 Notes is being amortized to interest expense over five years through June 2014.
Rambus will pay cash interest at an annual rate of 5% of the principal amount at issuance,
payable semi-annually in arrears on June 15 and December 15 of each year, beginning on December 15,
2009. Issuance costs were approximately $4.5 million of which $2.8 million is related to the
liability portion, which is being amortized to interest expense over five years (the expected term of
the debt), and $1.7 million is related to the equity portion. The 2014 Notes are Rambus general
unsecured obligation, ranking equal in right of payment to all of Rambus existing and future
senior indebtness, including the 2010 Notes, and senior in right of payment to any
of Rambus future indebtness that is expressly subordinated to the 2014 Notes.
31
The 2014 Notes are convertible into shares of Rambus Common Stock at an initial conversion
rate of 51.8 shares of Common Stock per $1,000 principal amount of 2014 Notes. This is equivalent
to an initial conversion price of approximately $19.31 per share of common stock. Holders may
surrender their 2014 Notes for conversion prior to March 15, 2014 only under the following
circumstances: (i) during any calendar quarter beginning after the calendar quarter ending
September 30, 2009, and only during such calendar quarter, if the closing sale price of the Common
Stock for 20 or more trading days in the period of 30 consecutive trading days ending on the last
trading day of the immediately preceding calendar quarter exceeds 130% of the conversion price in
effect on the last trading day of the immediately preceding calendar quarter, (ii) during the five
business day period after any 10 consecutive trading day period in which the trading price per
$1,000 principal amount of 2014 Notes for each trading day of such 10 consecutive trading day
period was less than 98% of the product of the closing sale price of the Common Stock for such
trading day and the applicable conversion rate, (iii) upon the occurrence of specified
distributions to holders of the Common Stock, (iv) upon a
fundamental change of Rambus as specified in the Indenture governing the 2014 Notes, or (v) if Rambus calls any or all of the 2014 Notes for
redemption, at any time prior to the close of business on the business day immediately preceding
the redemption date. On and after March 15, 2014, holders may convert their 2014 Notes at any time
until the close of business on the third business day prior to the maturity date, regardless of the
foregoing circumstances.
Upon
conversion of the 2014 Notes, Rambus will pay (i) cash equal to the lesser of the aggregate
principal amount and the conversion value of the 2014 Notes and (ii) shares of Rambus Common Stock for
the remainder, if any, of Rambus conversion obligation, in each case based on a daily conversion
value calculated on a proportionate basis for each trading day in the 20 trading day conversion
reference period as further specified in the Indenture.
Rambus may not redeem the 2014 Notes at its option prior to June 15, 2012. At any time on or
after June 15, 2012, Rambus will have the right, at its option, to redeem the 2014 Notes in whole
or in part for cash in an amount equal to 100% of the principal amount of the 2014 Notes to be
redeemed, together with accrued and unpaid interest, if any, if the closing sale price of the
Common Stock for at least 20 of the 30 consecutive trading days immediately prior to any date
Rambus gives a notice of redemption is greater than 130% of the conversion price on the date of
such notice.
Upon the occurrence of a fundamental change, holders may require Rambus to repurchase some or
all of their 2014 Notes for cash at a price equal to 100% of the principal amount of the 2014 Notes
being repurchased, plus accrued and unpaid interest, if any. In addition, upon the occurrence of
certain fundamental changes, as that term is defined in the Indenture, Rambus will, in certain
circumstances, increase the conversion rate for 2014 Notes converted in connection with such
fundamental changes by a specified number of shares of Common Stock, not to exceed 15.5401 per
$1,000 principal amount of the 2014 Notes.
The following events are
considered Events of Default under the Indenture which may result in the acceleration of
the maturity of the 2014 Notes:
|
(1) |
|
default in the payment when due of any principal of any of
the 2014 Notes at maturity, upon redemption or upon
exercise of a repurchase right or otherwise; |
|
|
(2) |
|
default in the payment of any interest, including
additional interest, if any, on any of the 2014 Notes, when
the interest becomes due and payable, and continuance of
such default for a period of 30 days; |
|
|
(3) |
|
Rambus failure to deliver cash or cash and shares of
Common Stock (including any additional shares deliverable
as a result of a conversion in connection with a make-whole
fundamental change) when required to be delivered upon the
conversion of any 2014 Note; |
|
|
(4) |
|
default in Rambus obligation to provide notice of the
occurrence of a fundamental change when required by the
Indenture; |
|
|
(5) |
|
Rambus failure to comply with any of its other agreements
in the 2014 Notes or the Indenture (other than those
referred to in clauses (1) through (4) above) for 60 days
after Rambus receipt of written notice to Rambus of such
default from the trustee or to Rambus and the trustee of
such default from holders of not less than 25% in aggregate
principal amount of the 2014 Notes then outstanding; |
|
|
(6) |
|
Rambus failure to pay when due the principal of, or
acceleration of, any indebtedness for money borrowed by
Rambus or any of its subsidiaries in excess of $30,000,000
principal amount, if such indebtedness is not discharged,
or such acceleration is not annulled, by the end of a
period of ten days after written notice to Rambus by the
trustee or to Rambus and the trustee by the holders of at
least 25% in aggregate principal amount of the 2014 Notes
then outstanding; and |
|
(7) |
|
certain events of bankruptcy, insolvency or reorganization
relating to Rambus or any of its material subsidiaries (as
defined in the Indenture). |
32
If an event of default, other than an event of default in clause (7) above with respect to
Rambus occurs and is continuing, either the trustee or the holders of at least 25% in aggregate
principal amount of the 2014 Notes then outstanding may declare the principal amount of, and
accrued and unpaid interest, including additional interest, if any, on the 2014 Notes then
outstanding to be immediately due and payable. If an event of default described in clause (7) above
occurs with respect to Rambus the principal amount of and accrued and unpaid interest, including
additional interest, if any, on the 2014 Notes will automatically become immediately due and
payable.
Zero Coupon Convertible Senior Notes due 2010.
On February 1, 2005, Rambus issued $300.0
million aggregate principal amount of zero coupon convertible senior notes due February 1, 2010
to Credit Suisse First Boston LLC and Deutsche Bank Securities as initial
purchasers who then sold the 2010 Notes to institutional investors. The 2010 Notes are convertible
at any time prior to the close of business on the maturity date into cash in an amount equal to the
lesser of:
|
(1) |
|
the principal amount of each note to be converted and |
|
|
(2) |
|
the conversion value, which is equal to (a) the applicable conversion rate,
multiplied by (b) the applicable stock price, as defined. |
|
|
|
If the conversion value is greater than the principal amount of each note, (as defined )
represented by the excess of conversion value, Rambus, at its option, may deliver net
shares, cash, or a combination of cash and shares of its Common Stock, with a value equal to
the net shares. |
The initial conversion price is $26.84 per share of Common Stock (which represents an initial
conversion rate of 37.2585 shares of Rambus Common Stock per $1,000 principal amount of 2010
Notes). The initial conversion price is subject to certain
adjustments, as specified in the indenture governing the 2010 Notes.
Upon the retrospective application of FSP APB 14-1, Rambus determined that the liability
component of the 2010 Notes was $200.3 million and the equity component was
$99.7 million. Subsequently, Rambus repurchased $140.0 million and $23.1 million face value of the
outstanding 2010 Notes in 2005 and 2008, respectively.
The remaining 2010 Notes liability is classified as a current liability at June 30, 2009 since
the notes are due February 1, 2010.
Additional paid in capital at June 30, 2009 and December 31, 2008 includes $47.9 million
related to the remaining equity component of the 2010 Notes. Additional paid in capital at June
30, 2009 includes $55.9 million related to the equity component of the 2014 Notes.
As of June 30, 2009, the if-converted value of the outstanding 2010 Notes and 2014 Notes is
less than the principal amount of the notes.
Interest expense related to the notes for the three and six months ended June 30, 2009 was as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(In thousands) |
|
2014 Notes amortization of discount at an additional effective
interest rate of 11.7% |
|
$ |
53 |
|
|
$ |
|
|
|
$ |
53 |
|
|
$ |
|
|
2014 Notes coupon interest at a rate of 5% |
|
|
42 |
|
|
|
|
|
|
|
42 |
|
|
|
|
|
2010 Notes amortization of discount at an effective interest rate of 8.4% |
|
|
2,722 |
|
|
|
2,944 |
|
|
|
5,392 |
|
|
|
5,832 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total interest expense |
|
$ |
2,817 |
|
|
$ |
2,944 |
|
|
$ |
5,487 |
|
|
$ |
5,832 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33
16. Subsequent Events
On July 10, 2009, an additional $22.5 million in aggregate principal amount of 2014 Notes were
issued as a result of the underwriters exercising their overallotment option related to the 2014
Notes. Issuance costs were approximately $0.5 million. The Company is currently evaluating the
allocation of the $22.5 million between liability and equity pursuant to FSP APB 14-1. These
additional notes have the same terms as the original $150.0 million of the 2014 Notes issued during
the quarter ended June 30, 2009. See Note 15, Convertible Notes, for terms.
34
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
This report contains forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements
relate to our expectations for future events and time periods. All statements other than statements
of historical fact are statements that could be deemed to be forward-looking statements, including
any statements regarding trends in future revenue or results of operations, gross margin or
operating margin, expenses, earnings or losses from operations, synergies or other financial items;
any statements of the plans, strategies and objectives of management for future operations; any
statements concerning developments, performance or industry ranking; any statements regarding
future economic conditions or performance; any statements regarding pending investigations, claims
or disputes; any statements of expectation or belief; and any statements of assumptions underlying
any of the foregoing. Generally, the words anticipate, believes, plans, expects, future,
intends, may, should, estimates, predicts, potential, continue and similar
expressions identify forward-looking statements. Our forward-looking statements are based on
current expectations, forecasts and assumptions and are subject to risks, uncertainties and changes
in condition, significance, value and effect. As a result of the factors described herein, and in
the documents incorporated herein by reference, including, in particular, those factors described
under Risk Factors, we undertake no obligation to publicly disclose any revisions to these
forward-looking statements to reflect events or circumstances occurring subsequent to filing this
report with the Securities and Exchange Commission.
Rambus, RDRAM, XDR, FlexIO and FlexPhase are trademarks or registered trademarks of Rambus
Inc. Other trademarks that may be mentioned in this quarterly report on Form 10-Q are the property
of their respective owners.
Industry terminology, used widely throughout this report, has been abbreviated and, as such,
these abbreviations are defined below for your convenience:
|
|
|
Double Data Rate
|
|
DDR |
Dynamic Random Access Memory
|
|
DRAM |
Fully Buffered-Dual Inline Memory Module
|
|
FB-DIMM |
Gigabits per second
|
|
Gb/s |
Graphics Double Data Rate
|
|
GDDR |
Input/Output
|
|
I/O |
Peripheral Component Interconnect
|
|
PCI |
Rambus Dynamic Random Access Memory
|
|
RDRAM |
Single Data Rate
|
|
SDR |
Synchronous Dynamic Random Access Memory
|
|
SDRAM |
eXtreme Data Rate
|
|
XDR |
From time to time we will refer to the abbreviated names of certain entities and, as such,
have provided a chart to indicate the full names of those entities for your convenience.
|
|
|
Advanced Micro Devices Inc.
|
|
AMD |
ARM Holdings plc
|
|
ARM |
Cadence Design Systems, Inc.
|
|
Cadence |
Cisco Systems, Inc.
|
|
Cisco |
Elpida Memory, Inc.
|
|
Elpida |
Fujitsu Limited
|
|
Fujitsu |
GDA Technologies, Inc.
|
|
GDA |
Hewlett-Packard Company
|
|
Hewlett-Packard |
Hynix Semiconductor, Inc.
|
|
Hynix |
Infineon Technologies AG
|
|
Infineon |
Inotera Memories, Inc.
|
|
Inotera |
Intel Corporation
|
|
Intel |
International Business Machines Corporation
|
|
IBM |
Joint Electron Device Engineering Council
|
|
JEDEC |
Juniper Networks, Inc.
|
|
Juniper |
Matsushita Electrical Industrial Co.
|
|
Matsushita |
Micron Technologies, Inc.
|
|
Micron |
Nanya Technology Corporation
|
|
Nanya |
NEC Electronics Corporation
|
|
NEC |
Optical Internetworking Forum
|
|
OIF |
35
|
|
|
Qimonda AG (formerly Infineons DRAM operations)
|
|
Qimonda |
Panasonic Corporation
|
|
Panasonic |
Peripheral Component Interconnect Special Interest Group
|
|
PCI-SIG |
Renesas Technology Corporation
|
|
Renesas |
Samsung Electronics Co., Ltd.
|
|
Samsung |
Sony Computer Electronics
|
|
Sony |
Spansion, Inc.
|
|
Spansion |
ST Microelectronics
|
|
ST Micro |
Synopsys Inc.
|
|
Synopsys |
Tessera Technologies, Inc.
|
|
Tessera |
Texas Instruments Inc.
|
|
Texas Instruments |
Toshiba Corporation
|
|
Toshiba |
Velio Communications
|
|
Velio |
Business Overview
We design, develop and license chip interface technologies and architectures that are
foundational to nearly all digital electronics products. Our chip interface technologies are
designed to improve the performance, power efficiency, time-to-market and cost-effectiveness of our
customers semiconductor and system products for computing, gaming and graphics, consumer
electronics and mobile applications.
As of June 30, 2009, our chip interface technologies are covered by more than 810 U.S. and
foreign patents. Additionally, we have approximately 560 patent applications pending. These patents
and patent applications cover important inventions in memory and logic chip interfaces, in addition
to other technologies. We believe that our chip interface technologies provide our customers a
means to achieve higher performance, improved power efficiency, lower risk, and greater
cost-effectiveness in their semiconductor and system products.
Our primary method of providing interface technologies to our customers is through our
patented innovations. We license our broad portfolio of patented inventions to semiconductor and
system companies who use these inventions in the development and manufacture of their own products.
Such licensing agreements may cover the license of part, or all, of our patent portfolio. Patent
license agreements are generally royalty bearing.
We also develop a range of solutions including leadership (which are Rambus-proprietary
interfaces or architectures widely licensed to our customers) and industry-standard chip interfaces
that we provide to our customers under license for incorporation into their semiconductor and
system products. Due to the often complex nature of implementing state-of-the art chip interface
technology, we offer engineering services to our customers to help them successfully integrate our
chip interface solutions into their semiconductors and systems. These technology license agreements
may have both a fixed price (non-recurring) component and ongoing royalties. Engineering services
are generally offered on a fixed price basis. Further, under technology licenses, our customers may
receive licenses to our patents necessary to implement the chip interface in their products with
specific rights and restrictions to the applicable patents elaborated in their individual contracts
with us.
We derive the majority of our annual revenue by licensing our broad portfolio of patents for
chip interfaces to our customers. Such licenses may cover part or all of our patent portfolio.
Leading semiconductor and system companies such as AMD, Fujitsu, Intel, NEC, Panasonic, Renesas,
and Toshiba have licensed our patents for use in their own products.
We derive additional revenue by licensing our leadership architectures and industry-standard
chip interfaces to customers for use in their semiconductor and system products. Our customers
include leading companies such as Elpida, IBM, Intel, Panasonic, Sony and Toshiba. Due to the
complex nature of implementing our technologies, we provide engineering services under certain of
these licenses to help our customers successfully integrate our technology solutions into their
semiconductors and system products. Additionally, licensees may receive, as an adjunct to their
technology license agreements, patent licenses as necessary to implement the technology in their
products with specific rights and restrictions to the applicable patents elaborated in their
individual contracts.
Royalties represent a substantial majority of our total revenue. The remaining part of our
revenue is contract services revenue which includes license fees and engineering services fees. The
timing and amounts invoiced to customers can vary significantly depending on specific contract
terms and can therefore have a significant impact on deferred revenue or unbilled receivables in
any given period.
36
We have a high degree of revenue concentration, with our top five licensees representing
approximately 79% and 78% of our revenue for the three and six months
ended June 30, 2009, respectively. This
compares with the three and six months ended June 30, 2008, in which revenue from our top five
licensees accounted for approximately 69% and 68% of our revenue, respectively. For the three
months ended June 30, 2009, revenue from Fujitsu, Sony, AMD, Toshiba and NEC each accounted for 10%
or more of our total revenue. For the six months ended June 30, 2009, revenue from Fujitsu, NEC,
AMD, Sony and Panasonic each accounted for 10% or more of our total revenue. For the three months
ended June 30, 2008, revenue from Fujistu, Elpida, Sony, AMD and Panasonic each accounted for 10%
or more of our total revenue. For the six months ended June 30, 2008, revenue from Fujitsu, Elpida
and Sony each accounted for 10% or more of our total revenue.
Our revenue from companies headquartered outside of the United States accounted for
approximately 83% and 82% of our total revenue for the three and six months ended June 30, 2009,
respectively as compared to 84% and 83% for the three and six months ended June 30, 2008, respectively. We expect
that we may continue to experience significant revenue concentration and have significant revenue
from sources outside the United States for the foreseeable future.
Historically, we have been involved in significant litigation stemming from the unlicensed use
of our inventions. Our litigation expenses have been high and difficult to predict and we
anticipate future litigation expenses will continue to be significant, volatile and difficult to
predict. If we are successful in the litigation and/or related licensing, our revenue could be
substantially higher in the future; if we are unsuccessful, our revenue would likely decline.
Furthermore, our success in litigation matters pending before courts and regulatory bodies that
relate to our intellectual property rights have impacted and will likely continue to impact our
ability and the terms upon which we are able to negotiate new or renegotiate existing licenses for
our technology.
We expect that revenue derived from international licensees will continue to represent a
significant portion of our total revenue in the future. To date, all of the revenue from
international licensees have been denominated in U.S. dollars. However, to the extent that such
licensees sales to systems companies are not denominated in U.S. dollars, any royalties that we
receive as a result of such sales could be subject to fluctuations in currency exchange rates. In
addition, if the effective price of licensed semiconductors sold by our foreign licensees were to
increase as a result of fluctuations in the exchange rate of the relevant currencies, demand for
licensed semiconductors could fall, which in turn would reduce our royalties. We do not use
financial instruments to hedge foreign exchange rate risk.
37
Results of Operations
The following table sets forth, for the periods indicated, the percentage of total revenue
represented by certain items reflected in our unaudited condensed consolidated statements of
operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
June 30, |
|
June 30, |
|
|
2009 |
|
2008 |
|
2009 |
|
2008 |
Revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Royalties |
|
|
91.8 |
% |
|
|
90.4 |
% |
|
|
93.8 |
% |
|
|
86.7 |
% |
Contract revenue |
|
|
8.2 |
% |
|
|
9.6 |
% |
|
|
6.2 |
% |
|
|
13.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of contract revenue* |
|
|
5.3 |
% |
|
|
18.4 |
% |
|
|
6.7 |
% |
|
|
18.3 |
% |
Research and development* |
|
|
58.2 |
% |
|
|
56.1 |
% |
|
|
61.8 |
% |
|
|
55.1 |
% |
Marketing, general and administrative* |
|
|
120.7 |
% |
|
|
66.5 |
% |
|
|
128.3 |
% |
|
|
75.7 |
% |
Costs (recovery) of restatement and
related legal activities |
|
|
(1.6 |
)% |
|
|
6.3 |
% |
|
|
(25.9 |
)% |
|
|
4.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses |
|
|
182.6 |
% |
|
|
147.3 |
% |
|
|
170.9 |
% |
|
|
153.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating loss |
|
|
(82.6 |
)% |
|
|
(47.3 |
)% |
|
|
(70.9 |
)% |
|
|
(53.3 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income and other income
(expense), net |
|
|
4.3 |
% |
|
|
8.1 |
% |
|
|
4.8 |
% |
|
|
9.9 |
% |
Interest expense |
|
|
(10.4 |
)% |
|
|
(8.2 |
)% |
|
|
(10.1 |
)% |
|
|
(7.6 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and other income (expense), net |
|
|
(6.1 |
)% |
|
|
(0.1 |
)% |
|
|
(5.3 |
)% |
|
|
2.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes |
|
|
(88.7 |
)% |
|
|
(47.4 |
)% |
|
|
(76.2 |
)% |
|
|
(51.0 |
)% |
Provision for income taxes |
|
|
0.1 |
% |
|
|
339.9 |
% |
|
|
0.0 |
% |
|
|
151.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
|
(88.8 |
)% |
|
|
(387.3 |
)% |
|
|
(76.2 |
)% |
|
|
(202.3 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* Includes stock-based compensation: |
|
Cost of contract revenue |
|
|
0.9 |
% |
|
|
3.8 |
% |
|
|
1.1 |
% |
|
|
4.4 |
% |
Research and development |
|
|
8.2 |
% |
|
|
10.5 |
% |
|
|
9.1 |
% |
|
|
10.2 |
% |
Marketing, general and administrative |
|
|
20.0 |
% |
|
|
10.7 |
% |
|
|
19.7 |
% |
|
|
11.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
|
|
|
|
|
Six Months |
|
|
|
|
|
|
Ended June 30, |
|
|
Change in |
|
|
Ended June 30, |
|
|
Change in |
|
(Dollars in millions) |
|
2009 |
|
|
2008 |
|
|
Percentage |
|
|
2009 |
|
|
2008 |
|
|
Percentage |
|
Total Revenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Royalties |
|
$ |
24.8 |
|
|
$ |
32.3 |
|
|
|
(23.3 |
)% |
|
$ |
50.9 |
|
|
$ |
65.4 |
|
|
|
(22.1 |
)% |
Contract revenue |
|
|
2.2 |
|
|
|
3.4 |
|
|
|
(35.1 |
)% |
|
|
3.4 |
|
|
|
10.1 |
|
|
|
(66.4 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue |
|
$ |
27.0 |
|
|
$ |
35.7 |
|
|
|
(24.4 |
)% |
|
$ |
54.3 |
|
|
$ |
75.5 |
|
|
|
(28.0 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Royalty Revenue
Patent Licenses
In the three and six months ended June 30, 2009, our largest source of royalties was related
to the license of our patents for SDR and DDR-compatible products. Royalties decreased
approximately $8.0 million and $12.9 million for SDR and DDR-compatible products in the three and
six months ended June 30, 2009, respectively, as compared to the three and six months ended June 30, 2008,
primarily due to the expiration of Elpida licensing agreement in the first quarter of 2008 for
which revenues were recognized through the three months ended June 30, 2008.
In the three and six months ended June 30, 2008, our largest source of royalties was related
to the license of our patents for SDR and DDR-compatible products. Royalties decreased
approximately $8.1 million and $22.0 million for SDR and DDR-compatible products in the three and
six months ended June 30, 2008, respectively, as compared to the same periods in 2007, primarily
due to decreased revenue from Fujitsu and Qimonda.
We are in negotiations with prospective and existing licensees. We expect SDR and
DDR-compatible royalties will continue to vary from period to period based on our success in
renewing existing license agreements and adding new licensees, as well as the level of variation in
our licensees reported shipment volumes, sales price and mix, offset in part by the proportion of
licensee payments that are fixed.
Technology Licenses
In the three and six months ended June 30, 2009, royalties from XDR, FlexIO, DDR and serial
link-compatible products represented the second largest category of royalties. Royalties from these
products decreased approximately $2.2 million and $3.2 million during the three and six months
ended June 30, 2009, respectively, as compared to the same periods in 2008. This decrease was
primarily due to lower royalties from the Sony PLAYSTATION®3
product due to lower shipment volume. In
the future, we expect
38
royalties from XDR, FlexIO, DDR and serial link-compatible products will continue to vary from
period to period based on our licensees shipment volumes, sales prices and product mix.
In the three and six months ended June 30, 2008, royalties from XDR, FlexIO, DDR and serial
link-compatible products represented the second largest category of royalties. Royalties from XDR,
FlexIO, DDR and serial link-compatible products increased approximately $0.9 million and $3.6
million during the three and six months ended June 30, 2008, respectively, as compared to the same
periods in 2007. This increase was primarily due to higher royalties from DDR and serial
link-compatible products from higher sales by our licensees. Royalties from the shipment of the
Sony PLAYSTATION®3 product remained relatively flat and increased $1.0 million during the three and
six months ended June 30, 2008, respectively, as compared to the same periods in 2007. In the
future, we expect royalties from XDR, FlexIO, DDR and serial link-compatible products will continue
to vary from period to period based on our licensees shipment volumes, sales prices and product
mix.
In the three and six months ended June 30, 2009, royalties from RDRAM-compatible products
represented the third largest source of royalties. Royalties from RDRAM memory chips and
controllers increased approximately $2.6 million and $1.7 million during the three and six months
ended June 30, 2009, respectively, as compared to the same periods in 2008. The increase was
primarily due to a one-time catch-up royalty payment for the Sony PlayStation®2 product in the
second quarter of 2009.
In the three and six months ended June 30, 2008, royalties from RDRAM-compatible products
represented the third largest source of royalties. Royalties from RDRAM memory chips and
controllers increased approximately $0.3 million and $0.9 million during the three and six months
ended June 30, 2008, respectively, as compared to the same periods in 2007. The increase was
primarily due to higher royalties from RDRAM controllers.
Contract Revenue
Percentage-of-Completion Contracts
Percentage of completion contract revenue decreased approximately $1.6 million and $5.4
million for the three and six months ended June 30, 2009, respectively, as compared to the same
periods in 2008. The decrease is due to decreased amount of work performed on both leadership and
industry standard chip interface contracts. We believe that percentage-of-completion contract
revenue recognized will continue to fluctuate over time based on our ongoing contractual
requirements, the amount of work performed, and by changes to work required, as well as new
contracts booked in the future.
Other Contracts
Revenue for other contracts increased approximately $0.4 million for the three months ended
June 30, 2009 and decreased $1.2 million for the six months ended June 30, 2009, as compared
to the corresponding periods in 2008. The increase for the three months ended June 30, 2009 is
mainly due to the completion of an $1.1 million industry
standard chip interface contract. The decrease for
the six months ended June 30, 2009 is due to decreased volume
from industry standard chip interface
contracts. We believe that other contracts revenue will continue to fluctuate over time based on
our ongoing contract requirements, the timing of completing engineering deliverables, as well as
new contracts booked in the future.
Engineering costs:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
|
|
Six Months Ended |
|
|
|
|
|
|
June 30, |
|
|
Change in |
|
|
June 30, |
|
|
Change in |
|
(Dollars in millions) |
|
2009 |
|
|
2008 |
|
|
Percentage |
|
|
2009 |
|
|
2008 |
|
|
Percentage |
|
Engineering costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of contract revenue |
|
$ |
1.2 |
|
|
$ |
5.2 |
|
|
|
(76.9 |
)% |
|
$ |
3.0 |
|
|
$ |
10.5 |
|
|
|
(71.5 |
)% |
Stock-based compensation |
|
|
0.2 |
|
|
|
1.4 |
|
|
|
(82.9 |
)% |
|
|
0.6 |
|
|
|
3.3 |
|
|
|
(81.0 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cost of contract revenue |
|
|
1.4 |
|
|
|
6.6 |
|
|
|
(78.1 |
)% |
|
|
3.6 |
|
|
|
13.8 |
|
|
|
(73.8 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
|
13.5 |
|
|
|
16.3 |
|
|
|
(17.0 |
)% |
|
|
28.6 |
|
|
|
33.9 |
|
|
|
(15.6 |
)% |
Stock-based compensation |
|
|
2.2 |
|
|
|
3.7 |
|
|
|
(41.2 |
)% |
|
|
5.0 |
|
|
|
7.6 |
|
|
|
(35.4 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total research and development |
|
|
15.7 |
|
|
|
20.0 |
|
|
|
(21.6 |
)% |
|
|
33.6 |
|
|
|
41.5 |
|
|
|
(19.2 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total engineering costs |
|
$ |
17.1 |
|
|
$ |
26.6 |
|
|
|
(35.5 |
)% |
|
$ |
37.2 |
|
|
$ |
55.3 |
|
|
|
(32.8 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
39
Total engineering costs decreased 35.5% and 32.8% for the three and six months ended June 30,
2009, respectively, as compared
to the same periods in 2008, primarily due to lower headcount and the related decrease in
salary, benefits and stock based compensation expenses as well as decreases in consulting and
facilities costs as a result of our cost reduction initiatives that commenced in the second half of
2008.
In the near term, we expect engineering expenses will continue to be lower than in 2008 as a
result of our cost reduction initiative undertaken in 2008. We intend to continue to make
investments in the infrastructure and technologies to maintain our leadership position in chip
interface technologies and quarterly expenses could vary.
Marketing, general and administrative costs:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
|
|
Six Months Ended |
|
|
|
|
|
|
June 30, |
|
|
Change in |
|
|
June 30, |
|
|
Change in |
|
(Dollars in millions) |
|
2009 |
|
|
2008 |
|
|
Percentage |
|
|
2009 |
|
|
2008 |
|
|
Percentage |
|
Marketing, general
and administrative
costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Marketing, general and
administrative costs |
|
$ |
12.2 |
|
|
$ |
10.9 |
|
|
|
11.8 |
% |
|
$ |
26.0 |
|
|
$ |
26.3 |
|
|
|
(1.0 |
)% |
Litigation expense |
|
|
15.0 |
|
|
|
9.1 |
|
|
|
65.2 |
% |
|
|
33.0 |
|
|
|
22.3 |
|
|
|
48.1 |
% |
Stock-based compensation |
|
|
5.4 |
|
|
|
3.8 |
|
|
|
41.4 |
% |
|
|
10.7 |
|
|
|
8.5 |
|
|
|
25.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total marketing,
general and
administrative costs |
|
$ |
32.6 |
|
|
$ |
23.8 |
|
|
|
37.0 |
% |
|
$ |
69.7 |
|
|
$ |
57.1 |
|
|
|
22.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total marketing, general and administrative costs increased 37.0% and 22.1% for the three and
six months ended June 30, 2009, respectively, as compared to the
same periods in 2008 due primarily
to the increased litigation expenses related to ongoing major cases and increased stock based
compensation expenses primarily related to nonvested equity awards granted during 2008.
Non-litigation related marketing, general and administrative costs increased 11.8% for the three
months ended June 30, 2009 as compared to the same period in 2008 due primarily to the higher
allocation of information technology and facilities expenses. Non-litigation related marketing,
general and administrative costs for the six months ended June 30, 2009 remained relatively flat as
compared to the same period in 2008 as the reduced consulting and professional fees and decrease in
overall marketing expenses related to cost reduction initiatives taken in 2008 are offset by higher
allocation of information technology and facilities expenses from higher percentage of headcount in
marketing, general and administrative. Salary expenses for the three and six months ended June 30,
2009 remained relatively flat as compared to the same periods in 2008 due to an internal
reorganization from our engineering group to the licensing and marketing group and corporate
development group offset by a decrease in headcount due to the cost reduction initiative.
In the future, marketing, general and administrative costs will vary from period to period
based on the trade shows, advertising, legal, and other marketing and administrative activities
undertaken, and the change in sales, marketing and administrative headcount in any given period.
Litigation expenses are expected to vary from period to period due to the variability of litigation
activities, but are expected to remain at levels higher than 2008 for the foreseeable future.
Costs (recovery) of restatement and related legal activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
|
|
Six Months Ended |
|
|
|
|
|
|
June 30, |
|
|
Change in |
|
|
June 30, |
|
|
Change in |
|
(Dollars in millions) |
|
2009 |
|
|
2008 |
|
|
Percentage |
|
|
2009 |
|
|
2008 |
|
|
Percentage |
|
Cost (recovery)
of restatement and
related legal
activities |
|
$ |
(0.4 |
) |
|
$ |
2.3 |
|
|
NM* |
|
$ |
(14.1 |
) |
|
$ |
3.2 |
|
|
NM* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
NM percentage is not meaningful as the change is too large |
Costs (recovery) of restatement and related legal activities consist primarily of
investigation, audit, legal and other professional fees related to the 2006-2007 stock option
investigation and the filing of the restated financial statements and related litigation.
Recovery of restatement and related legal activities were $0.4 million for the three months
ended June 30, 2009 primarily due to recognition of a settlement of $1.9 million from an insurance
carrier in connection with the derivative and class action lawsuits. Recovery of restatement and
related legal activities were $14.1 million for the six months ended June 30, 2009 primarily due to
recognition of settlements of $11.9 million from the insurance carriers and the receipt of $4.5
million from former executives as part of their settlement agreements with Rambus in connection
with the derivative and class action lawsuits. The $16.4 million was recorded as a recovery of
costs of restatement and related legal activities. Until all the litigation and related issues are
resolved, we anticipate that there could be additional amounts relating to these matters in the future.
40
Interest and other income (expense), net:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
|
|
|
|
|
Six Months |
|
|
|
|
|
|
Ended June 30, |
|
|
Change in |
|
|
Ended June 30, |
|
|
Change in |
|
(Dollars in millions) |
|
2009 |
|
|
2008 |
|
|
Percentage |
|
|
2009 |
|
|
2008 |
|
|
Percentage |
|
Interest
income and other income, net |
|
$ |
1.2 |
|
|
$ |
2.9 |
|
|
|
(59.7 |
)% |
|
$ |
2.6 |
|
|
$ |
7.5 |
|
|
|
(65.2 |
)% |
Interest expense |
|
|
(2.8 |
) |
|
|
(2.9 |
) |
|
|
(4.3 |
)% |
|
|
(5.5 |
) |
|
|
(5.8 |
) |
|
|
(5.9 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and other income (expense), net |
|
$ |
(1.6 |
) |
|
$ |
(0.0 |
) |
|
|
NM |
* |
|
$ |
(2.9 |
) |
|
$ |
1.7 |
|
|
|
(272.0 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
NM percentage is not meaningful as the change is too large |
Interest income and other income, net, consists primarily of interest income
generated from investments in high quality fixed income securities and foreign currency gains and
losses. The decrease in interest income and other income, net, for the three and six
months ended June 30, 2009 as compared to the same periods in 2008 was primarily due to lower
average investment balances and lower yields on invested balances during the period.
Interest expense primarily consists of non-cash interest expense related to the amortization
of the debt discount on the zero coupon convertible senior notes. On June 29, 2009, Rambus issued
$150.0 million aggregate principal amount of 5% convertible senior notes due June 15, 2014 (the
2014 Notes). Rambus expects interest expense to increase substantially in the near term as a
result of the coupon interest and the non-cash interest expense related to the amortization of the
debt discount on the 2014 Notes. See Note 15 Convertible Notes of Notes to Unaudited Condensed
Consolidated Financial Statements for additional details.
Provision for income taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
|
|
Six Months Ended |
|
|
|
|
|
|
June 30, |
|
|
Change in |
|
|
June 30, |
|
|
Change in |
|
(Dollars in millions) |
|
2009 |
|
|
2008 |
|
|
Percentage |
|
|
2009 |
|
|
2008 |
|
|
Percentage |
|
Provision for income taxes |
|
$ |
0.0 |
|
|
$ |
121.4 |
|
|
NM |
|
$ |
0.0 |
|
|
$ |
114.2 |
|
|
NM |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective tax rate |
|
|
(0.1 |
)% |
|
|
(716.0 |
)% |
|
|
|
|
|
|
(0.1 |
)% |
|
|
(296.8 |
)% |
|
|
|
|
|
|
|
* |
|
NM percentage is not meaningful as the change is too large |
Our effective tax rate for the three and six months ended June 30, 2009 is lower than the U.S.
statutory tax rate applied to our net loss due to a full valuation allowance on our U.S. net
deferred tax assets, foreign income taxes and state income taxes, partially offset by refundable
research and development tax credits.
Our effective tax rate for the three and six months ended June 30, 2008 was higher than the
U.S. statutory tax rate applied to our net loss primarily due to the establishment of a full
valuation allowance on our U.S. net deferred tax assets.
Liquidity and Capital Resources
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
|
June 30, |
|
|
December 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(In millions) |
|
Cash and cash equivalents |
|
$ |
318.0 |
|
|
$ |
116.2 |
|
Marketable securities |
|
|
162.4 |
|
|
|
229.6 |
|
|
|
|
|
|
|
|
Total cash, cash equivalents, and marketable securities |
|
$ |
480.4 |
|
|
$ |
345.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended |
|
|
June 30, |
|
|
2009 |
|
2008 |
|
|
(In millions) |
Net cash used in operating activities |
|
$ |
(18.3 |
) |
|
$ |
(25.7 |
) |
Net cash provided by investing activities |
|
$ |
64.1 |
|
|
$ |
51.4 |
|
Net cash provided by (used in) financing activities |
|
$ |
155.9 |
|
|
$ |
(13.4 |
) |
41
Liquidity
Although we used cash for operating activities in the first half of 2009, our management
continues to believe that total cash, cash equivalents and marketable securities will continue at
adequate levels to finance our operations, projected capital expenditures and commitments for the
next twelve months. Cash needs for the first half of 2009 were funded primarily from investing and
financing activities, as investments in marketable securities matured and were not reinvested,
proceeds from the issuance of the 2014 Notes and the issuance of common stock under equity
incentive plans.
Operating Activities
Cash used in operating activities of $18.3 million for the six months ended June 30, 2009 was
primarily attributable to the net loss adjusted for non-cash items, including stock-based
compensation expense, non-cash interest expense and depreciation/amortization expense. Changes in
operating assets and liabilities for the six months ended June 30, 2009 primarily included
decreases in accrued litigation expenses due to recognition of proceeds of $5.0 million from an
insurance company related to the derivative and class action lawsuits offset by
increases in accounts payable due to the timing of vendor payments.
Cash used in operating activities of $25.7 million for the six months ended June 30, 2008 was
primarily attributable to the net loss adjusted for non-cash items, including the tax provision
related to the deferred tax asset valuation allowance, stock-based compensation expense,
depreciation and amortization expense and non-cash interest expense. Changes in operating assets
and liabilities for the six months ended June 30, 2008 primarily included a decrease in accrued
litigation expenses due to payments related to the class action lawsuit settlement.
Investing Activities
Cash provided by investing activities of approximately $64.1 million for the six months ended
June 30, 2009 primarily consisted of proceeds from the maturities of available-for-sale marketable
securities of $164.2 million, partially offset by purchases of available-for-sale marketable
securities of $97.0 million. In addition, we paid $1.6 million to acquire intangible assets and
$1.5 million to acquire property and equipment, primarily computer software licenses.
Cash provided by investing activities of approximately $51.4 million for the six months ended
June 30, 2008 primarily consisted of proceeds from the maturities and sales of available-for-sale
marketable securities of $305.1 million, partially offset by purchases of available-for-sale
marketable securities of $246.5 million. In addition, we purchased $7.0 million of property and
equipment, primarily computer software licenses.
Financing Activities
Cash provided by financing activities was $155.9 million for the six months ended June 30,
2009. We received $146.3 million from the issuance of the 2014 Notes during the period. Proceeds
received from the issuance of common stock under equity incentive plans totaled approximately $9.7
million.
Cash used in financing activities was $13.4 million for the six months ended June 30, 2008. We
repurchased stock with an aggregate price of $24.9 million under our share repurchase program. We
also made payments under installment payment plans to acquire software license agreements. During
the six months ended June 30, 2008, proceeds received from the issuance of common stock under
equity incentive plans totaled approximately $12.8 million.
We currently anticipate that existing cash, cash equivalents and marketable securities
balances and cash flows from operations will be adequate to meet our cash needs for at least the
next 12 months and to satisfy our cash requirement to pay for our zero coupon convertible senior
notes due in February 2010 with an aggregate principal amount of $137.0 million. We do not
anticipate any liquidity constraints as a result of either the current credit environment or
investment fair value fluctuations. We have no intent to sell, there is no requirement to sell and
we believe that we can recover the amortized cost of these investments. We have found no evidence
of impairment due to credit losses in our portfolio. We continually monitor the credit risk in our
portfolio and mitigate our credit risk exposures in accordance with our policies. We may also incur
additional expenditures related to future potential restructuring activities. As described
elsewhere in this Managements Discussion and Analysis of Financial Condition and Results of
Operations and this Quarterly Report on Form 10-Q, we are involved in ongoing litigation related
to our intellectual property and our past stock option investigation. Any adverse settlements or
judgments in any of this litigation could have a material adverse impact on our results of
operations, cash balances and cash flows in the period in which such events occur.
42
Contractual Obligations
On February 1, 2005, we issued $300.0 million aggregate principal amount of zero coupon
convertible senior notes (the 2010 Notes) due February 1, 2010 to Credit Suisse First Boston LLC
and Deutsche Bank Securities as initial purchasers who then sold the convertible notes to
institutional investors. We have elected to pay the principal amount of the 2010 Notes in cash when
they are due. Subsequently, we repurchased a total of $163.1 million face value of the outstanding
2010 Notes in 2005 and 2008. The aggregate principal amount of convertible notes outstanding as of
June 30, 2009 was $137.0 million, offset by an unamortized debt discount of $6.3 million. The debt
discount is expected to be amortized over the remaining seven months until maturity of the 2010 Notes.
See Note 15, Convertible Notes of Notes to Unaudited Condensed Consolidated Financial Statements,
for additional details.
On
June 29, 2009, we entered into an Indenture (the
Indenture) by and between us and U.S. Bank, National
Association, as trustee, relating to the issuance by us of $150.0 million aggregate principal amount of 5% convertible
senior notes due June 15, 2014 (the 2014 Notes). The aggregate principal amount of 2014 Notes
outstanding as of June 30, 2009 was $150.0 million, offset by unamortized debt discount of $57.5
million. The debt discount is expected to be amortized over the remaining 60 months until maturity
of the 2014 Notes on June 15, 2014. See Note 15, Convertible Notes of Notes to Unaudited
Condensed Consolidated Financial Statements, for additional details.
As of June 30, 2009, our material contractual obligations are (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due by Year |
|
|
|
|
|
|
|
Remainder |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
of 2009 |
|
|
2010 |
|
|
2011 |
|
|
2012 |
|
|
2013 |
|
|
Thereafter |
|
Contractual obligations(1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating leases |
|
$ |
12,825 |
|
|
$ |
4,941 |
|
|
$ |
6,668 |
|
|
$ |
747 |
|
|
$ |
469 |
|
|
$ |
|
|
|
$ |
|
|
Convertible notes |
|
|
286,950 |
|
|
|
|
|
|
|
136,950 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
150,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
299,775 |
|
|
$ |
4,941 |
|
|
$ |
143,618 |
|
|
$ |
747 |
|
|
$ |
469 |
|
|
$ |
|
|
|
$ |
150,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The above table does not reflect possible payments in connection with uncertain tax benefits
associated with FIN 48 of approximately $10.0 million, including $8.1 million recorded as a
reduction of long-term deferred tax assets and $1.9 million in long-term income taxes payable,
as of June 30, 2009. Although it is possible that some of the unrecognized tax benefits could
be settled within the next 12 months, we cannot reasonably estimate the outcome at this time. |
Share Repurchase Program
In October 2001, the Board approved a share repurchase program of our Common Stock,
principally to reduce the dilutive effect of employee stock options. To date, the Board has
approved the authorization to repurchase up to 19.0 million shares of our outstanding Common Stock
over an undefined period of time. During the six months ended June 30, 2009, we did not repurchase
any Common Stock. As of June 30, 2009, we had repurchased a cumulative total of approximately 16.8
million shares of our Common Stock with an aggregate price of approximately $233.8 million since
the commencement of this program. As of June 30, 2009, there remained an outstanding authorization
to repurchase approximately 2.2 million shares of our outstanding Common Stock.
We record stock repurchases as a reduction to stockholders equity. As prescribed by APB
Opinion No. 6, Status of Accounting Research Bulletins, we record a portion of the purchase price
of the repurchased shares as an increase to accumulated deficit when the cost of the shares
repurchased exceeds the average original proceeds per share received from the issuance of Common
Stock.
Critical Accounting Policies and Estimates
The discussion and analysis of our financial condition and results of operations are based
upon our condensed consolidated financial statements, which have been prepared in accordance with
accounting principles generally accepted in the United States. The preparation of these financial
statements requires us to make estimates and judgments that affect the reported amounts of assets,
liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. On
an ongoing basis, we evaluate our estimates, including those related to revenue recognition,
investments, income taxes, litigation and other contingencies. We base our estimates on historical
experience and on various other assumptions that are believed to be reasonable under the
circumstances, the results of which form the basis for making judgments about the carrying values
of assets and liabilities that are not readily apparent from other sources. Actual results may
differ from these estimates under different assumptions or conditions. Our critical accounting
estimates include those regarding (1) revenue recognition, (2) litigation, (3) income taxes and (4)
stock-based compensation. For a discussion of our critical accounting estimates, see Item 7.
Managements Discussion and Analysis of Financial Condition and
Results of Operations Critical Accounting Policies and Estimates in our Annual Report on
Form 10-K for the year ended December 31, 2008.
43
Marketable Securities
Available-for-sale securities are carried at fair value, based on quoted market prices, with
the unrealized gains or losses reported, net of tax, in stockholders equity as part of accumulated
other comprehensive income (loss). The amortized cost of debt securities is adjusted for
amortization of premiums and accretion of discounts to maturity, both of which are included in
interest and other income, net. Realized gains and losses are recorded on the specific
identification method and are included in interest and other income, net. We review our investments
in marketable securities for possible other than temporary impairments on a regular basis. If any
loss on investment is believed to be other than temporary, a charge will be recognized in
operations. In evaluating whether a loss on a debt security is other than temporary, we consider
the following factors: 1) our intent to sell the security, 2) if we intend to hold the security,
whether or not it is more likely than not that we will be required to sell the security before
recovery of the securitys amortized cost basis and 3) even if we intend to hold the security,
whether or not we expect the security to recover the entire amortized cost basis. Due to the high
credit quality and short term nature of our investments, there have been no other than temporary
impairments recorded to date. The classification of funds between short-term and long-term is based
on whether the securities are available for use in operations or other purposes.
Convertible Notes
See Note 15, Convertible Notes of Notes to Unaudited Condensed Consolidated Financial
Statements regarding the accounting policy in regards to the adoption of FSP APB 14-1 Accounting
for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including Partial
Cash Settlement).
Recent Accounting Pronouncements
See
Note 2, Summary of Significant Accounting Policies of Notes to Unaudited Condensed
Consolidated Financial Statements for discussion of recent accounting pronouncements including the
respective expected dates of adoption.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
We are exposed to financial market risks, primarily arising from the effect of interest rate
fluctuations on our investment portfolio. Interest rate fluctuation may arise from changes in the
markets view of the quality of the security issuer, the overall economic outlook, and the time to
maturity of our portfolio. We mitigate this risk by investing only in high quality, highly liquid
instruments. Securities with original maturities of one year or less must be rated by two of the
three industry standard rating agencies as follows: A1 by Standard & Poors, P1 by Moodys and/or
F-1 by Fitch. Securities with original maturities of greater than one year must be rated by two of
the following industry standard rating agencies as follows: AA- by Standard & Poors, Aa3 by
Moodys and/or AA- by Fitch. By corporate policy, we limit the amount of our credit exposure to
$10.0 million for any one issuer. Our policy requires that at least 10% of the portfolio be in
securities with a maturity of 90 days or less. In addition, we may make investments in U.S.
Treasuries, U.S. Agencies, corporate bonds and municipal bonds and notes with maturities up to 36
months. However, the bias of our investment portfolio is shorter maturities.
We invest our cash equivalents and marketable securities in a variety of U.S. dollar financial
instruments such as Treasuries, Government Agencies, Commercial Paper and Corporate Notes. Our
policy specifically prohibits trading securities for the sole purposes of realizing trading
profits. However, we may liquidate a portion of our portfolio if we experience unforeseen liquidity
requirements. In such a case if the environment has been one of rising interest rates we may
experience a realized loss, similarly, if the environment has been one of declining interest rates
we may experience a realized gain. As of June 30, 2009, we had an investment portfolio of fixed
income marketable securities of $476.9 million including cash equivalents. If market interest rates
were to increase immediately and uniformly by 10% from the levels as of June 30, 2009, the fair
value of the portfolio would decline by approximately $0.2 million. Actual results may differ
materially from this sensitivity analysis.
44
The table below summarizes the book value, fair value, unrealized gains and related weighted
average interest rates for our cash equivalents and marketable securities portfolio as of June 30,
2009 and December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2009 |
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Weighted |
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Rate of |
|
(dollars in thousands) |
|
Fair Value |
|
|
Book Value |
|
|
Gains |
|
|
Losses |
|
|
Return |
|
Money Market Funds |
|
$ |
311,452 |
|
|
$ |
311,452 |
|
|
$ |
|
|
|
$ |
|
|
|
|
0.19 |
% |
Municipal Bonds and Notes |
|
|
1,011 |
|
|
|
1,000 |
|
|
|
11 |
|
|
|
|
|
|
|
3.85 |
% |
U.S. Government Bonds and Notes |
|
|
116,514 |
|
|
|
115,691 |
|
|
|
823 |
|
|
|
|
|
|
|
2.10 |
% |
Corporate Notes, Bonds, and Commercial Paper |
|
|
47,873 |
|
|
|
47,604 |
|
|
|
284 |
|
|
|
(15 |
) |
|
|
2.82 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash equivalents and marketable securities |
|
|
476,850 |
|
|
|
475,747 |
|
|
|
1,118 |
|
|
|
(15 |
) |
|
|
|
|
Cash |
|
|
3,536 |
|
|
|
3,536 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash, cash equivalents and marketable securities |
|
$ |
480,386 |
|
|
$ |
479,283 |
|
|
$ |
1,118 |
|
|
$ |
(15 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008 |
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Weighted |
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Rate of |
|
(dollars in thousands) |
|
Fair Value |
|
|
Book Value |
|
|
Gains |
|
|
Losses |
|
|
Return |
|
Money Market Funds |
|
$ |
110,732 |
|
|
$ |
110,732 |
|
|
$ |
|
|
|
$ |
|
|
|
|
0.90 |
% |
Municipal Bonds and Notes |
|
|
1,000 |
|
|
|
1,000 |
|
|
|
|
|
|
|
|
|
|
|
3.85 |
% |
U.S. Government Bonds and Notes |
|
|
149,304 |
|
|
|
148,178 |
|
|
|
1,126 |
|
|
|
|
|
|
|
2.79 |
% |
Corporate Notes, Bonds, and Commercial Paper |
|
|
79,308 |
|
|
|
79,275 |
|
|
|
197 |
|
|
|
(164 |
) |
|
|
3.06 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash equivalents and marketable securities |
|
|
340,344 |
|
|
|
339,185 |
|
|
|
1,323 |
|
|
|
(164 |
) |
|
|
|
|
Cash |
|
|
5,509 |
|
|
|
5,509 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash, cash equivalents and marketable securities |
|
$ |
345,853 |
|
|
$ |
344,694 |
|
|
$ |
1,323 |
|
|
$ |
(164 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
We bill our customers in U.S. dollars. Although the fluctuation of currency exchange rates may
impact our customers, and thus indirectly impact us, we do not attempt to hedge this indirect and
speculative risk. Our overseas operations consist primarily of small business development offices
in any one country and one design center in India. We monitor our foreign currency exposure;
however, as of June 30, 2009, we believe our foreign currency exposure is not material enough to
warrant foreign currency hedging.
The fair value of our convertible notes is subject to interest rate risk, market risk and
other factors due to the convertible feature. The fair value of the convertible notes will
generally increase as interest rates fall and decrease as interest rates rise. In addition, the
fair value of the convertible notes will generally increase as our common stock prices increase and
decrease as the stock prices fall. The interest and market value changes affect the fair value of
our convertible notes but do not impact our financial position, cash flows or results of operations
due to the fixed nature of the debt obligations. Additionally, we do not carry the convertible
notes at fair value. We present the fair value of the convertible notes for required disclosure
purposes. The following table summarizes certain information related to our convertible notes as of
June 30, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Given a 10% |
|
|
Fair Value Given a 10% |
|
(in thousands) |
|
Fair Value |
|
|
Increase in Market Prices |
|
|
Decrease in Market Prices |
|
Zero Coupon Convertible Senior Notes due 2010 |
|
$ |
137,806 |
|
|
$ |
151,587 |
|
|
$ |
124,025 |
|
5% Convertible Senior Notes due 2014 |
|
|
157,200 |
|
|
|
172,920 |
|
|
|
141,480 |
|
|
|
|
|
|
|
|
|
|
|
Total convertible notes |
|
$ |
295,006 |
|
|
$ |
324,507 |
|
|
$ |
265,505 |
|
|
|
|
|
|
|
|
|
|
|
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures designed to ensure that information required to
be disclosed in the reports we file or submit pursuant to the Securities and Exchange Act of 1934
as amended (Exchange Act) is recorded, processed, summarized and reported within the time periods
specified in the rules and forms of the Securities and Exchange Commission, and that such
information is accumulated and communicated to our management, including our Chief Executive
Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required
disclosure.
Management, with the participation of the Chief Executive Officer and Chief Financial Officer,
evaluated the effectiveness of the design and operation of our disclosure controls and procedures
as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act as of the end of the period covered
by this report. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer
have concluded that, as of June 30, 2009, our disclosure controls and procedures were effective.
45
Changes in Internal Control Over Financial Reporting
There were no changes in internal control over financial reporting during the quarter ended
June 30, 2009 that have materially affected, or are reasonably likely to materially affect, our
internal control over financial reporting.
PART IIOTHER INFORMATION
Item 1. Legal Proceedings
The information required by this item regarding legal proceedings is incorporated by reference
to the information set forth in Note 13 Litigation and Asserted Claims of Notes to Unaudited
Condensed Consolidated Financial Statements of this Form 10-Q.
Item 1A. Risk Factors
Because of the following factors, as well as other variables affecting our operating results,
past financial performance may not be a reliable indicator of future performance, and historical
trends should not be used to anticipate results or trends in future periods. See also Note
Regarding Forward-looking Statements elsewhere in this report.
Litigation, Regulation and Business Risks Related to our Intellectual Property
We face current and potential adverse determinations in litigation stemming from our efforts to
protect and enforce our patents and intellectual property, which could broadly impact our
intellectual property rights, distract our management and cause a substantial decline in our
revenue and stock price.
We seek to diligently protect our intellectual property rights. In connection with the
extension of our licensing program to SDR SDRAM-compatible and DDR SDRAM-compatible products, we
became involved in litigation related to such efforts against different parties in multiple
jurisdictions. In each of these cases, we have claimed infringement of certain of our patents,
while the manufacturers of such products have generally sought damages and a determination that the
patents in suit are invalid, unenforceable, and not infringed. Among other things, the opposing
parties have alleged that certain of our patents are unenforceable because we engaged in document
spoliation, litigation misconduct and/or acted improperly during our 1991 to 1995 participation in
the JEDEC standard setting organization (including allegations of antitrust violations and unfair
competition). See Note 13, Litigation and Asserted Claims of Notes to Unaudited Condensed
Consolidated Financial Statements.
There can be no assurance that any or all of the opposing parties will not succeed, either at
the trial or appellate level, with such claims or counterclaims against us or that they will not in
some other way establish broad defenses against our patents, achieve conflicting results, or
otherwise avoid or delay paying royalties for the use of our patented technology. Moreover, there
is a risk that if one party prevails against us, other parties could use the adverse result to
defeat or limit our claims against them; conversely, there can be no assurance that if we prevail
against one party, we will succeed against other parties on similar claims, defenses, or
counterclaims. In addition, there is the risk that the pending litigations and other circumstances
may cause us to accept less than what we now believe to be fair consideration in settlement.
Any of these matters, whether or not determined in our favor or settled by us, is costly, may
cause delays (including delays in negotiating licenses with other actual or potential licensees),
will tend to discourage future design partners, will tend to impair adoption of our existing
technologies and divert the efforts and attention of our management and technical personnel from
other business operations. In addition, we may be unsuccessful in our litigation if we have
difficulty obtaining the cooperation of former employees and agents who were involved in our
business during the relevant periods related to our litigation and are now needed to assist in
cases or testify on our behalf. Furthermore, any adverse determination or other resolution in
litigation could result in our losing certain rights beyond the rights at issue in a particular
case, including, among other things: our being effectively barred from suing others for violating
certain or all of our intellectual property rights; our patents being held invalid or unenforceable
or not infringed; our being subjected to significant liabilities; our being required to seek
licenses from third parties; our being prevented from licensing our patented technology; or our
being required to renegotiate with current licensees on a temporary or permanent basis. Even if we
are successful in our litigation, there is no guarantee that the applicable opposing parties will
be able to pay any damages awards timely or at all as a result of financial difficulties or
otherwise. Delay or any or all of these adverse results could cause a substantial decline in our
revenue and stock price.
46
An adverse resolution by or with a governmental agency, such as the European Commission or patent
offices, could result in severe limitations on our ability to protect and license our intellectual
property, and would cause our revenue to decline substantially.
From time to time, we are subject to proceedings by government agencies. These proceedings, or
one by any other governmental agency, may result in adverse determinations against us or in other
outcomes that could limit our ability to enforce or license our intellectual property, and could
cause our revenue to decline substantially.
In addition, third parties have and may attempt to use adverse findings by a government agency
to limit our ability to enforce or license our patents in private litigations and to assert claims
for monetary damages against us. Although we have successfully defeated certain attempts to do so,
there can be no assurance that other third parties will not be successful in the future or that
additional claims or actions arising out of adverse findings by a government agency will not be
asserted against us.
Further, third parties have sought and may seek review and reconsideration of the
patentability of inventions claimed in certain of our patents by U.S. Patent and Trademark Office
(PTO) and/or the European Patent Office (the EPO). Currently, we are subject to several
re-examination proceedings, including proceedings initiated by NVIDIA, Samsung, Hynix and Micron as
a defensive action in connection with our litigation against those companies. An adverse decision
by the PTO or EPO could invalidate some or all of these patent claims and could also result in
additional adverse consequences affecting other related U.S. or European patents, including in our
intellectual property litigation. If a sufficient number of such patents are impaired, our ability
to enforce or license our intellectual property would be significantly weakened and this could
cause our revenue to decline substantially.
The pendency of any governmental agency acting as described above may impair our ability to
enforce or license our patents or collect royalties from existing or potential licensees, as our
litigation opponents may attempt to use such proceedings to delay or otherwise impair any pending
cases and our existing or potential licensees may await the final outcome of any proceedings before
agreeing to new licenses or pay royalties.
Litigation or other third-party claims of intellectual property infringement could require us to
expend substantial resources and could prevent us from developing or licensing our technology on a
cost-effective basis.
Our research and development programs are in highly competitive fields in which numerous third
parties have issued patents and patent applications with claims closely related to the subject
matter of our research and development programs. We have also been named in the past, and may in
the future be named, as a defendant in lawsuits claiming that our technology infringes upon the
intellectual property rights of third parties. In the event of a third-party claim or a successful
infringement action against us, we may be required to pay substantial damages, to stop developing
and licensing our infringing technology, to develop non-infringing technology, and to obtain
licenses, which could result in our paying substantial royalties or our granting of cross licenses
to our technologies. Threatened or ongoing third-party claims or infringement actions may prevent
us from pursuing additional development and licensing arrangements for some period. For example, we
may discontinue negotiations with certain customers for additional licensing of our patents due to
the uncertainty caused by our ongoing litigation on the terms of such licenses or of the terms of
such licenses on our litigation. We may not be able to obtain licenses from other parties at a
reasonable cost, or at all, which could cause us to expend substantial resources, or result in
delays in, or the cancellation of, new product.
If we are unable to successfully protect our inventions through the issuance and enforcement of
patents, our operating results could be adversely affected.
We have an active program to protect our proprietary inventions through the filing of patents.
There can be no assurance, however, that:
47
|
|
|
any current or future U.S. or foreign patent applications will be approved and not be
challenged by third parties; |
|
|
|
|
our issued patents will protect our intellectual property and not be challenged by third
parties; |
|
|
|
|
the validity of our patents will be upheld; |
|
|
|
|
our patents will not be declared unenforceable; |
|
|
|
|
the patents of others will not have an adverse effect on our ability to do business; |
|
|
|
|
Congress or the U.S. courts or foreign countries will not change the nature or scope of
rights afforded patents or patent owners or alter in an adverse way the process for seeking
patents; |
|
|
|
|
changes in law will not be implemented that will affect our ability to protect and
enforce our patents and other intellectual property; |
|
|
|
|
new legal theories and strategies utilized by our competitors will not be successful; or |
|
|
|
|
others will not independently develop similar or competing chip interfaces or design
around any patents that may be issued to us. |
If any of the above were to occur, our operating results could be adversely affected.
Our inability to protect and own the intellectual property we create would cause our business to
suffer.
We rely primarily on a combination of license, development and nondisclosure agreements,
trademark, trade secret and copyright law, and contractual provisions to protect our non-patentable
intellectual property rights. If we fail to protect these intellectual property rights, our
licensees and others may seek to use our technology without the payment of license fees and
royalties, which could weaken our competitive position, reduce our operating results and increase
the likelihood of costly litigation. The growth of our business depends in large part on the use of
our intellectual property in the products of third party manufacturers, and our ability to enforce
intellectual property rights against them to obtain appropriate compensation. In addition,
effective trade secret protection may be unavailable or limited in certain foreign countries.
Although we intend to protect our rights vigorously, if we fail to do so, our business will suffer.
We rely upon the accuracy on our licensees recordkeeping, and any inaccuracies or payment disputes
for amounts owed to us under our licensing agreements may harm our results of operations.
Many of our license agreements require our licensees to document the manufacture and sale of
products that incorporate our technology and report this data to us on a quarterly basis. While
licenses with such terms give us the right to audit books and records of our licensees to verify
this information, audits rarely are undertaken because they can be expensive, time consuming, and
potentially detrimental to our ongoing business relationship with our licensees. Therefore, we rely
on the accuracy of the reports from licensees without independently verifying the information in
them. Our failure to audit our licensees books and records may result in our receiving more or
less royalty revenue than we are entitled to under the terms of our license agreements. If we
conduct royalty audits in the future, such audits may trigger disagreements over contract terms
with our licensees and such disagreements could hamper customer relations, divert the efforts and
attention of our management from normal operations and impact our business operations and financial
condition.
48
We may not be able to satisfy, and Qimonda may avoid, the requirements under the Qimonda settlement
and license agreement that would require Qimonda to pay us up to an additional $100.0 million in
royalty payments.
On March 21, 2005, we entered into a settlement and patent license agreement with Infineon
(and its former parent Siemens), which was assigned to Qimonda (formerly Infineons DRAM
operations) in October 2006 in connection with Infineons spin-off of Qimonda. The agreement, among
other things, provides that if we enter into licenses with certain other DRAM manufacturers,
Qimonda will be required to make certain additional payments to us that may aggregate up to $100.0
million. As we have not yet succeeded in entering into these additional license agreements
necessary to trigger Qimondas obligations, Qimondas quarterly payment ceased as of the first
quarter of 2008. The quarterly payments with Qimonda will not recommence until we enter into
additional license agreements with certain other DRAM manufacturers. We may not succeed in entering
into these additional license agreements necessary to trigger Qimondas obligations under the
settlement and patent license agreement to pay to us additional amounts, thereby reducing the value
of the settlement and license agreement to us.
In addition, Qimonda commenced insolvency proceedings in Germany in January 2009, with the
intent to restructure Qimonda and its affiliates. On June 8, 2009, Rambus received written notice
from the court appointed administrator in the insolvency proceedings of Qimonda (the
Administrator) of the Administrators election of Non-Performance under Section 103 of the German
Insolvency Code with respect to the license agreement. According to this notice, the Administrator
has determined the license agreement is no longer enforceable by either party as of April 1, 2009.
Furthermore, the notice states that the Administrator has terminated the license agreement. The
Administrator has indicated that he is commencing a liquidation of Qimondas assets. As a result of
the Administrators actions, we may be unable to obtain any future payment from Qimonda or its
successors.
An acquisition by Qimonda of a third party DRAM manufacturer could make it more difficult for us to
obtain royalty rates we believe are appropriate and could reduce the number of companies in our
antitrust litigation.
On or about July 8, 2008, we amended our patent license agreement with Qimonda. As discussed
above, while the status and enforceability of the amended agreement is unclear due to Qimondas
insolvency proceedings, the amended agreement grants a supplemental term license of approximately
the same scope as the original term license originally provided for in the agreement, but specifies
that in the event Infineon ceases to control or otherwise own a majority of Qimonda shares, certain
competitors would not accede to this license upon such competitors acquisition of control of
Qimonda. Furthermore, such acquiring competitor would not receive the benefit of a release from
Rambus for past damages, including past infringement of Rambus patent portfolio. To the extent
that Qimonda acquires another company, including such certain competitors, the acquired company
would accede to the license and would be eligible to receive the benefit of the release from Rambus
for past damages. Following such an acquisition by Qimonda, the combined entity would be required
to pay a stepped up payment calculated in accordance with the percentage increase in the DRAM
volume brought about by the acquisition. Such an increase in the payments could make it more
difficult for us to obtain the royalties we believe are appropriate from the market as a whole.
Such an acquisition by Qimonda of any of the certain competitors would in addition reduce the
number of companies from which we may seek compensation for the antitrust injury alleged by us in
our pending price-fixing action in San Francisco. Except in the case of the certain competitors,
the extension of any such benefits to a third party entity, whether acquiring control or otherwise
a majority of shares of Qimonda or being acquired by Qimonda, could, in addition, result in the
release of claims to such third party entity, thus reducing the number of companies from which we
may seek compensation for patent damages.
Any dispute regarding our intellectual property may require us to indemnify certain licensees, the
cost of which could severely hamper our business operations and financial condition.
In any potential dispute involving our patents or other intellectual property, our licensees
could also become the target of litigation. While we generally do not indemnify our licensees, some
of our license agreements provide limited indemnities, some require us to provide technical support
and information to a licensee that is involved in litigation involving use of our technology, and
we may agree to indemnify others in the future. Our indemnification and support obligations could
result in substantial expenses. In addition to the time and expense required for us to indemnify or
supply such support to our licensees, a licensees development, marketing and sales of licensed
semiconductors could be severely disrupted or shut
49
down as a result of litigation, which in turn could severely hamper our business operations
and financial condition.
Risks Associated With Our Business, Industry and Market Conditions
If market leaders do not adopt our innovations, our results of operations could decline.
An important part of our strategy is to penetrate market segments for chip interfaces by
working with leaders in those market segments. This strategy is designed to encourage other
participants in those segments to follow such leaders in adopting our chip interfaces. If a high
profile industry participant adopts our chip interfaces but fails to achieve success with its
products or adopts and achieves success with a competing chip interface, our reputation and sales
could be adversely affected. In addition, some industry participants have adopted, and others may
in the future adopt, a strategy of disparaging our memory solutions adopted by their competitors or
a strategy of otherwise undermining the market adoption of our solutions.
We target system companies to adopt our chip interface technologies, particularly those that
develop and market high volume business and consumer products, which have traditionally been
focused on PCs, including PC graphics processors, and video game consoles, but also are expanding
to include HDTVs, cellular and digital phones, PDAs, digital cameras and other consumer electronics
that incorporate all varieties of memory and chip interfaces. In particular, our strategy includes
gaining acceptance of our technology in high volume consumer applications, including video game
consoles, such as the Sony PlayStation®2 and Sony PLAYSTATION®3, HDTVs and
set top boxes. We are subject to many risks beyond our control that influence whether or not a
particular system company will adopt our chip interfaces, including, among others:
|
|
|
competition faced by a system company in its particular industry; |
|
|
|
|
the timely introduction and market acceptance of a system companys products; |
|
|
|
|
the engineering, sales and marketing and management capabilities of a system company; |
|
|
|
|
technical challenges unrelated to our chip interfaces faced by a system company in
developing its products; |
|
|
|
|
the financial and other resources of the system company; |
|
|
|
|
the supply of semiconductors from our licensees in sufficient quantities and at
commercially attractive prices; |
|
|
|
|
the ability to establish the prices at which the chips containing our chip interfaces are
made available to system companies; and |
|
|
|
|
the degree to which our licensees promote our chip interfaces to a system company. |
There can be no assurance that consumer products that currently use our technology will
continue to do so, nor can there be any assurance that the consumer products that incorporate our
technology will be successful in their segments thereby generating expected royalties, nor can
there be any assurance that any of our technologies selected for licensing will be implemented in a
commercially developed or distributed product.
If any of these events occur and market leaders do not successfully adopt our technologies,
our strategy may not be successful and, as a result, our results of operations could decline.
50
We operate in an industry that is highly cyclical and in which the number of our potential
customers may be in decline as a result of industry consolidation, and we face intense competition
that may cause our results of operations to suffer.
The semiconductor industry is intensely competitive and has been impacted by price erosion,
rapid technological change, short product life cycles, cyclical market patterns and increasing
foreign and domestic competition. As the semiconductor industry is highly cyclical, significant
economic downturns characterized by diminished demand, erosion of average selling prices,
production overcapacity and production capacity constraints could affect the semiconductor
industry. We are currently experiencing such a period of economic downturn. As a result, we may
face a reduced number of licensing wins, tightening of customers operating budgets, difficulty or
inability of our customers to pay our licensing fees, extensions of the approval process for new
licenses, as discussed below, and consolidation among our customers, all of which may adversely
affect the demand for our technology and may cause us to experience substantial period-to-period
fluctuations in our operating results.
Many of our customers operate in industries that have experienced significant declines as a
result of the current economic downturn. In particular, DRAM manufacturers, which make up a
majority of our existing and potential licensees, have suffered material losses and other adverse
effects to their businesses. These factors may result in industry consolidation as companies seek
to reduce costs and improve profitability through business combinations. Consolidation among our
existing DRAM and other customers may result in loss of revenues under existing license agreements.
Consolidation among companies in the DRAM and other industries within which we license our
technology may reduce the number of future licensees for our products and services. In either case,
consolidation in the DRAM and other industries in which we operate may negatively impact our
short-term and long-term business prospects, licensing revenues and results of operations.
Some semiconductor companies have developed and support competing logic chip interfaces
including their own serial link chip interfaces and parallel bus chip interfaces. We also face
competition from semiconductor and intellectual property companies who provide their own DDR memory
chip interface technology and solutions. In addition, most DRAM manufacturers, including our XDR
licensees, produce versions of DRAM such as SDR, DDRx and GDDRx SDRAM which compete with XDR chips.
We believe that our principal competition for memory chip interfaces may come from our licensees
and prospective licensees, some of which are evaluating and developing products based on
technologies that they contend or may contend will not require a license from us. In addition, our
competitors are also taking a system approach similar to ours in seeking to solve the application
needs of system companies. Many of these companies are larger and may have better access to
financial, technical and other resources than we possess. Wider applications of other developing
memory technologies, including FLASH memory, may also pose competition to our licensed memory
solutions.
JEDEC has standardized what it calls extensions of DDR, known as DDR2 and DDR3. Other efforts
are underway to create other products including those sometimes referred to as GDDR4 and GDDR5, as
well as new ways to integrate products such as system-in-package DRAM. To the extent that these
alternatives might provide comparable system performance at lower or similar cost than XDR memory
chips, or are perceived to require the payment of no or lower royalties, or to the extent other
factors influence the industry, our licensees and prospective licensees may adopt and promote
alternative technologies. Even to the extent we determine that such alternative technologies
infringe our patents, there can be no assurance that we would be able to negotiate agreements that
would result in royalties being paid to us without litigation, which could be costly and the
results of which would be uncertain. In the industry standard and leadership serial link chip
interface business, we face additional competition from semiconductor companies that sell discrete
transceiver chips for use in various types of systems, from semiconductor companies that develop
their own serial link chip interfaces, as well as from competitors, such as ARM and Synopsys, which
license similar serial link chip interface products and digital controllers. At the 10 Gb/s speed,
competition will also come from optical technology sold by system and semiconductor companies.
There are standardization efforts under way or completed for serial links from standard bodies such
as PCI-SIG and OIF. We may face increased competition from these types of consortia in the future
that could negatively impact our serial link chip interface business.
In the FlexIO processor bus chip interface market segment, we face additional competition from
semiconductor companies who develop their own parallel bus chip interfaces, as well as competitors
who license similar parallel bus chip interface products. We may also see competition from industry
consortia or standard setting bodies that could negatively impact our FlexIO processor bus chip
interface business.
51
As with our memory chip interface products, to the extent that competitive alternatives to our
serial or parallel logic chip interface products might provide comparable system performance at
lower or similar cost, or are perceived to require the payment of no or lower royalties, or to the
extent other factors influence the industry, our licensees and prospective licensees may adopt and
promote alternative technologies, which could negatively impact our memory and logic chip interface
business.
If for any of these reasons we cannot effectively compete in these primary market segments,
our results of operations could suffer.
In order to grow, we may have to invest more resources in research and development than
anticipated, which could increase our operating expenses and negatively impact our operating
results.
If new competitors, technological advances by existing competitors, our entry into new
markets, or other competitive factors require us to invest significantly greater resources than
anticipated in our research and development efforts, our operating expenses would increase. For the
three and six months ended June 30, 2009, research and development expenses were $15.7 million and
$33.6 million, respectively, including stock-compensation of approximately $2.2 million and $5.0
million, respectively. If we are required to invest significantly greater resources than
anticipated in research and development efforts without an increase in revenue, our operating
results could decline. Research and development expenses are likely to fluctuate from time to time
to the extent we make periodic incremental investments in research and development, and these
investments may be independent of our level of revenue. In order to grow, which may include
entering new markets, we anticipate that we will continue to devote substantial resources to
research and development. We expect these expenses to increase in absolute dollars in the
foreseeable future due to the increased complexity and the greater number of products under
development as well as selectively hiring additional employees.
Our revenue is concentrated in a few customers, and if we lose any of these customers, our revenue
may decrease substantially.
We have a high degree of revenue concentration, with our top five licensees representing
approximately 79% and 78% of our revenue for the three and six months ended June 30, 2009,
respectively, and 69% and 68% of our revenue for the three and six months ended June 30, 2008,
respectively. For the three months ended June 30, 2009, revenue from Fujitsu, Sony, AMD, Toshiba
and NEC each accounted for 10% or more of our total revenue. For the six months ended June 30,
2009, revenue from Fujitsu, NEC, AMD, Sony and Panasonic each accounted for 10% or more of our
total revenue. For the three months ended June 30, 2008, revenue from Fujitsu, Elpida, Sony, AMD
and Panasonic each accounted for 10% or more of our total revenue. For the six months ended June
30, 2008, revenue from Fujitsu, Elpida and Sony each accounted for 10% or more of our total
revenue. We may continue to experience significant revenue concentration for the foreseeable
future.
In addition, some of our commercial agreements require us to provide certain customers with
the lowest royalty rate that we provide to other customers for similar technologies, volumes and
schedules. These clauses may limit our ability to effectively price differently among our
customers, to respond quickly to market forces, or otherwise to compete on the basis of price. The
particular licensees which account for revenue concentration have varied from period to period as a
result of the addition of new contracts, expiration of existing contracts, industry consolidation,
the expiration of deferred revenue schedules under existing contracts, and the volumes and prices
at which the licensees have recently sold licensed semiconductors to system companies. These
variations are expected to continue in the foreseeable future, although we anticipate that revenue
will continue to be concentrated in a limited number of licensees.
We are in negotiations with licensees and prospective licensees to reach patent license
agreements for DRAM devices and DRAM controllers. We expect that patent license royalties will
continue to vary from period to period based on our success in renewing existing license agreements
and adding new licensees, as well as the level of variation in our licensees reported shipment
volumes, sales price and mix, offset in part by the proportion of licensee payments that are fixed.
A number of our material license agreements are scheduled to expire throughout 2010, including
those of three licensees, each of which accounted for more
52
than 10% of our revenue in 2008. We are currently in discussions with those licensees whose
agreements are scheduled to expire in 2010. However, we cannot provide any assurance that we will
reach agreement on renewal terms or that the royalty rates we will be entitled to receive under the
new agreements will be as favorable to us as our current agreements. If we are unsuccessful in
renewing any of these patent license agreements, our results of operations may decline
significantly.
Weakening global economic conditions may adversely affect demand for our products and services.
Our operations and performance depend significantly on worldwide economic conditions, and the
U.S. and world economies are undergoing a period of recession. Uncertainty about current global
economic conditions poses a risk as consumers and businesses may postpone spending in response to
tighter credit, negative financial news and declines in income or asset values, which could have a
material negative effect on the demand for the products of our licensees in the foreseeable future.
Other factors that could influence demand include continuing increases in fuel and energy costs,
competitive pressures, including pricing pressures, from companies that have competing products,
changes in the credit market, conditions in the residential real estate and mortgage markets,
consumer confidence, and other macroeconomic factors affecting consumer spending behavior. If our
licensees experience reduced demand for their products as a result of economic conditions or
otherwise, our business and results of operations could be harmed. In addition, a continuation of
current conditions in credit markets could limit our ability to obtain external financing to fund
our operations and capital expenditures.
If our commercial counterparties are unable to fulfill their financial and other obligations to us,
our business and results of operations may be affected adversely.
The downturn in worldwide economic conditions threatens the financial health of our commercial
counterparties, including companies with whom we have entered into licensing arrangements and
litigation settlements that provide for ongoing payments to us, and their ability to fulfill their
financial and other obligations to us. As discussed in further detail above, we are a party to a
settlement and licensing agreement with Qimonda, which provides that, subject to certain conditions
that have not yet been fulfilled, Qimonda may be required to make additional royalty payments to us
of up to $100.0 million. In January 2009, Qimonda filed for bankruptcy, and in June 2009, we
terminated their license. On June 8, 2009, Rambus received notice that the Qimonda Administrator
has determined that the license agreement is no longer enforceable by either party as of April 1,
2009. In addition, Spansion, which was one of our licensees and owes us an immaterial amount, filed
a voluntary petition for Chapter 11 reorganization relief in Delaware federal court in March 2009,
and is now operating as debtors-in-possession under the jurisdiction of the bankruptcy court.
Because bankruptcy courts have the power to modify or cancel contracts of the petitioner which
remain subject to future performance and alter or discharge payment obligations related to
pre-petition debts, we may receive less than all of the payments that we would otherwise be
entitled to receive from Qimonda or Spansion as a result of their bankruptcy proceedings. If we are
unable to collect all of such payments owed to us, or if other of our commercial counterparties
enter into bankruptcy or otherwise seek to renegotiate their financial obligations to us as a
result of the deterioration of their financial health, our business and results of operations may
be affected adversely.
Our business and operating results may be harmed if we undertake any restructuring activities or if
we are unable to manage growth in our business.
From time to time, we may undertake to restructure our business, such as the reduction in our
workforce that we announced in August 2008. There are several factors that could cause a
restructuring to have an adverse effect on our business, financial condition and results of
operations. These include potential disruption of our operations, the development of our
technology, the deliveries to our customers and other aspects of our business. Employee morale and
productivity could also suffer and we may lose employees whom we want to keep. Loss of sales,
service and engineering talent, in particular, could damage our business. Any restructuring would
require substantial management time and attention and may divert management from other important
work. Employee reductions or other restructuring activities also cause us to incur restructuring
and related expenses such as severance expenses. Moreover, we could encounter delays in executing
any restructuring plans, which could cause further disruption and additional unanticipated expense.
53
Our business historically has experienced periods of rapid growth that have placed, and may
continue to place, significant demands on our managerial, operational and financial resources. In
managing this growth, we must continue to improve and expand our management, operational and
financial systems and controls. We also need to continue to expand, train and manage our employee
base. We cannot assure you that we will be able to timely and effectively meet demand and maintain
the quality standards required by our existing and potential customers and licensees. If we
ineffectively manage our growth or we are unsuccessful in recruiting and retaining personnel, our
business and operating results will be harmed.
If we cannot respond to rapid technological change in the semiconductor industry by developing new
innovations in a timely and cost effective manner, our operating results will suffer.
The semiconductor industry is characterized by rapid technological change, with new
generations of semiconductors being introduced periodically and with ongoing improvements. We
derive most of our revenue from our chip interface technologies that we have patented. We expect
that this dependence on our fundamental technology will continue for the foreseeable future. The
introduction or market acceptance of competing chip interfaces that render our chip interfaces less
desirable or obsolete would have a rapid and material adverse effect on our business, results of
operations and financial condition. The announcement of new chip interfaces by us could cause
licensees or system companies to delay or defer entering into arrangements for the use of our
current chip interfaces, which could have a material adverse effect on our business, financial
condition and results of operations. We are dependent on the semiconductor industry to develop test
solutions that are adequate to test our chip interfaces and to supply such test solutions to our
customers and us.
Our continued success depends on our ability to introduce and patent enhancements and new
generations of our chip interface technologies that keep pace with other changes in the
semiconductor industry and which achieve rapid market acceptance. We must continually devote
significant engineering resources to addressing the ever increasing need for higher speed chip
interfaces associated with increases in the speed of microprocessors and other controllers. The
technical innovations that are required for us to be successful are inherently complex and require
long development cycles, and there can be no assurance that our development efforts will ultimately
be successful. In addition, these innovations must be:
|
|
|
completed before changes in the semiconductor industry render them obsolete; |
|
|
|
|
available when system companies require these innovations; and |
|
|
|
|
sufficiently compelling to cause semiconductor manufacturers to enter into licensing
arrangements with us for these new technologies. |
Finally, significant technological innovations generally require a substantial investment
before their commercial viability can be determined. There can be no assurance that we have
accurately estimated the amount of resources required to complete the projects, or that we will
have, or be able to expend, sufficient resources required for these types of projects. In addition,
there is market risk associated with these products, and there can be no assurance that unit
volumes, and their associated royalties, will occur. If our technology fails to capture or maintain
a portion of the high volume consumer market, our business results could suffer.
If we cannot successfully respond to rapid technological changes in the semiconductor industry
by developing new products in a timely and cost effective manner our operating results will suffer.
Some of our revenue is subject to the pricing policies of our licensees over whom we have no
control.
We have no control over our licensees pricing of their products and there can be no assurance
that licensee products using or containing our chip interfaces will be competitively priced or will
sell in significant volumes. One important requirement for our memory chip interfaces is for any
premium charged by our licensees in the price of memory and controller chips over alternatives to
be reasonable in comparison to the perceived benefits of the chip interfaces. If the benefits of
our technology do not match
54
the price premium charged by our licensees, the resulting decline in sales of products
incorporating our technology could harm our operating results.
Our licensing cycle is lengthy and costly and our marketing and licensing efforts may be
unsuccessful.
The process of persuading customers to adopt and license our chip interface technologies can
be lengthy and, even if successful, there can be no assurance that our chip interfaces will be used
in a product that is ultimately brought to market, achieves commercial acceptance, or results in
significant royalties to us. We generally incur significant marketing and sales expenses prior to
entering into our license agreements, generating a license fee and establishing a royalty stream
from each licensee. The length of time it takes to establish a new licensing relationship can take
many months. In addition, our ongoing intellectual property litigation and regulatory actions have
and will likely continue to have an impact on our ability to enter into new licenses and renewals
of licenses. As such, we may incur costs in any particular period before any associated revenue
stream begins. If our marketing and sales efforts are very lengthy or unsuccessful, then we may
face a material adverse effect on our business and results of operations as a result of delay or
failure to obtain royalties.
Future revenue is difficult to predict for several reasons, and our failure to predict revenue
accurately may cause us to miss analysts estimates and result in our stock price declining.
Our lengthy and costly license negotiation cycle makes our future revenue difficult to predict
because we may not be successful in entering into licenses with our customers on our estimated
timelines.
While some of our license agreements provide for fixed, quarterly royalty payments, many of
our license agreements provide for volume-based royalties. The sales volume and prices of our
licensees products in any given period can be difficult to predict. As a result, our actual
results may differ substantially from analyst estimates or our forecasts in any given quarter.
In addition, a portion of our revenue comes from development and support services provided to
our licensees. Depending upon the nature of the services, a portion of the related revenue may be
recognized ratably over the support period, or may be recognized according to contract accounting.
Contract revenue accounting may result in deferral of the service fees to the completion of the
contract, or may be recognized over the period in which services are performed on a
percentage-of-completion basis. There can be no assurance that the product development schedule for
these projects will not be changed or delayed. All of these factors make it difficult to predict
future licensing revenue and may result in our missing previously announced earnings guidance or
analysts estimates which would likely cause our stock price to decline.
Our quarterly and annual operating results are unpredictable and fluctuate, which may cause our
stock price to be volatile and decline.
Since many of our revenue components fluctuate and are difficult to predict, and our expenses
are largely independent of revenue in any particular period, it is difficult for us to accurately
forecast revenue and profitability. Factors other than those set forth above, which are beyond our
ability to control or assess in advance, that could cause our operating results to fluctuate
include:
|
|
|
semiconductor and system companies acceptance of our chip interface products; |
|
|
|
the success of high volume consumer applications, such as the Sony
PLAYSTATION® 3; |
|
|
|
the dependence of our royalties upon fluctuating sales volumes and prices of licensed
chips that include our technology; |
|
|
|
the seasonal shipment patterns of systems incorporating our chip interface products; |
|
|
|
the loss of any strategic relationships with system companies or licensees; |
|
|
|
semiconductor or system companies discontinuing major products incorporating our chip
interfaces;
|
55
|
|
|
the unpredictability of litigation results and the timing and amount of any litigation
expenses; |
|
|
|
changes in our chip and system company customers development schedules and levels of
expenditure on research and development; |
|
|
|
our licensees terminating or failing to make payments under their current contracts or
seeking to modify such contracts, whether voluntarily or as a result of financial
difficulties; |
|
|
|
changes in our strategies, including changes in our licensing focus and/or possible
acquisitions of companies with business models different from our own; and |
|
|
|
changes in the economy and credit market and their effects upon demand for our technology
and the products of our licensees. |
For the three months ended June 30, 2009 and 2008, royalties accounted for 92% and 90%,
respectively, of our total revenue. For the six months ended June 30, 2009 and 2008, royalties
accounted for 94% and 87%, respectively, of our total revenue.
We believe that royalties will continue to represent a majority of total revenue for the
foreseeable future. Royalties are generally recognized in the quarter in which we receive a report
from a licensee regarding the sale of licensed chips in the prior quarter; however, royalties are
recognized only if collectability is assured. As a result of these uncertainties and effects being
outside of our control, royalty revenue is difficult to predict and makes it difficult to develop
accurate financial forecasts, which could cause our stock price to become volatile and decline.
A substantial portion of our revenue is derived from sources outside of the United States and this
revenue and our business generally are subject to risks related to international operations that
are often beyond our control.
For the three and six months ended June 30, 2009, revenue from our sales to international
customers constituted approximately 83% and 82% of our total revenue, respectively. For the three
and six months ended June 30, 2008, revenue from our sales to international customers constituted
approximately 84% and 83% of our total revenue, respectively. We currently have international
operations in India (design), Japan (business development), Taiwan (business development) and
Germany (business development). As a result of our continued focus on international markets, we
expect that future revenue derived from international sources will continue to represent a
significant portion of our total revenue.
To date, all of the revenue from international licensees has been denominated in U.S. dollars.
However, to the extent that such licensees sales to systems companies are not denominated in U.S.
dollars, any royalties which are based as a percentage of the customers sales that we receive as a
result of such sales could be subject to fluctuations in currency exchange rates. In addition, if
the effective price of licensed semiconductors sold by our foreign licensees were to increase as a
result of fluctuations in the exchange rate of the relevant currencies, demand for licensed
semiconductors could fall, which in turn would reduce our royalties. We do not use financial
instruments to hedge foreign exchange rate risk.
Our international operations and revenue are subject to a variety of risks which are beyond
our control, including:
|
|
|
export controls, tariffs, import and licensing restrictions and other trade barriers; |
|
|
|
profits, if any, earned abroad being subject to local tax laws and not being repatriated
to the United States or, if repatriation is possible, limited in amount; |
|
|
|
changes to tax codes and treatment of revenue from international sources, including being
subject to foreign tax laws and potentially being liable for paying taxes in that foreign
jurisdiction;
|
56
|
|
|
foreign government regulations and changes in these regulations; |
|
|
|
social, political and economic instability; |
|
|
|
lack of protection of our intellectual property and other contract rights by
jurisdictions in which we may do business to the same extent as the laws of the United
States; |
|
|
|
changes in diplomatic and trade relationships; |
|
|
|
cultural differences in the conduct of business both with licensees and in conducting
business in our international facilities and international sales offices; |
|
|
|
operating centers outside the United States; |
|
|
|
hiring, maintaining and managing a workforce remotely and under various legal systems;
and |
We and our licensees are subject to many of the risks described above with respect to
companies which are located in different countries, particularly home video game console and PC
manufacturers located in Asia and elsewhere. There can be no assurance that one or more of the
risks associated with our international operations could not result in a material adverse effect on
our business, financial condition or results of operations.
We may make future acquisitions or enter into mergers, strategic transactions or other arrangements
that could cause our business to suffer.
As part of our strategic initiatives, we currently are evaluating, and expect to continue to
engage in, investments in or acquisitions of companies, products or technologies, and the entry
into strategic transactions or other arrangements. These acquisitions, investments, transactions or
arrangements are likely to range in size, some of which may be significant. If we make an
acquisition, we may experience difficulty integrating that companys or divisions personnel and
operations, which could negatively affect our operating results. In addition:
|
|
|
the key personnel of the acquired company may decide not to work for us; |
|
|
|
we may experience additional financial and accounting challenges and complexities in
areas such as tax planning, cash management and financial reporting; |
|
|
|
our ongoing business may be disrupted or receive insufficient management attention; |
|
|
|
we may not be able to recognize the cost savings or other financial benefits we
anticipated; and |
|
|
|
our increasing international presence resulting from acquisitions may increase our
exposure to international currency, tax and political risks. |
In connection with future acquisitions or mergers, strategic transactions or other
arrangements, we may incur substantial expenses regardless of whether the transaction occurs. In
addition, we may be required to assume the liabilities of the companies we acquire. By assuming the
liabilities, we may incur liabilities such as those related to intellectual property infringement
or indemnification of customers of acquired businesses for similar claims, which could materially
and adversely affect our business. We may have to incur debt or issue equity securities to pay for
any future acquisition, the issuance of which could involve restrictive covenants or be dilutive to
our existing stockholders.
57
Unanticipated changes in our tax rates or in the tax laws and regulations could expose us to
additional income tax liabilities which could affect our operating results and financial condition.
We are subject to income taxes in both the United States and various foreign jurisdictions.
Significant judgment is required in determining our worldwide provision (benefit) for income taxes
and, in the ordinary course of business, there are many transactions and calculations where the
ultimate tax determination is uncertain. Our effective tax rate could be adversely affected by
changes in the mix of earnings in countries with differing statutory tax rates, changes in the
valuation of deferred tax assets and liabilities, changes in tax laws and regulations as well as
other factors. For example, the state of California has enacted regulations which limit the use of
net operating losses and certain tax credits, including research and development credits, that
apply for 2008 and 2009, which could lead to an increase in our effective tax rate. Our tax
determinations are regularly subject to audit by tax authorities and developments in those audits
could adversely affect our income tax provision. Although we believe that our tax estimates are
reasonable, the final determination of tax audits or tax disputes may be different from what is
reflected in our historical income tax provisions which could affect our operating results.
Our results of operations could vary as a result of the methods, estimates, and judgments we use in
applying our accounting policies.
The methods, estimates, and judgments we use in applying our accounting policies have a
significant impact on our results of operations, including the reported amounts of assets,
liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities, as
described elsewhere in this report. On an ongoing basis, we evaluate our estimates, including those
related to revenue recognition, such as percentage-of-completion contracts, investments, income
taxes, litigation, goodwill and intangibles, and other contingencies. Such methods, estimates, and
judgments are, by their nature, subject to substantial risks, uncertainties, and assumptions, and
factors may arise over time that lead us to change our methods, estimates, and judgments. In
addition, actual results may differ from these estimates under different assumptions or conditions.
Changes in those methods, estimates, and judgments could significantly affect our results of
operations. In particular, the calculation of share-based compensation expense under Statement of
Financial Accounting Standards No. 123(R) (SFAS No. 123(R)) requires us to use valuation
methodologies and a number of assumptions, estimates, and conclusions regarding matters such as
expected forfeitures, expected volatility of our share price, and the exercise behavior of our
employees. Furthermore, there are no means, under applicable accounting principles, to compare and
adjust our expense if and when we learn about additional information that may affect the estimates
that we previously made, with the exception of changes in expected forfeitures of share-based
awards. Factors may arise that lead us to change our estimates and assumptions with respect to
future share-based compensation arrangements, resulting in variability in our share-based
compensation expense over time. Changes in forecasted stock-based compensation expense could impact
our cost of contract revenue, research and development expenses, marketing, general and
administrative expenses and our effective tax rate, which could have an adverse impact on our
results of operations.
If we are unable to attract and retain qualified personnel, our business and operations could
suffer.
Our success is dependent upon our ability to identify, attract, compensate, motivate and
retain qualified personnel, especially engineers, who can enhance our existing technologies and
introduce new technologies. Competition for qualified personnel, particularly those with
significant industry experience, is intense, in particular in the San Francisco Bay Area where we
are headquartered and in the area of Bangalore, India where we have a design center. We are also
dependent upon our senior management personnel. The loss of the services of any of our senior
management personnel, or key sales personnel in critical markets, or critical members of staff, or
of a significant number of our engineers could be disruptive to our development efforts or business
relationships and could cause our business and operations to suffer.
58
Decreased effectiveness of equity-based compensation could adversely affect our ability to attract
and retain employees.
We have historically used stock options and other forms of stock-based compensation as key
components of our employee compensation program in order to align employees interests with the
interests of our stockholders, encourage employee retention and provide competitive compensation
and benefit packages. As a result of changes in previous accounting principles, we have incurred
increased compensation costs associated with our stock-based compensation programs. In addition, if
we face any difficulty relating to obtaining stockholder approval of our equity compensation plans,
it could make it harder or more expensive for us to grant stock-based payments to employees in the
future. As a result of these factors leading to lower equity compensation of our employees, we may
find it difficult to attract, retain and motivate employees, and any such difficulty could
materially adversely affect our business.
Our operations are subject to risks of natural disasters, acts of war, terrorism or widespread
illness at our domestic and international locations, any one of which could result in a business
stoppage and negatively affect our operating results.
Our business operations depend on our ability to maintain and protect our facility, computer
systems and personnel, which are primarily located in the San Francisco Bay Area. The San Francisco
Bay Area is in close proximity to known earthquake fault zones. Our facility and transportation for
our employees are susceptible to damage from earthquakes and other natural disasters such as fires,
floods and similar events. Should an earthquake or other catastrophes, such as fires, floods, power
loss, communication failure or similar events disable our facilities, we do not have readily
available alternative facilities from which we could conduct our business, which stoppage could
have a negative effect on our operating results. Acts of terrorism, widespread illness and war
could also have a negative effect at our international and domestic facilities.
Risks Related to Corporate Governance and Capitalization Matters
The price of our common stock may fluctuate significantly, which may make it difficult for holders
to resell their shares when desired or at attractive prices.
Our common stock is listed on the NASDAQ Global Select Market under the symbol RMBS. The
trading price of our common stock has been subject to wide fluctuations which may continue in the
future in response to, among other things, the following:
|
|
|
new litigation or developments in current litigation, including an unfavorable outcome to us
from court proceedings relating to our litigation with Hynix, Micron, Nanya, Samsung and
NVIDIA; |
|
|
|
|
any progress, or lack of progress, real or perceived, in the development of products that
incorporate our chip interfaces; |
|
|
|
|
our signing or not signing new licensees; |
|
|
|
|
announcements of our technological innovations or new products by us, our licensees or our
competitors; |
|
|
|
|
positive or negative reports by securities analysts as to our expected financial results; and |
|
|
|
|
developments with respect to patents or proprietary rights and other events or factors. |
In addition, the stock market in general, and prices for companies in our industry in
particular, have experienced extreme volatility that often has been unrelated to the operating
performance of such companies.
59
These broad market and industry fluctuations may adversely affect the price of our common
stock, regardless of our operating performance. Because our issued senior convertible notes are
convertible into shares of our common stock, volatility or depressed prices of our common stock
could have a similar effect on the trading price of our notes. In addition, the existence of the
notes may encourage short selling in our common stock by market participants because the conversion
of the notes could depress the price of our common stock.
Sales of substantial amounts of shares of our common stock in the public market, or the
perception that those sales may occur, could cause the market price of our common stock to decline.
In addition, lack of positive performance in our stock price may adversely affect our ability
to retain key employees.
Compliance with changing regulation of corporate governance and public disclosure may result in
additional expenses.
Changing laws, regulations and standards relating to corporate governance and public
disclosure, including new Securities and Exchange Commission (the SEC), regulations and Nasdaq
rules, are creating uncertainty for companies such as ours. These new or changed laws, regulations
and standards are subject to varying interpretations in many cases due to their lack of
specificity, and as a result, their application in practice may evolve over time as new guidance is
provided by regulatory and governing bodies, which could result in continuing uncertainty regarding
compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance
practices. We intend to invest resources to comply with evolving laws, regulations and standards,
and this investment may result in increased general and administrative expenses and a diversion of
management time and attention from revenue generating activities to compliance activities. If our
efforts to comply with new or changed laws, regulations and standards differ from the activities
intended by regulatory or governing bodies due to ambiguities related to practice, our reputation
may be harmed.
We have been party to, and may in the future be subject to, lawsuits relating to securities law
matters which may result in unfavorable outcomes and significant judgments, settlements and legal
expenses which could cause our business, financial condition and results of operations to suffer.
In connection with our stock option investigation, we and certain of our current and former
officers and directors, as well as our current auditors, were subject to several stockholder
derivative actions, securities fraud class actions and/or individual lawsuits filed in federal
court against us and certain of our current and former officers and directors. The complaints
generally allege that the defendants violated the federal and state securities laws and state law
claims for fraud and breach of fiduciary duty. While we have settled the derivative and securities
fraud class actions, the individual lawsuits continue to be adjudicated. For more information about
the historic litigation described above, see Note 13, Litigation and Asserted Claims of Notes to
Unaudited Condensed Consolidated Financial Statements. The amount of time to resolve these current
and any future lawsuits is uncertain, and these matters could require significant management and
financial resources which could otherwise be devoted to the operation of our business. Although we
have expensed or accrued for certain liabilities that we believe will result from certain of these
actions, the actual costs and expenses to defend and satisfy all of these lawsuits and any
potential future litigation may exceed our current estimated accruals, possibly significantly.
Unfavorable outcomes and significant judgments, settlements and legal expenses in the litigation
related to our past stock option granting practices and in any future litigation concerning
securities law claims could have material adverse impacts on our business, financial condition,
results of operations, cash flows and the trading price of our common stock.
We are leveraged financially, which could adversely affect our ability to adjust our business to
respond to competitive pressures and to obtain sufficient funds to satisfy our future research and
development needs, and to defend our intellectual property.
We have indebtedness. On February 1, 2005, we issued $300 million aggregate principal amount
of senior convertible notes due February 2010, referred to as the 2010 Notes, of which $137 million
aggregate
60
principal amount remained outstanding as of June 30, 2009. We recently have issued $172.5
million aggregate principal amount of our senior convertible notes due June 2014, referred to as
the 2014 Notes.
The degree to which we are leveraged could have important consequences, including, but not
limited to, the following:
|
|
|
our ability to obtain additional financing in the future for working
capital, capital expenditures, acquisitions, litigation, general
corporate or other purposes may be limited; |
|
|
|
|
a substantial portion of our cash flows from operations will be
dedicated to the payment of the principal of our indebtedness as we
are required to pay the principal amount of our convertible notes in
cash upon conversion if specified conditions are met or when due,
including the $137 million aggregate principal amount of the 2010
Notes upon their maturity in February 2010; |
|
|
|
|
if upon any conversion of our notes we are required to satisfy our
conversion obligation with shares of our common stock or we are
required to pay a make-whole premium with shares of our common
stock, our existing stockholders interest in us would be diluted; and |
|
|
|
|
we may be more vulnerable to economic downturns, less able to
withstand competitive pressures and less flexible in responding to
changing business and economic conditions. |
A failure to comply with the covenants and other provisions of our debt instruments could
result in events of default under such instruments, which could permit acceleration of all of our
notes. Any required repayment of our notes as a result of a fundamental change or other
acceleration would lower our current cash on hand such that we would not have those funds available
for use in our business.
If we are at any time unable to generate sufficient cash flow from operations to service our
indebtedness when payment is due, we may be required to attempt to renegotiate the terms of the
instruments relating to the indebtedness, seek to refinance all or a portion of the indebtedness or
obtain additional financing. There can be no assurance that we will be able to successfully
renegotiate such terms, that any such refinancing would be possible or that any additional
financing could be obtained on terms that are favorable or acceptable to us.
Provisions of our outstanding notes could discourage an acquisition of us by a third party.
Certain provisions of our outstanding 2010 Notes and 2014 Notes could make it more difficult
or more expensive for a third party to acquire us. Upon the occurrence of certain transactions
constituting a fundamental change, holders of the notes will have the right, at their option, to
require us to repurchase, at a cash repurchase price equal to 100% of the principal amount plus
accrued and unpaid interest on the notes, all of their notes or any portion of the principal amount
of such notes in multiples of $1,000. We may also be required to issue additional shares of our
common stock upon conversion of such notes in the event of certain fundamental changes.
If securities or industry analysts change their recommendations regarding our stock adversely, our
stock price and trading volume could decline.
The trading market for our common stock is influenced by the research and reports that
industry or securities analysts publish about us, our business or our market. If one or more of the
analysts who cover us change their recommendation regarding our stock adversely, our stock price
would likely decline. If one or more of these analysts ceases coverage of our company or fails to
regularly publish reports on us, we could lose visibility in the financial markets, which in turn
could cause our stock price or trading volume to decline.
61
Our restated certificate of incorporation and bylaws, our stockholder rights plan, and Delaware law
contain provisions that could discourage transactions resulting in a change in control, which may
negatively affect the market price of our common stock into which the notes are convertible.
Our restated certificate of incorporation, our bylaws, our stockholder rights plan and
Delaware law contain provisions that might enable our management to discourage, delay or prevent
a change in control. In addition, these provisions could limit the price that investors would be
willing to pay in the future for shares of our common stock. Pursuant to such provisions:
|
|
|
our board of directors is authorized, without prior stockholder approval, to create and
issue preferred stock, commonly referred to as blank check preferred stock, with rights
senior to those of common stock; |
|
|
|
|
our board of directors is staggered into two classes, only one of which is elected at each
annual meeting; |
|
|
|
|
stockholder action by written consent is prohibited; |
|
|
|
|
nominations for election to our board of directors and the submission of matters to be
acted upon by stockholders at a meeting are subject to advance notice requirements; |
|
|
|
|
certain provisions in our bylaws and certificate of incorporation such as notice to
stockholders, the ability to call a stockholder meeting, advance notice requirements and
action of stockholders by written consent may only be amended with the approval of
stockholders holding 66 2/3% of our outstanding voting stock; |
|
|
|
|
the ability of our stockholders to call special meetings of stockholders is prohibited; and |
|
|
|
|
our board of directors is expressly authorized to make, alter or repeal our bylaws. |
In addition, the provisions in our stockholder rights plan could make it more difficult for a
potential acquirer to consummate an acquisition of our company. We are also subject to Section 203
of the Delaware General Corporation Law, which provides, subject to enumerated exceptions, that if
a person acquires 15% or more of our outstanding voting stock, the person is an interested
stockholder and may not engage in any business combination with us for a period of three years
from the time the person acquired 15% or more of our outstanding voting stock.
|
|
|
Item 2. |
|
Unregistered Sales of Equity Securities and Use of Proceeds |
Not Applicable
|
|
|
Item 3. |
|
Defaults Upon Senior Securities |
Not Applicable
62
|
|
|
Item 4. |
|
Submission of Matters to a Vote of Security Holders |
On April 30, 2009, Rambus held its 2009 Annual Meeting of Stockholders. The matters voted upon
at the meeting for stockholders of record as of February 27, 2009 and the vote with respect to each
such matter are set forth below:
(i) Election of five Class II directors for a term of two years expiring in 2011:
|
|
|
|
|
|
|
|
|
|
|
For |
|
Withheld |
J. Thomas Bentley. |
|
|
67,992,840 |
|
|
|
25,149,644 |
|
P. Michael Farmwald, Ph.D. |
|
|
82,831,308 |
|
|
|
10,311,176 |
|
Penelope A. Herscher |
|
|
68,990,332 |
|
|
|
24,152,152 |
|
David Shrigley |
|
|
67,753,658 |
|
|
|
25,388,826 |
|
Eric Stang |
|
|
68,983,311 |
|
|
|
24,159,173 |
|
(ii) Approval of amending our 2006 Equity Incentive Plan to increase the number of shares of
common stock of the Company reserved for issuance under such plan by 6,500,000 shares:
|
|
|
|
|
|
|
For: 38,793,103
|
|
Against: 21,388,408
|
|
Abstentions: 187,049
|
|
Broker Non-Votes: 32,773,924 |
(iii) Ratification of appointment of PricewaterhouseCoopers LLP as our independent registered
public accounting firm for the period ending December 31, 2009:
|
|
|
|
|
For: 79,249,448
|
|
Against: 12,461,011
|
|
Abstentions: 1,432,025 |
The term for Class I continuing directors
Bruce Dunlevie, Dr. Sunlin Chou, Mark Horowitz, Ph.D., Harold Hughes
and Abraham Sofaer will expire at the annual meeting of stockholders to
be held in 2010. There were 104,448,165 shares issued, outstanding and eligible to vote at the
meeting.
|
|
|
Item 5. |
|
Other Information |
Not Applicable
Refer to the Exhibit Index of this quarterly report on Form 10-Q.
63
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
RAMBUS INC.
|
|
Date: July 31, 2009 |
By: |
/s/ Satish Rishi
|
|
|
|
Satish Rishi |
|
|
|
Senior Vice President, Finance and
Chief Financial Officer |
|
|
64
INDEX TO EXHIBITS
|
|
|
Exhibit |
|
|
Number |
|
Description of Document |
|
1.1 (1)
|
|
Underwriting Agreement dated June 23, 2009 among Rambus Inc. and Credit Suisse Securities (USA) LLC and J.P.
Morgan Securities Inc. |
|
|
|
3.1 (2)
|
|
Amended and Restated Certificate of Incorporation of Registrant filed May 29, 1997. |
|
|
|
3.2 (3)
|
|
Certificate of Amendment of Amended and Restated Certificate of Incorporation of Registrant filed June 14, 2000. |
|
|
|
3.3 (4)
|
|
Amended and Restated Bylaws of Registrant dated November 13, 2007. |
|
|
|
4.1 (5)
|
|
Indenture between Rambus Inc. and U.S. Bank, National Association, dated as of June 29, 2009. |
|
|
|
4.2 (6)
|
|
Form of Note for Rambus Inc.s 5% Convertible Senior Notes due 2014. |
|
|
|
12.1 (7)
|
|
Computation of ratio of earnings to fixed charges. |
|
|
|
31.1
|
|
Certification of Principal Executive Officer, pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities
Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
31.2
|
|
Certification of Principal Financial Officer, pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities
Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
32.1
|
|
Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002. |
|
|
|
32.2
|
|
Certification of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002. |
|
|
|
(1) |
|
Incorporated by reference to Exhibit 1.1 to the Form 8-K filed on June 29, 2009. |
|
(2) |
|
Incorporated by reference to Exhibit 3.1 to the Form 10-K filed on December 15, 1997. |
|
(3) |
|
Incorporated by reference to Exhibit 3.1 to the Form 10-Q filed on May 4, 2001. |
|
(4) |
|
Incorporated by reference to Exhibit 3.3 to the Form 10-Q filed on August 4, 2008. |
|
(5) |
|
Incorporated by reference to Exhibit 4.1 to the Form 8-K filed on June 29, 2009. |
|
(6) |
|
Incorporated by reference to Exhibit 4.1 to the Form 8-K filed on June 29, 2009. |
|
(7) |
|
Incorporated by reference to Exhibit 12.1 to the Form S-3 filed on June 22, 2009. |
65